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CHAPTER I 
 
INTRODUCTION 
 
 In this introductory chapter, I primarily focus on striatal excitatory 
glutamatergic synaptic transmission as well as the anatomy and molecular 
mechanisms underlying motor learning and the formation of goal-directed and 
habit based learning.  I further consider the role of dopamine in the modulation of 
glutamatergic transmission, including alterations in glutamatergic synaptic 
transmission, plasticity, and morphology following dopamine depletion and 
subsequent levodopa administration.  I further compare and contrast long lasting 
synaptic plasticity and its mechanisms in hippocampus with striatal plasticity.  
Furthermore, I introduce an important kinase, CaMKII, as well as the GluN2B 
subunit of the NMDAR and their role in synaptic plasticity.  Finally, I review 
medium spiny neuron excitability and its modulation by numerous players 
including a novel role for CaMKII.  The work in this area will not only improve the 
basic understanding of excitatory transmission in the striatum and the role of 
CaMKII in these processes including the formation of normal motor repertoires, 
but also will lend understanding to neurodegenerative disorders, addiction and 
other striatal-based disorders.   
 The basal ganglia are a collection of subcortical nuclei that subserve a 
variety of behaviors, including motor planning, procedural learning, and 
motivation state   Although there is no universal agreement on which nuclei 
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comprise the basal ganglia (early anatomists used basal ganglia to refer to all 
large subcortical masses, including the thalamus), the term today generally refers 
to the neostriatum (caudate nucleus and putamen) and its projection targets.   
 As knowledge has accrued concerning the anatomical organization of the 
striatum, including its characteristic cell types and efferent projections, the term 
neostriatum has reduced to the simpler term striatum.  The striatum 
encompasses a dorsal portion (with its pallidal and nigral targets) as well as the 
ventral striatum, including the nucleus accumbens and its targets in the ventral 
pallidum.  While anatomical studies have revealed an overarching theme for the 
dorsal and ventral striatum, subdivisions within each of these structures have 
become apparent, with corresponding functional specialization.  For example, 
within the dorsal striatum, the dorsomedial aspect appears to be associated with 
goal-directed learning in rodents, while the dorsolateral striatum is associated 
with habit learning (Yin and Knowlton, 2006). The ventral striatum includes the 
multi-compartment nucleus accumbens (shell, core, and septal pole) and the 
olfactory tubercle, and plays a critical role in translating motivational states into 
goal-directed behavior (Robbins et al., 2008).  
Given the diverse behavioral conditions in which striatal function appears 
critical, it is not surprising that there are a number of disorders that are 
associated with basal ganglia pathology.  Among these are Parkinson’s and 
Huntington’s diseases, dystonia, and Tourette’s syndrome.  Several psychiatric 
conditions, including obsessive-compulsive disorder, substance abuse, and 
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schizophrenia, also appear in part to be reflecting changes in basal ganglia 
function.  
 
Basal Ganglia Circuitry  
 As noted above, a formal definition of the basal ganglia is lacking.  Our 
current informal use of the term has evolved over the past century as advances 
in our understanding of the anatomy of the brain have grown.  Today most 
consider the basal ganglia to be a collection of subcortical structures with 
interconnected neurons.  Such a loose definition encompasses the striatum, 
containing both interneurons and medium spiny neurons, the latter type of cell 
projecting to several downstream sites.  Targets of the rodent dorsal striatum 
include the globus pallidus, subthalamic nucleus, and substantia nigra.  From 
these targets, projections are directed to thalamic relay nuclei, which in turn 
innervate various neocortical regions.  Finally, the cortex projects in a 
topographically-defined manner back onto the striatum.  Differences in the 
topographical organization of these projection systems are thought to relate to 
different functional attributes of the striatum (Figure 1).  
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Figure 1.  Simplified diagram of basal ganglia circuitry.  Excitatory 
glutamatergic connections are indicated by green arrows, inhibitory 
GABAergic connections by red arrows, and modulatory dopaminergic 
connections by black arrows.  Dotted arrows from the striatum to the GPi/SNR 
mark the direct and indirect pathways.  GPe, globus pallidus external segment; 
GPi, globus pallidus internal segment; SNR, substantia nigra pars reticulata; 
SNC, substantia nigra pars compacta; STN, subthalamic nucleus; PF, 
parafascicular nucleus; IL, intralaminar thalamic nucleus; MEA, midbrain 
extrapyramidal area; SC, superior colliculus    
5 
 
 The afferents that innervate the striatum are not typically included in the 
definition of basal ganglia.  This is a somewhat surprising omission, particularly 
because all parts of the cortex innervate the striatum, thus rendering the striatum 
a funnel through which cortical information is relayed back to the cortex to hone 
subsequent motor and cognitive acts.  Another major input to the dorsal striatum 
of the rodent originates in the thalamic central medial complex (including the 
central medial, centrolateral, and paracentral nuclei) and the parafascicular 
nucleus.  These thalamostriatal neurons, like their corticostriatal counterparts, 
are glutamatergic (Smith et al., 2004).  The third and final major input to the 
striatum originates in the ventral midbrain dopamine cell groups of the substantia 
nigra, retrorubral field, and ventral tegmental area.  There are a restricted 
number of other “minor” afferents, including those from the globus pallidus, 
ventral pallidum and contiguous basal forebrain, as well as the serotonin neurons 
of the dorsal and median raphe in the upper brainstem.  The ventral striatum, 
including the nucleus accumbens, which abuts both the septum and the striatum, 
receives inputs from sites adjacent to those that innervate the dorsal striatum, 
thus defining a parallel set of ventral basal ganglia structures.  Although one 
might guess that the connections of the various parts of the basal ganglia are 
fully known, it is becoming clear even after the advent of the modern era of 
neuroanatomical tract-tracing methods, that there are gaps in our knowledge.  
 The major type of striatal neuron is the medium spiny neuron (MSN).   
Approximately 95% of striatal neurons are MSNs, with a cell body of medium size 
(~9-17 µm in diameter) and radially extending dendrites that are densely studded 
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with dendritic spines.   These GABAergic MSNs are the projection neurons of the 
striatum (Tepper et al., 2007).    
 Different portions of the relatively long dendrites of MSNs, with their high 
density of dendritic spines, are targeted by various inputs to the neuron (Bolam et 
al., 2000). Recurrent collaterals of one MSN often terminate on the soma or 
proximal-most dendrite of another MSN (Taverna et al., 2008; Chuhma et al., 
2011).  Striatal interneurons similarly synapse onto the soma or most proximal 
dendritic segment of MSNs (Kita et al., 1990; Bennett and Bolam, 1994).    In 
contrast, cortical afferents synapse onto spines located more distally on the 
dendrite, as do the terminals of dopamine neurons in the substantia nigra (Kemp 
and Powell, 1971; Hersch et al., 1995).  A single cortical terminal generally 
synapses with a single dendritic spine (Kincaid et al., 1998).  Thus, even modest 
changes in the numbers of MSN dendritic spines, particularly those on distal 
portions of the dendrite, can have major effects on ability of afferent volleys to be 
propagated to the cell body and thence to projection targets of MSNs (Plotkin et 
al., 2011).  
 MSNs, despite their morphological similarities, are not a homogeneous 
population of cells. Indeed, subtle variations in the dendritic tree of MSNs have 
led one group to characterize five different types of MSNs on structural grounds, 
although the great majority of MSNs fall into one class (Chang et al., 1982).  
Medium spiny neurons can also be differentiated on the basis of their projection 
targets, the receptors they express, and the co-transmitters in addition to GABA 
that they possess; these three factors co-segregate to yield two major 
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populations of MSNs.   One type of MSN sends a dense projection to the globus 
pallidus (GP), with the other type densely innervating the substantia nigra (SN).  
Retrograde tract tracing studies from these sites have consistently revealed two 
non-overlapping populations of MSNs.  The MSNs that innervate the SN form the 
so-called direct pathway, while those that project to the GP, neurons of which in 
turn send their projections to the SN, form the indirect pathway.  These two 
populations of MSNs differ on the basis of the dopamine receptor they express, 
with the direct pathway cells expressing the D1 receptor and the striatopallidal 
indirect pathway cells expressing the D2 receptor. Expression of other dopamine 
receptors, including the D3 receptor of the D2 class of dopamine receptors 
follows the D1/D2 segregation to different MSNs under basal conditions but not in 
pathophysiological states.  Finally, MSNs can be differentiated on the basis of 
their co-transmitter.  Direct pathway D1-expressing MSNs uses tachykinin 
peptides such as substance P as a co-transmitter, while D2-expressing 
striatopallidal MSNs contain enkephalin.    
 The direct and indirect pathway MSNs have figured prominently in models 
of basal ganglia function, with these two striatofugal pathways contributing to 
opposing effects on thalamic output to the cortex.  Activation of the direct 
pathway disinhibits the thalamus, increasing output to the cortex and promoting 
intended movement, while activation of the indirect pathway further inhibits 
thalamocortical neurons preventing unintended movements.  These ideas have 
figured prominently in our approach to diseases of the basal ganglia.  For 
example, it is hypothesized that there is an imbalance of these two pathways in 
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Parkinson’s disease, tipping the balance in favor of the indirect pathway and 
therefore inhibiting voluntary movement.   
 While this model has been invaluable in guiding research into the 
pathophysiology of parkinsonism, over the years it has become clear that various 
aspects of the model are incorrect and that the model often lacks predictive 
validity (DeLong and Wichmann, 2009).  Moreover, the structural basis for the 
differences in MSNs now appears to reflect a limitation of the retrograde-tract 
tracing methods originally used to label the two types of cells.  Thus, more recent 
single cell labeling studies have revealed that essentially all MSNs project to both 
the GP and SN, but with markedly different axonal arbors (Wu et al., 2000).   The 
direct MSNs have a large axonal plexus in the SN, with a very small axon 
terminal array in the GP–so small that it is insufficient to accumulate significant 
amounts of the retrograde transporter.  Conversely, the axons of indirect pathway 
MSNs collateralize extensively in the GP but have a very small axonal arbor in 
the SN.  While strictly speaking these data belie the concept of the direct and 
indirect pathways, functional data indicate that striatal efferent projections do 
indeed segregate into two classes, with one type of MSN primarily modulating 
the SN and the other the GP (Squire, 2003).   The idea of the direct and indirect 
pathways having opposing effects on behavior has undergone a renaissance 
recently with the use of optogenetic approaches to exclusively stimulate the 
direct or indirect pathway in vivo (Kravitz et al., 2010).     
 A very different type of segregation of MSNs from the direct and indirect 
pathway distinction can be seen when examining the intra-striatal spatial 
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localization of MSNs. The striatum which seems uniform at first glance under a 
light microscope can be further divided into unique compartments based of 
immunohistochemical staining patterns and connectivity. The most commonly 
used marker to define these regions is the mu opioid receptor.  Mu opioid 
receptor-expressing clusters of cells have been called striosomes or patches, 
and occupy about 15% of the volume of the striatum, with the much larger diffuse 
compartment named the matrix (Gerfen, 1992a).  MSNs that contribute to the 
direct and indirect pathways are found in both compartments, yet direct pathway 
MSNs in the patch compartment project to the substantia nigra pars compacta 
(SNc), instead of the substantia nigra pars reticulata (SNr) (Gerfen, 1984).   In 
contrast to MSNs that contribute to the direct and indirect pathways, which are 
intermingled throughout the striatum, distinct compartments of MSNs that 
express the mu opioid receptor (Herkenham and Pert, 1981), substance P 
(Bolam et al., 1988), but lack cholinergic markers (Graybiel and Ragsdale, 1978) 
can be seen as patches throughout the striatum.  Superimposed and surrounding 
these patches is the larger matrix area containing MSNs that do not express the 
mu opioid receptor and is instead rich in acetylcholinesterase, choline 
acetyltransferase (ChAT), somatostatin and calbindin (Graybiel and Ragsdale, 
1978; Gerfen et al., 1985; Graybiel et al., 1986).  These neurochemical 
localizations suggest that ChAT and somatostatin positive low threshold spiking 
interneurons reside predominantly in the matrix.  Fast spiking interneurons axons 
however have been observed in both regions (Cowan et al., 1990).  The 
patch/matrix organization is particularly important during development (Johnston 
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et al., 1990; Gerfen, 1992b).  Although these two compartments were at one time 
thought to receive inputs from spatially segregated cortical cells, more recent 
data have suggested that one cannot define these compartments based strictly 
on the origin of their cortical innervations.  Nonetheless, important functional 
differences have emerged, with relative activity in MSNs across the two 
compartments suggested to be disturbed in several basal ganglia disorders, 
including those involving disturbances of habit, such as obsessive-compulsive 
disorder and Tourette’s syndrome (Graybiel, 2008). 
 
Dorsal Striatal Subregions: Dorsal Lateral Versus Dorsal Medial Striatum 
 In primates the dorsal striatum is divided by the internal capsule 
separating the medially located caudate nucleus from the laterally positioned 
putamen.  Yet in rodents there is no real clear division between dorsal medial 
(caudate-like) and dorsal lateral (putamen-like) striatum. Instead the internal 
capsule which is made up of descending motor axon bundles honeycombs the 
striatum (Voorn et al., 2004).  While these rodent striatal regions lack defined 
boundaries, there are distinct anatomical and functional differences.  First, inputs 
to the dorsal medial striatum are primarily from association cortices while the 
dorsal lateral striatum receives inputs from the sensorimotor cortex (McGeorge 
and Faull, 1989).  The ventral striatum receives inputs from limbic and frontal 
cortex (Brog et al., 1993).  Other differences between regions include cell type 
preference and gene expression differences.  Parvalbumin positive fast spiking 
interneurons are more readily seen in lateral versus medial striatum, while 
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somatostatin-positive low threshold spiking neurons are more prevalent in medial 
striatum (Gerfen et al., 1985; Kita et al., 1990).  Cannabinoid CB1R are highly 
expressed in the dorsal lateral and nucleus accumbens but show little expression 
in the dorsal medial striatum (Herkenham et al., 1991).  In contrast, calbindin is 
highly expressed in dorsal medial striatum with very minimal expression in the 
dorsal lateral region (Gerfen et al., 1985).  Expression of the dopamine 
transporter is also highly enriched in the dorsal lateral striatum and less so in 
medial and ventral regions where catechol-O-methyltransferase (COMT) instead 
dominates (Matsumoto et al., 2003; Arbuthnott and Wickens, 2007).  Additional 
differences in subregion plasticity and behavior control will be reviewed later. 
        
The Dendritic Spine: Gateway to the Medium Spiny Neuron 
 Dendritic spines on striatal MSNs receive excitatory drive from the cortex 
and thalamus, the former relaying the consequences of higher order processing 
and the latter of ascending reticular drive to the MSN.   The cortical influence 
over MSNs has been intensively studied over the past generation.  The heads of 
MSN dendritic spines receive a single excitatory input from a cortical neuron, with 
the neck of the spine often being the site at which dopamine axons from the 
substantia nigra synapse, forming a synaptic triad.  At the individual spine level, 
this close spatial arrangement allows dopamine to modulate incoming excitatory 
glutamatergic drive (Kemp and Powell, 1971; Freund et al., 1984; Smith and 
Kieval, 2000).  While reports suggest that the frequency of dopaminergic 
synapses onto MSN spines is lower than originally proposed (Freund et al., 1984; 
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Groves et al., 1994), even in those cases where dopamine axons do not synapse 
onto the spine one finds that dopamine terminals are located within 1.0 µm of a 
spine, allowing volume (paracrine) transmission and emphasizing temporal as 
well as spatial regulation of MSNs (Arbuthnott and Wickens, 2007).  
Dopaminergic boutons represent nearly 10% of all the synapses in the striatum 
(Groves et al., 1994) and there is evidence that the dopamine released from this 
dense matrix of en passant synapses is not able to be adequately limited by 
reuptake or metabolic mechanisms suggesting an important role of dopamine in 
volume transmission (Cragg and Rice, 2004).  The primarily extrasynaptic 
localization of dopamine receptors at glutamatergic synapses (Hersch et al., 
1995; Yung et al., 1995) further fits with this model where they are linked to 
modulation of dendritic conductances and integration of synaptic depolarization 
(Nicola et al., 2000). 
 In addition to dopaminergic modulation of cortical drive onto MSNs at the 
level of the MSN spine, D2 heteroceptors on glutamatergic corticostriatal 
terminals can also tonically inhibit glutamate release from these terminals 
(Bamford et al., 2004).  The cortical influence over striatal cells is critical because 
MSNs have spontaneous fluctuations in their membrane potential, ranging from a 
relatively hyperpolarized “downstate” around -80mV to a more depolarized 
“upstate” around -50mV (Wilson and Groves, 1981).  While the downstate is 
maintained by a rapidly activating inwardly rectifying potassium (Kir) current 
which limits membrane depolarization, transition to the upstate appears to be 
determined largely by strong, correlated release of glutamate from corticostriatal 
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glutamatergic terminals leading to sufficient depolarization to inactivate Kir 
(Wilson and Kawaguchi, 1996; Plenz and Kitai, 1998).  The closure of dendritic 
Kir channels increases the input resistance of the neuron and reduces the overall 
electrotonic length.  Spiking is only observed in the upstate, but not all upstate 
transitions lead to the firing of an action potential.  The upstate transition persists 
as long as there is sufficient excitatory drive to maintain depolarization, often for 
hundreds of milliseconds, and evidence suggests that the transitions are more 
prominent under anesthesia but far noisier in the waking state (Mahon et al., 
2006).  These different states of the MSN membrane dictate if an incoming volley 
to the MSN will depolarize the cell.  Simultaneous activation of many cortical 
afferents at various points on the MSN dendritic tree is needed to depolarize 
MSNs from a hyperpolarized potential to action potential firing (Wilson and 
Kawaguchi, 1996; Carter and Sabatini, 2004; Carter et al., 2007).  Upstate 
transition magnitude is determined by voltage-sensitive potassium conductances 
which are activated by depolarization and subsequently limit its extent (Wilson 
and Kawaguchi, 1996).  Upstates correlate amongst neighboring MSNs, 
consistent with the idea that convergent cortical inputs drive these transitions 
(Stern et al., 1998).  The different states determine properties underlying synaptic 
conductance.  In the down state, excitatory postsynaptic potentials are primarily 
AMPAR-mediated, while upstates recruit NMDARs.  This leads to prolonged 
excitatory potentials in the upstate which lead to a greater likelihood of temporal 
summation.  Additionally, in the upstate the main source of calcium entry is 
through NMDARs and L-type calcium channels that have been shown to be very 
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important in the induction of long-lasting synaptic plasticity (Choi and Lovinger, 
1997a; Carter and Sabatini, 2004; Adermark and Lovinger, 2007a).  Recently, it 
was shown that uncaging of glutamate on multiple dendritic spines on distal 
dendrites evoked somatic upstates lasting hundreds of milliseconds, while 
uncaging on more proximal sites only produced modest potential changes 
(Plotkin et al., 2011).  These state transitions were dependent on NMDAR and T- 
and R-type calcium channels.  This study shows that distally regenerative 
upstate transition can occur with the concerted stimulation of only tens of 
synapses.           
 
Role of Dopamine in Basal Ganglia Function 
 A unique feature of the striatum is the extraordinarily dense dopaminergic 
innervation that it receives.  A remarkable study employing a viral vector to target 
green fluorescent protein to the membranes of neurons has found that single 
dopamine neurons in the substantia nigra give rise to remarkably long intra-
striatal axons (up to 780,000 µm, i.e., 780 cm in length), and that the dense 
portion of the striatal axonal plexus derived from one nigral dopamine neuron can 
cover up to 5.7% of the total striatal volume (Matsuda et al., 2009).  As such, 
even one dopamine neuron can influence a very large number of striatal MSNs, 
and it is therefore not surprising that striatal dopamine plays a critical role in 
modulating motor behavior and learning.  
While the timing and magnitude of dopamine release is important for 
normal voluntary movement, the firing patterns of dopamine neurons do not 
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correlate with voluntary movements.  Instead dopamine neurons of the ventral 
tegmental area and substantia nigra play a central role in positive reinforcement 
learning (Mirenowicz and Schultz, 1994, 1996).  Midbrain DA neurons are 
spontaneously active, firing at low frequencies (1-8Hz) at rest in vivo (Schultz, 
2007).  This firing maintains a basal level of tonic dopamine that binds to high 
affinity D2Rs, maintaining normal striatal function (Richfield et al., 1989).  
Alternatively, dopamine neurons show phasic or burst-like firing patterns 
following unexpected reward.  These bursts of action potentials transiently 
elevate dopamine levels at the synapse activating lower affinity D1Rs.  However 
after repeated conditioning sessions with an environmental cue (e.g., a light or 
tone) preceding the reward, phasic firing of dopamine neurons can be induced by 
the cue alone, as a predictor of a reward (Schultz, 1998).  In the case of a 
predicted reward the actual delivery of reward does not lead to an increase firing.  
If reward is delayed a depression in firing rates occurs at the original time and 
instead activation occurs at the new time (Fiorillo et al., 2008; Zaghloul et al., 
2009).  Also the delay itself decreases the dopamine response to the same 
reward (Kobayashi and Schultz, 2008).  Aversive events such as air puffs, 
hypertonic saline and electric shock actually enhance firing in awake animals in a 
small proportion of dopamine neurons, but the majority of dopamine neurons 
show reductions or no change in firing (Mirenowicz and Schultz, 1996; Joshua et 
al., 2008; Matsumoto and Hikosaka, 2009).  Whether the small percentage of 
dopamine neurons activated by aversive events causes a functionally relevant 
release of dopamine is still controversial (Mirenowicz and Schultz, 1996; Young, 
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2004).  Overall, these findings have led to the hypothesis that dopamine acts as 
a mean reward prediction error signal, acting to gauge between subjective 
expected and actual reward (Schultz, 1997).  Natural rewards, as well as many 
drugs of abuse (Wise, 2004), elevate dopamine concentrations in the nucleus 
accumbens (Ahn and Phillips, 2007) and striatum (Nakazato, 2005).  Long lasting 
neuroadaptations in dopamine tone can be observed in response to behavioral 
states including stress, uncertainty, and protracted drug use (Schultz, 2007).  
Recent studies utilizing channelrhodopsin to stimulate firing of dopamine neurons 
induces Pavlovian place preference conditioning in mice (Tsai et al., 2009).       
Canonically, D1 and D5 receptors normally enhance cAMP levels while 
D2, D3, and D4 receptors inhibit the production of cAMP.  Phasic bursts of 
dopamine are hypothesized to preferentially activate low affinity D1 receptors, 
while tonic release of dopamine would favor high affinity D2 receptor binding 
(Lovinger et al., 2003).  In addition to D1 and D2 receptor expressing cells in the 
dorsal striatum, expression of D3, D4 and D5 receptors are present at varying 
extents.  Striatal GABAergic interneurons express primarily D5 receptors, while 
cholinergic interneurons express both D2 and D5 receptors (Yan et al., 1997; 
Yan and Surmeier, 1997).  While the expression levels of these dopamine 
receptors are lower than D1 and D2 receptors they most likely have important 
functional roles.  While there is little expression of D4 and D5 receptor in MSNs 
(Bergson et al., 1995), the D3 receptor is expressed at significant levels in a 
subpopulation of D1 receptor-expressing cells.  In fact many drugs that are 
intended to be specific for D2 receptors actually bind to D3 receptors as well.   
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Interestingly, following dopamine depletion and subsequent levodopa 
administration D3 receptors are upregulated in the dorsal striatum (Bordet et al., 
1997).  Additionally, in dyskinetic monkeys D3 receptor binding is higher than in 
non-dyskinetic or control monkeys following dopamine depletion and levodopa 
administration.  Also D3 receptor binding levels in the striatum correlated with the 
severity of levodopa-induced dyskinesias (Guigoni et al., 2005).  Brain-derived 
neurotrophic factor (BDNF) is important in D3 receptor expression and the 
maintenance of its expression.  Moreover, the administration of a D3 receptor 
partial agonist strongly attenuates levodopa-induced dyskinesias (Guillin et al., 
2003).  These data exemplify the importance of examining other less 
characterized dopamine receptors in the striatum and their possible connection 
to basal ganglia related disorders. 
   
Role of Acetylcholine in Striatal Function 
Acetylcholine (ACh) represents another important neuromodulator class in 
the striatum.  Acetylcholine is released by cholinergic interneurons which are 
tonically active, releasing Ach locally and possibly via a volume transmission 
mechanism (Izzo and Bolam, 1988; Contant et al., 1996).  Even though 
cholinergic interneurons represent a small proportion of the total striatal neuron 
population, there dense and widespread release of Ach plays an important role 
modulating glutamatergic transmission, synaptic plasticity and ultimately action 
selection and decision-making.  In vivo, cholinergic neurons are tonically active 
(<10Hz) during rest, but during behaviorally salient stimuli the neurons show 
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bursting followed by a pause in firing lasting for up to a second (Aosaki et al., 
1995; Ding et al., 2010).  The pause seems to require coordinated inputs from 
SNc and intralaminar thalamic nuclei (Matsumoto et al., 2001).  When the 
burst/pause was recreated in a brain slice the pattern of stimulation initiates a 
brief presynaptic M2R modulation followed by a slow M1R modulation which may 
serve to reset the corticostriatal circuit allowing for possible reassessment and 
suppression of action selection (Ding et al., 2010).       
Both nicotinic and muscarinic receptors transduce ACh signals in the 
striatum.  Nicotinic receptors (nAChR) are ligand-gated ion channels that are 
expressed on DA terminals and on fast spiking interneurons (Koos and Tepper, 
2002; Zhou et al., 2002).  Muscarinic receptors are GPCRs widely expressed on 
axon terminals to the striatum and by all striatal neurons that have been 
examined.  The muscarinic receptors can be divided into the M1-class (M1, M3, 
M5), which is coupled to Gq/11 and activates PLC and M2-class (M2, M4), which 
couples to Gi/o and inhibits adenylyl cyclase (AC).  The M1 and M4 are the most 
abundant in the striatum at the tissue level.  M1Rs are found in both direct and 
indirect MSNs, while M4R are more highly expressed in direct-pathway MSNs 
(Bernard et al., 1992; Ince et al., 1997; Yan et al., 2001).  M2R are exclusively 
located in cholinergic interneurons where along with M4R they function as 
autoreceptors limiting ACh release (Bernard et al., 1992; Alcantara et al., 2001).  
Glutamatergic afferents to MSNs contain M2-class mAChRs and their activation 
reduces glutamatergic EPSCs (Pakhotin and Bracci, 2007; Higley et al., 2009).  
Yet postsynaptic activation of M1Rs potentiates the postsynaptic response to 
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glutamate without altering glutamate receptor number and/or function (Higley et 
al., 2009).  At first glance, M2R-mediated inhibition seems to oppose the M1R-
mediated potentiation, but under bursts of action potentials the M2-mediated 
presynaptic inhibition can be overcome tuning synapses to repetitive stimulation.           
    
Synaptic Triad 
Glutamatergic synapses on MSN dendritic spines are a major site of long-
lasting neuroadaptations and likely a key site underlying the neural correlates of 
motor learning.  Dopamine plays an important role in regulating plasticity in the 
striatum.  In addition to dopamine the striatum receives highly topographic 
glutamatergic thalamostriatal projections from intralaminar nuclei, such as the 
centromedian and parafascicular nuclei, and non-intralaminar nuclei (Smith et al., 
2004).  Thalamic inputs, unlike cortical inputs, target a higher percentage of 
dendritic shafts in both rats and monkeys (Smith and Bolam, 1990; Sadikot et al., 
1992; Smith et al., 1994; Sidibe and Smith, 1996).  In monkeys, centromedian 
projections preferentially synapse onto “direct” pathway neurons versus “indirect” 
pathway neurons (Sidibe and Smith, 1996).  In addition to innervating distinct 
targets, there is evidence that synaptic transmission is not similar between these 
inputs.  For example, the probability of release at cortical and thalamic 
glutamatergic synapses on MSNs appears to be different (Smeal et al., 2007; 
Ding et al., 2008). Further studies utilizing techniques to better separate these 
distinct inputs are necessary to characterize their properties.  
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While electron microscopy analysis of D2R immunohistochemical 
localization on glutamatergic synaptic terminals is controversial, revealing 
exceedingly rare or low levels of D2R (Fisher et al., 1994; Sesack et al., 1994; 
Hersch et al., 1995; Wang and Pickel, 2002), an elegant study by Sulzer’s group 
showed functional evidence of presynaptic dopamine acting to reduce glutamate 
release (Bamford et al., 2004).  Utilizing a dye (FM1-43) to load glutamatergic 
synaptic vesicles they were able to monitor release via destaining coupled with 
electrochemical recordings to directly measure the effects of dopamine at the 
level of individual presynaptic terminals.  Interestingly, another study showed that 
the inhibition of glutamate release by D2R stimulation was frequency dependent; 
resulting in inhibition of glutamate release at higher frequency stimulation (20Hz), 
but not at lower frequencies (1Hz) (Yin and Lovinger, 2006).  This inhibition was 
dependent on CB1R, mGluRs, and rises in internal calcium levels.  These data 
suggest a postsynaptic mechanism for D2R-mediated control of glutamatergic 
synaptic transmission, but they leave open the question of exactly where the 
D2Rs are localized that mediate this inhibition.  
 
GABAergic MSN Synapses 
Another component of the corticostriatal circuitry that needs consideration 
in order to understand synaptic transmission and MSNs firing is the influence of 
local inhibitory collaterals.  MSNs have local GABAergic connections to other 
neighboring MSNs.  This feedback may underlie lateral inhibition (Beiser et al., 
1997), but its functional significance has been controversial.  One reason for this 
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is that many of the recurrent inhibitory synapses are on distal dendrites (Wilson 
and Groves, 1980; Bolam et al., 1993) leading to space clamp issues and 
difficultly measuring these distal inhibitory currents with a somatic patch 
electrode.  In randomly selected MSN neighbors using dual-patch techniques the 
percentage of synaptically connected neighbors is small (10-15%) (Czubayko 
and Plenz, 2002; Guzman et al., 2003; Koos et al., 2004), yet optogenetic 
approaches suggest a much higher degree of connectivity (Chuhma et al., 2011).  
Using D1R and D2R BAC transgenic mice it was found that indirect pathway 
MSNs connect to both direct and other indirect pathway MSNs, but direct 
pathway MSNs only connect to other direct pathway MSNs (Taverna et al., 
2008).  Additional study will be needed to understand the functional significance 
of GABAergic recurrent connectivity.          
Other sources of GABAergic inhibition come from intrinsic GABAergic 
interneurons, which make up a very small percentage of the total striatal 
neuronal pool.  Fast spiking (FS) interneurons receive excitatory inputs from the 
cortex and thalamus and synapse on or near the soma of direct and indirect 
pathway MSNs (Koos and Tepper, 1999; Sidibe and Smith, 1999; Planert et al., 
2010).  A report suggested preferential connectivity of FS interneurons with direct 
pathway MSNs (Gittis et al., 2010).  Individual MSNs are estimated to receive 4-
27 FS interneuron synapses and a single FS interneuron can connect to 135-541 
MSNs allowing for bursts from single FS interneurons to significantly delay AP 
firing in numerous MSNs (Koos and Tepper, 1999).  FS interneuron activation is 
the primary mechanism for feed-forward inhibition, contributing to action selection 
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by inhibiting MSNs in circuits with competing inappropriate actions 
(Parthasarathy and Graybiel, 1997; Gage et al., 2010).  They are enriched in the 
dorsal lateral striatum, suggesting an important role in sensorimotor integration 
(Kita et al., 1990; Bennett and Bolam, 1994).  Indeed, mice with decreased 
numbers of striatal fast spiking interneurons exhibit procedural learning deficits 
(Marrone et al., 2006).  Another GABAergic interneuron subtype includes the 
somatostatin/ neuropeptide Y (SOM/NPY) expressing interneuron that forms 
another feed-forward circuit in the striatum (Tepper et al., 2010).  These 
interneurons are also referred to as low-threshold spiking (LTS) interneurons due 
to their firing properties.  LTS interneurons exhibit high input resistance, 
depolarized resting potentials, plateau potentials, and low threshold spiking 
(Kawaguchi, 1993).  LTS interneurons receive glutamatergic inputs from the 
cortex and the thalamus as well as a dopaminergic innervation (Vuillet et al., 
1989; Sidibe and Smith, 1999; Hidaka and Totterdell, 2001).  Little is known of 
their functional importance, but their innervation of distal MSN dendrites hampers 
their understanding (Gittis et al., 2010).  Even less is known about another LTS 
striatal interneuron that is immunopositive for calretinin (Tepper and Bolam, 
2004).    
 
The Glutamate Synapse 
Glutamate synapses in the striatum contains a presynaptic terminal that 
releases glutamate and a postsynaptic dendritic spine filled with receptors that 
bind glutamate.  These receptors come in two varieties: ionotropic and 
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metabotropic glutamate receptors.  Two major ionotropic glutamate receptors are 
the AMPA and NMDA receptor subtypes, which are defined by their specific 
pharmacological sensitivity to the respective agonists and are tethered to the 
postsynaptic density (PSD) by associated anchoring and scaffolding proteins.  
AMPA receptors (AMPARs), which mediate the majority of fast excitatory 
transmission in the brain, are tetramers that are made up of some combination of 
GluA1-GluA4 AMPAR subunits.  Most AMPARs respond to synaptic glutamate 
release by gating a monovalent cation current that helps depolarize the 
postsynaptic terminal.  Tetrameric NMDA receptors (NMDARs) are thought to 
contain two obligatory GluN1 subunits and some combination of GluN2A-2D 
subunit and GluN3A or 3B.  Binding of glutamate and glycine to GluN2 and 
GluN1 subunits, respectively, gates a cation channel that a) fluxes calcium and 
b) is blocked at hyperpolarized membrane potentials by a magnesium ion.  The 
magnesium block of NMDARs is relieved by a strong depolarization greater than 
what is achieved via upstate transitions.  Thus, NMDARs act as coincidence 
detectors allowing calcium influx following coincident presynaptic release of 
neurotransmitters coupled with AMPA-mediated postsynaptic depolarization.  
The consequential rise in intracellular calcium is a critical trigger for long-term 
changes in the efficacy of transmission at these synapses.     
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NMDAR-dependent Synaptic Plasticity: Hippocampal Long-term 
Potentiation and Depression 
Glutamatergic synapses have a unique ability to undergo long lasting 
changes in synaptic efficacy in response to very transient signals. The pioneering 
work of Bliss and Lomo in the perforant-pathway dentate gyrus synapse using 
high frequency stimulation to induce a long lasting potentiation of excitatory 
transmission set the stage for much of the subsequent work published on neural 
plasticity (Bliss and Lomo, 1973).  Two classic forms of synaptic plasticity, long-
term potentiation (LTP) and long-term depression (LTD) have been characterized 
initially in the hippocampus and involve long-lasting changes in glutamatergic 
transmission.  NMDAR -dependent LTP and LTD in the CA1 region of the 
hippocampus has been the most widely studied form of plasticity.  These activity 
dependent, long-lasting synaptic adaptations are hypothesized to play key roles 
in learning and memory.  High frequency stimulation or stimulation paired with 
postsynaptic depolarization leads to the induction of an NMDAR-dependent form 
of LTP in the CA1 region of the hippocampus.  Additionally, LTP has been shown 
to persist for at least hours in vitro and for months in vivo (Abraham et al., 2002).  
While late phases of LTP, like learning and memory, are dependent on gene 
transcription and new protein synthesis (Madison et al., 1991), a transient (2-3 
second) elevation of calcium via NMDARs seems to be sufficient for induction of 
this form of LTP  (Lynch et al., 1983; Malenka et al., 1988; Malenka et al., 1992).  
One important mediator of NMDAR-dependent LTP in the hippocampus, no 
matter the induction mechanism, is the postsynaptic calcium-activated kinase, 
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CaMKII (Lisman et al., 2002).  A major locus of potentiation is postsynaptic via an 
activity-dependent increase in function and/or number of AMPARs at the 
synapse (Malenka and Nicoll, 1999; Malinow and Malenka, 2002; Song and 
Huganir, 2002; Bredt and Nicoll, 2003).  Potentiation can proceed by the addition 
of new AMPARs at the synapse or by the recruitment of AMPARs to synapses 
that initially only contain NMDARs.  So-called “silent” synapses (synapses that 
only contain NMDAR) are thought to be key sites for NMDAR-dependent LTP.  
The unsilencing of synapses in adulthood is thought to be similar to LTP in that it 
shares its NMDAR- and CaMKII-dependence, and data suggest that LTP is 
induced in part by the unsilencing of synapses (Liao et al., 1992; Manabe et al., 
1992; Liao et al., 1995).  A decrease in synaptic failure rates following LTP 
induction supports the idea that CaMKII activation converts silent synapses into 
functional contacts (Lledo et al., 1995).  Lledo et al. showed that the addition of 
constitutively active CaMKII in the recording pipette leads to a decrease in the 
number of synaptic failures, an increase in the amplitude of the evoked 
responses and an increase in the spontaneous EPSC frequency and amplitude 
(Lledo et al., 1995).  These data in part can be interpreted as an increase in the 
number of silent synapses following the activation of CaMKII.   Wu et al. also 
presented data implicating CaMKII in the unsilencing of synapses: early during 
development retinotectal synapses of the frog are silent, lacking AMPARs, but 
upon transfection with a constitutively active CaMKII fragment (tCaMKII) the 
strength of AMPAR mediated transmission increases and the fraction of silent 
synapses decreases (Wu et al., 1996).   Additionally, LTP at hippocampal 
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synapses is also thought to involve enlargement of the postsynaptic dendritic 
spine (Lisman and Harris, 1993; Lisman and Zhabotinsky, 2001).  Indeed, 
induction of LTP at single dendritic spines by local uncaging of glutamate results 
in actin-dependent structural enlargement (Fukazawa et al., 2003; Matsuzaki et 
al., 2004).  Previous studies have shown that introduction of constitutively active 
CaMKII into hippocampal neurons is sufficient to induce spine growth (Jourdain 
et al., 2003). 
While NMDAR-dependent LTP in the CA1 region of the hippocampus is 
the most studied form of plasticity, another major form of potentiation is NMDAR-
independent LTP as found at the mossy fiber-CA3 synapses of the hippocampus 
(Harris and Cotman, 1986).  This form of LTP, dubbed mossy fiber LTP, is 
thought to be modulated by kainate receptors (Bortolotto et al., 1999; Contractor 
et al., 2001; More et al., 2004).  Moreover, in contrast to NMDAR-LTD, mossy 
fiber LTP is thought to be maintained presynaptically, involving an increase in the 
probability of synaptic vesicle release.  Other studies suggest that R-type calcium 
channels (Breustedt et al., 2003; Dietrich et al., 2003), calcium activated adenylyl 
cyclases (AC1/8)(Xia et al., 1991; Glatt and Snyder, 1993), cAMP-PKA signaling 
(Huang et al., 1994; Weisskopf et al., 1994; Huang et al., 1995; Lopez-Garcia et 
al., 1996; Tong et al., 1996), the synaptic vesicle protein Rab3a (Castillo et al., 
1997), and the active zone protein RIM1α are all important in mossy fiber LTP 
(Castillo et al., 2002).   
In addition to LTP, NMDAR activation can also produce long-term 
depression (LTD) at glutamate synapses in the hippocampus.  Typically, this LTD 
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is induced in the CA1 region of the hippocampus via prolonged low frequency 
stimulation (0.5-3Hz) (Dudek and Bear, 1992; Mulkey and Malenka, 1992).  This 
LTD is dependent on NMDARs, increases in postsynaptic calcium, and activation 
of serine-threonine protein phosphatases (Mulkey and Malenka, 1992; Mulkey et 
al., 1993; Mulkey et al., 1994), which are thought to drive internalization of 
AMPARs (Carroll et al., 1999; Beattie et al., 2000).  Dephosphorylation at GluA1 
Ser845, a site that seems to be constitutively phosphorylated under basal 
conditions, accompanies LTD induction (Lee et al., 1998).    
In addition to NMDA receptor-dependent LTD, an mGluR-dependent form 
of LTD (Bolshakov and Siegelbaum, 1994; Oliet et al., 1997) can be elicited in 
several brain regions by paired-pulse low frequency stimulation (PP-LFS) or bath 
application of the group 1 selective agonist (R,S)-3,5-dihydroxyphenylglycine 
(DHPG) (Ito et al., 1982; Kano and Kato, 1987; Huber et al., 2000).  Both forms 
of mGluR-LTD via PP-LFS or DHPG occlude each other suggesting similar 
expression mechanisms (Huber et al., 2001), but there are notable mechanistic 
differences from NMDAR-mediated LTD.  mGluR-LTD was first characterized at 
parallel fiber-Purkinje cell synapses of the cerebellum and is primarily dependent 
on mGluR1 activation and the resulting activation of PKC.  Within the cerebellum, 
PKC phosphorylates GluR2 at Ser880 leading to the clathrin-dependent removal 
of GluR2/3 containing AMPA receptors from the synapse (Wang and Linden, 
2000; Chung et al., 2003).  Induction of hippocampal mGluR-LTD is independent 
of NMDARs and does not occlude the induction of NMDAR-dependent LTD, 
suggesting it utilizes different mechanisms (Oliet et al., 1997).  Hippocampal 
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mGluR-LTD has been shown to be dependent on intracellular calcium 
concentration in certain experiments (Oliet et al., 1997) yet independent of 
intracellular calcium concentration in others (Fitzjohn et al., 1999).  In the 
hippocampus, mGluR-LTD seems to depend on both mGluR5 and mGluR1 
receptors: a combination of mGluR1 and mGluR5 antagonists is required to block 
its induction (Huber et al., 2001), but hippocampal mGluR-LTD is totally blocked 
in mGluR5-KO mice and only partially blocked in mGluR1KO mice (Volk et al., 
2006).  This suggests that activation of these two receptors produces synergistic 
responses to induce LTD.  Group 1 mGluRs, like mGluR1 or 5, couple to 
effectors via Gαq G proteins.  The addition of GDPβS to the patch pipette or 
recordings in Gαq (-,-) mice inhibited the induction of mGluR-LTD.  Activation of 
group 1 mGluRs leads to the activation of phospholipase C, increasing IP3 and 
DAG levels.  Activation of these two signaling molecules leads to the liberation of 
calcium from internal stores and in combination with DAG activates PKC.  In 
experiments where a PKC inhibitor was added to the patch pipette, the induction 
of mGluR-LTD in both the hippocampus and cerebellum was blocked (Linden 
and Connor, 1991; Wang et al., 2007).  Group I mGluR-LTD also involves the 
mitogen-activated protein kinase/extracellular signal regulated kinase 
(MAPK/ERK) pathway.  Indeed ERK inhibitors block the induction of mGluR-LTD 
in the hippocampus (Huber et al., 2000; Huber et al., 2001; Gallagher et al., 
2004; Volk et al., 2006; Ronesi and Huber, 2008) and cerebellum (Ahn et al., 
1999; Kawasaki et al., 1999).      
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ERK signaling can regulate translation machinery, which suggests that 
mGluR-LTD may regulate translation of new proteins.  There is much evidence 
suggesting that mGluR-LTD requires new protein synthesis (Huber et al., 2001), 
yet some reports suggest it may be independent of new protein synthesis (Huber 
et al., 2000; Moult et al., 2008).  The putative new protein synthesized and 
needed during mGluR-LTD is possibly the AMPA receptor GluA2 subunit, due to 
the fact that mGluR-LTD is blocked following pretreatment with siRNA and 
oligonucleotides blocking GluA2 translation (Mameli et al., 2007).  Group I 
mGluR-LTD induction is also thought to be dependent on activation of 
postsynaptic protein tyrosine phosphatases, specifically striatal-enriched tyrosine 
phosphatase (STEP), which dephosphorylates the GluA2 subunit of AMPARs 
triggering lateral diffusion and subsequent endocytosis (Moult et al., 2002; Huang 
and Hsu, 2006; Moult et al., 2006; Gladding et al., 2009).  However, conflicting 
results do not allow a conclusive statement about the primary locus for induction 
of mGluR-LTD (presynaptic, postsynaptic, or both).  Inconsistencies could be 
possibly explained by the use of different experimental bath temperatures and/or 
animal ages.  Additional work will be needed to delineate complex mechanisms 
underlying the induction and expression of mGluR-LTD. 
 
CaMKII and Plasticity 
CaMKII is a calcium/calmodulin-activated kinase that is highly expressed 
throughout the brain and is enriched in the postsynaptic density (PSD) of 
glutamatergic synapses (Lisman et al., 2002).  Recent, estimates of the 
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concentration of CaMKII in the dendritic spine is around 100µM (Feng et al., 
2011).  The predominant neuronal CaMKIIα and CaMKIIβ isoforms are enriched 
in the forebrain and cerebellum, respectively (Yamagata et al., 2009).  One or 
more CaMKII isoforms assemble to form a dodecameric holoenzyme and it has 
been estimated that around 80 CaMKII holoenzymes reside in the average 
dendritic spine (Chen et al., 2005; Shinohara et al., 2008).  Many lines of 
evidence show that CaMKII responds to changes in intracellular calcium levels to 
promote biochemical signaling cascades that lead to potentiated synaptic 
transmission (Figure 2).  While signaling via CaMKII is an important mechanism 
underlying synaptic potentiation, alternate signaling pathways like cAMP-PKA 
and MAPK signaling pathways may also be engaged depending the induction 
parameters, but this extensive literature will not be reviewed here (Thomas and 
Huganir, 2004).  CaMKII is activated during hippocampal LTP induction and its 
activation is necessary and sufficient for LTP (Malinow et al., 1989; Tokumitsu et 
al., 1990; Otmakhov et al., 1997; Lisman et al., 2002; Colbran, 2004; Sanhueza 
et al., 2007).  A recent study found that a knock-in mutation of CaMKIIα to 
inactivate the kinase disrupts LTP induction, the associated enlargement of 
spines, and spatial learning (Yamagata et al., 2009).  Following robust calcium 
entry into the postsynaptic neuron, CaMKII is rapidly autophosphorylated at 
threonine 286, converting the enzyme from a calcium-dependent into a calcium-
independent form (Miller and Kennedy, 1986; Fukunaga et al., 1993; Rich and 
Schulman, 1998; Lee et al., 2009).  Activation of CaMKII drives the translocation 
of the enzyme from the cytoplasm to the PSD, where it can bind to important 
31 
 
plasticity-associated proteins like NMDARs (Strack and Colbran, 1998; Leonard 
et al., 1999; Shen and Meyer, 1999).  CaMKII’s potential to remain active in the 
PSD/spine long after the postsynaptic calcium transient has subsided is why it is 
often thought of as a molecular switch capable of long-term memory storage.  
Indeed, increased threonine 286 phosphorylation of CaMKII can persist for at 
least sixty minutes (Barria et al., 1997b).  However, one study reported that 
autonomous CaMKII activity returned to basal levels within minutes of LTP 
induction (Lengyel et al., 2004), suggesting that mechanisms other than 
threonine 286 phosphorylation control autonomous CaMKII activity.  Although the 
Thr286 autophosphorylated CaMKII may have roles independent of autonomous 
kinase activity during LTP maintenance, this study also highlights an uncertain 
role for CaMKII activity during LTP maintenance.   Indeed, labs have reported 
that intracellular perfusion of CaMKII inhibitor peptides after LTP induction does 
not disrupt maintenance (Malenka et al., 1989).  In contrast, one recent study 
found that LTP maintenance can be disrupted by bath application of newly 
developed membrane-permeant CaMKII inhibitor following LTP induction 
(Sanhueza et al., 2007).  It is possible that membrane permeant peptides have 
better access to block CaMKII activity in the appropriate subcellular compartment 
(e.g., in the spines/PSD).  Alternatively, the requirement for CaMKII activity may 
depend on the induction mechanism, or be evident only during certain phases of 
LTP maintenance.  Interestingly, behavioral studies suggest that CaMKII activity 
in restricted time windows is required for memory consolidation (Wang et al., 
2003; Wan et al., 2010) 
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Figure 2.  Role of CaMKII in Synaptic Plasticity and LTP in Dendritic Spines.  
Calcium influx via NMDAR leads to the activation of CaMKII and the potentiation of 
synaptic transmission. Activated CaMKII translocates to the PSD where it can bind 
the GluN2B subunit of the NMDAR prolonging its activation.  Active CaMKII can 
potentiate excitatory synaptic transmission by driving new AMPAR to the synapse or 
phosphorylating existing AMPARs (at the GluR1 S831 site) enhancing the average 
conductance.  CaMKII’s phosphorylation of stargazin allows for the binding of 
AMPARs to PSD-95 increasing the dwell time of AMPAR in the synapse.  Active 
CaMKII also plays structural roles in dendritic spine and synapse enlargement.    
Image from (Lisman et al., 2012) 
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Despite uncertainties about the role of CaMKII activity during LTP 
maintenance, a critical role of Thr286 phosphorylation was elegantly 
demonstrated by the creation of knock-in transgenic mice with a non-
phosphorylated alanine residue replacing Thr286 in CaMKIIα.  The resulting 
disruption of CaMKII phosphorylation at Thr286 leads to profound disruption of 
hippocampal LTP (Giese et al., 1998).  Conversely, transgenic mice 
overexpressing CaMKIIα with a threonine 286 to aspartate mutation 
(CaMKIIαT286D), which mimics autophosphorylation, leads to a loss in LTP 
induction at lower frequencies and shifts the size and direction of synaptic 
change in favor of LTD induction (Mayford et al., 1995; Mayford et al., 1996).  
These data suggest that CaMKII serves as a sensor of the level of neuronal 
activity controlling the frequency-response function (Bienenstock et al., 1982).  
Additionally, overexpression of CaMKIIαT286D in the adult forebrain disrupts 
spatial memory and fear conditioned memory (Mayford et al., 1996). 
Another important phosphorylation site on CaMKII is the Thr305/306 site, 
in the calmodulin-binding domain.  Following T286 phosphorylation, T305/306 
sites are phosphorylated, strongly reducing calcium/calmodulin-dependent 
kinase activity (Hanson and Schulman, 1992; Jama et al., 2009; Coultrap et al., 
2010).  Phospho-T305/306 inhibits CaMKII from binding and/or prevents 
dissociation from the PSD which is associated with learning deficits (Elgersma et 
al., 2002).  Indeed, enhanced phosphorylation of T305/306 sites is linked to 
disrupted plasticity in a mouse model of Angelman’s disease (Weeber et al., 
2003).     
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CaMKII activation shares many similarities with the induction of LTP.  To 
determine if two forms of plasticity use a similar mechanism an occlusion test can 
be performed.  For example, LTP induction by HFS is prevented or occluded 
following potentiation induced by activated CaMKII, and vice-versa, suggesting a 
common downstream mechanism (Pettit et al., 1994; Lledo et al., 1995).  
Addition of activated CaMKII in the patch pipette can mimic LTP by enhancing 
the amplitude and frequency of spontaneous excitatory postsynaptic currents 
(sEPSCs, action potential dependent and independent currents that are recorded 
in a voltage clamped neuron in response to the release of synaptic glutamate)
 
and decreasing the failure rate which is attributed with an increase in the 
probability of release (Lledo et al., 1995).  These results suggest that CaMKII 
alone is sufficient to enhance synaptic transmission and that this enhancement 
shares common features underlying the mechanism seen following LTP 
induction.   
The activation of CaMKII can strengthen synaptic transmission by multiple 
mechanisms.  Active CaMKII can phosphorylate AMPAR GluA1 subunits at 
serine 831 and increase the conductance state of AMPARs (Barria et al., 1997a; 
Mammen et al., 1997; Derkach et al., 1999; Lee et al., 2000).  The mechanism of 
the increase in conductance state was recently revealed.  A knock-in mutation 
encoding a S831 pseudo-phosphorylated GluR1 does not alter conductance 
state magnitude.  Instead, it increases the likelihood of high conductance state 
transitions (Kristensen et al., 2011).  At least for heteromeric GluR1/GluR2-
containing AMPARs this increase in conductance only occurred in the presence 
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of stargazin.  Phosphorylation of GluR1Ser831 is increased following LTP induction 
and inhibiting CaMKII blocks phosphorylation at this site (Barria et al., 1997b).  
However, LTP can still occur when phosphorylation at GluR1Ser831 is blocked.  
Only when GluR1Ser845 is also inhibited is LTP disrupted, suggesting that 
additional mechanisms as well as distinct interactions between these 
phosphorylation sites underlie synaptic potentiation (Hayashi et al., 2000; Lee et 
al., 2010).   
Another important postsynaptic mechanism is the activity-dependent, 
CaMKII-dependent trafficking of AMPARs to the synapse (Shi et al., 1999; Opazo 
and Choquet, 2011).  Hayashi et al. showed that constitutively activated CaMKII 
leads to the insertion of new AMPARs in the synapse; one potential mechanism 
driving the potentiation seen following LTP induction (Hayashi et al., 2000).  A 
more recent study showed by tagging AMPARs with a quantum dot that the 
molecular dynamics and trafficking of AMPARs could be observed (Opazo et al., 
2010).  Extrasynaptic AMPARs were trapped at the synapses by phosphorylation 
of an auxiliary protein stargazin by CaMKII.  Phosphorylation of stargazin allows 
AMPARs to bind to PSD-95 and increases the overall dwell time of AMPARs at 
the synapse.  Mutation of the putative CaMKII phosphorylation sites on stargazin 
did not affect surface expression, but prevented the enhancement in synaptic 
transmission seen following LTP induction (Tomita et al., 2005).  While CaMKII is 
involved in the trafficking of AMPARs from extrasynaptic sites to synapses by 
likely phosphorylating stargazin during LTP, the initial exocytosis of AMPARs is 
thought to depend on RAS-ERK pathway, RAB-GTPase proteins, kalirin-7, 
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SNARE proteins, certain syntaxin isoforms and myosin V, a molecular motor 
protein (Zhu et al., 2002; Park et al., 2004; Xie et al., 2007; Wang et al., 2008; 
Kennedy et al., 2010; Patterson et al., 2010).  Indeed, CaMKII inhibition only 
partially inhibits exocytosis, leaving room for additional calcium sensors to be 
identified (Patterson et al., 2010).  Inhibition of exocytosis or any of the above 
mentioned proteins does not affect the first 20 minutes of LTP, yet has a strong 
effect on subsequent LTP.  The initial potentiation is thought to be maintained by 
trafficking from extrasynaptic stores (Makino and Malinow, 2009).   However, 
despite the preponderance of data linking CaMKIIα to LTP induction in cortex 
and hippocampus, it is worth noting that CaMKIIα can also play a key role in the 
induction of LTD at parallel fiber-Purkinje cell synapses in the cerebellum (Hansel 
et al., 2006). 
More recent optical methods utilizing glutamate uncaging on single 
dendritic spines combined with high-resolution imaging of CaMKII activation with 
the Camui activity sensor has given more insight into the role CaMKII plays 
during the induction of LTP.  The Camui sensor is a modified CaMKII subunit 
with an enhanced monomeric green-fluorescent protein (mEGFP) and a 
resonance energy-accepting chromoprotein (REAch) attached to opposite ends 
(Takao et al., 2005).  During activation of CaMKII a conformational change 
occurs that moves the fluorescence resonance energy transfer (FRET) acceptor 
and donors farther apart thus reducing the FRET signal.  This FRET sensor with 
allows for monitoring of CaMKII at the single spine level with real-time two-
photon fluorescence lifetime imaging (2pFLIM).  In hippocampal pyramidal 
37 
 
neuron spines, glutamate uncaging activated CaMKII quickly and it remained 
localized exclusively to the activated spine.  The activation of wildtype CaMKII 
decayed within 1-2 minutes to baseline, but the T286 to alanine mutant reduced 
the duration of CaMKII activation to seconds (Lee et al., 2009).  The short lived 
activation of CaMKII combined with slow diffusion due binding to PSD partners 
along with a narrow dendritic spine neck limits the spread of plasticity to 
neighboring spines.          
Structural plasticity often is linked to synaptic plasticity.  LTP is often 
accompanied by a rapid and persistent increase in dendritic spine volume.  This 
increase is linked to CaMKII activation and can be mimicked by overexpression 
of active CaMKII (Lee et al., 2009; Pi et al., 2010b).  A slower process of synapse 
enlargement, dependent on protein synthesis, increases the pre and 
postsynaptic compartments size (Ostroff et al., 2002; Tanaka et al., 2008).  A 
study suggested that CaMKII phosphorylation of the guanine-nucleotide 
exchange factor (GEF) kalirin-7 may mediate activity-dependent spine 
enlargement and enhanced AMPAR-mediated synaptic transmission under some 
conditions (Xie et al., 2007). 
While an overwhelming majority of research on CaMKII is on its role in 
excitatory transmission, some recent work has begun to look at the role of 
CaMKII in inhibitory transmission.  Moderate increases in calcium levels lead to 
the translocation of CaMKII to GABAR synapses and the insertion of new 
GABAAR at the inhibitory synapse (Marsden et al., 2010).  Deeper investigation 
of the role of CaMKII in inhibitory synaptic transmission is needed.       
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GluN2B Subunit of the NMDAR and Plasticity 
The N-methyl-D-aspartate (NMDA) receptor is a heteromeric ligand-gated 
ion channel that passes sodium, potassium and calcium as well as interacts with 
multiple intracellular proteins.  It is comprised of a combination of four subunits 
from seven known subunits including obligatory GluN1 subunits (formerly NR1, 
ζ1), and some combination of GluN2A-2D (formerly NR2A-2D or ε1-4), and/or 
GluN3A-3B (formerly NR3A-3B).  The precise combination of subunits 
determines the functional properties of the NMDAR channels.   The NR1 subunit 
undergoes alternative splicing yielding eight unique functional splice forms.  
GluN2A-2D subunits arise from multiple, related genes whose specific 
expression profiles vary based on developmental and regional regulation (Cull-
Candy and Leszkiewicz, 2004).  GluN2A and GluN2B subunits exist in a di-
heteromer (GluN1/GluN2A or GluN1/GluN2B) or in a tri-heteromer 
(GluN1/GluN2A/GluN2B), with around one-third of the subunits in the tri-
heteromer form in the adult hippocampus - yielding unique functional properties 
(Al-Hallaq et al., 2007).   Importantly, the GluN2B subunit has received a lot of 
attention being implicated in learning and memory, pain perception, feeding 
behaviors and numerous human neurological disorders.  
Developmentally, GluN2B protein is expressed in the entire embryonic 
brain, yet is restricted to the forebrain in the adult (Watanabe et al., 1992).  
Expression levels of GluN2B in the forebrain are highest in the early postnatal 
brain and then declines while GluN2A levels increase as the animal ages 
(Hoffmann et al., 2000; Yashiro and Philpot, 2008; Stoneham et al., 2010).  
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Regionally, GluN2B and GluN2A are most abundant in the cortex, hippocampus, 
striatum, olfactory bulb and thalamus.  GluN2B-containing NMDAR have lower 
peak current densities and lower peak channel open probabilities than GluN2A-
containing receptors.  Additionally, deactivation is significantly slower for 
GluN2B-containing versus GluN2A-containing NMDARs.  These single channel 
kinetic differences lead to macroscopic kinetic differences including a slower rise 
and decay time of GluN2B - containing NMDAR versus GluN2A - containing  
NMDARs (Monyer et al., 1994; Vicini et al., 1998; Chen et al., 1999).  These 
differences allow GluN2B-containing receptors larger charge transfer and an 
increased time window for detecting synaptic coincidence which plays a role in 
the induction of synaptic plasticity (Erreger et al., 2005).  This suggests that 
GluN2B-containing NMDAR carry more calcium per unit of current than GluN2A-
containing NMDARs (Sobczyk et al., 2005).  Additionally, GluN2B is thought to 
be located more peri-synaptically, while GluN2A is thought to be centrally located 
at the synapse (Dalby and Mody, 2003; Townsend et al., 2003; Zhao and 
Constantine-Paton, 2007), yet these findings still remain controversial 
(Mohrmann et al., 2000; Harris and Pettit, 2007).  While reports have connected 
increases in synapse size with potentiated synaptic transmission, the density of 
synaptic GluN2B subunits in the CA1 region of the hippocampus is constant 
regardless of spine size (Shinohara et al., 2008).   
The affinity of activated CaMKII binding to GluN2B is far greater than for 
activated CaMKII binding GluN2A (Strack and Colbran, 1998; Mayadevi et al., 
2002) and this CaMKII-GluN2B complex has been shown to be important the 
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induction of LTP (Bayer et al., 2001; Barria and Malinow, 2005).  Indeed deletion 
of the GluN2B c-terminal tail disrupts LTP induction in hippocampal neurons, but 
does not affect NMDAR-mediated currents (Foster et al., 2010).  Overexpression 
of GluN2B in the forebrain of transgenic mice leads to the enhanced activation of 
NMDAR receptors and enhanced LTP.  Additionally, GluN2B overexpressing 
mice showed enhanced long term memory for a novel object in a retention test, 
enhanced fear memory (contextual and cued), and enhanced spatial memory in 
the Morris water maze (Tang et al., 1999).  Alternatively, overexpression of 
GluN2B c-terminal tails actually show reductions in LTP magnitude and exhibit 
learning deficits (Zhou et al., 2007).  While these deficits were suggested to arise 
from the disruption of the CaMKII-GluN2B complex, it seems likely that several 
other intracellular interactions would also be affected.     
Traditional GluN2B knock out animals die soon after birth (Kutsuwada et 
al., 1996), but can survive a few days with hand feeding.  Similarly, mice 
expressing a truncation of the C-terminal domain of the GluN2B subunit die 
perinatally (Sprengel et al., 1998).  Alternatively, GluN2A or GluN2C KOs are 
viable (Lu et al., 2001; Fagiolini et al., 2003; Logan et al., 2007; Zhao and 
Constantine-Paton, 2007; Zhang et al., 2012), suggesting an indispensable role 
for GluN2B in perinatal development, feeding and other physiological functions.  
Utilizing autaptic hippocampal cultures, voltage clamp recordings show that 
GluN2BKO animals express a NMDAR-mediated EPSC, but have faster 
deactivation kinetics and are less sensitive to glycine.  These neurons are more 
sensitive to blockade by zinc and less sensitive to the GluN2B-slective antagonist 
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ifenprodil (Tovar et al., 2000).  These data suggest that GluN2A can partially 
compensate for the loss of GluN2B subunits at the synapse.  In the first perinatal 
days, GluN2BKO mice show impaired whisker-related barrelette structure and 
primary afferent terminal clustering in the brain stem.  In the hippocampus of 
these mice NMDAR-meditated responses are absent as well as NMDAR-
dependent LTD (Kutsuwada et al., 1996). 
Differing studies have implicated GluN2B subunits in striatal plasticity and 
pathology.  In animal models of Parkinson’s disease dopamine depletion of the 
striatum leads to a reconfiguration of GluN subunits with a reduction particularly 
in GluN2B levels (Oh et al., 1999; Dunah et al., 2000; Hallett et al., 2005; 
Gardoni et al., 2006).  Antagonists of the GluN2B-containing receptor have 
shown antiparkinsonian actions in both rodents and monkeys (Nash et al., 2000; 
Steece-Collier et al., 2000; Nash et al., 2004).  Other studies suggest a 
therapeutic benefit for GluN2B antagonism reducing dyskinesias in animal 
models of Parkinson’s disease, while GluN2A antagonists may exacerbate 
dyskinesias (Hallett and Standaert, 2004; Morissette et al., 2006; Ouattara et al., 
2009; Rylander et al., 2009).  In Huntington’s disease models (HD) transgenic 
mice show potentiated GluN2B currents, suggesting the disease may involve 
abnormal GluN2B activity (Li et al., 2003).  HD mice show increased GluN2B 
surface expression, current and toxicity (Shehadeh et al., 2006; Fan et al., 2007) 
and GluN2B overexpression enhances MSN cell loss (Heng et al., 2009).  More 
recent studies suggest elevated extrasynaptic GluN2B subunit number in the 
striatum of transgenic mice expressing the full length version of human 
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huntington protein and that these alterations are seen prior to motor dysfunction 
and neuronal loss (Milnerwood et al., 2010).  Interestingly, the dorsal lateral 
striatum has a higher GluN2A to GluN2B ratio than the ventral medial striatum 
(Chapman et al., 2003), possibly playing a role in the shift in normal goal-directed 
to habit-based learning seen with repeated training (Yin et al., 2009).  Overall, 
GluN2B is important in synaptic plasticity and learning and memory, and some 
striatal-associated diseases show disrupted GluN2B signaling.                   
Lines of evidence support a role for GluN2B favoring the induction of LTP.  
Many experiments have used ifenprodil, a relatively GluN2B selective antagonist, 
to determine if GluN2B subunits play a role in LTP.  Ifenprodil blocks the 
induction of LTP using a pairing protocol in immature hippocampal slice cultures.  
Overexpression of GluN2A, leading to a replacement of GluN2B subunit 
containing NMDARs, also attenuates the induction of LTP (Barria and Malinow, 
2005).  Although other reports suggest GluN2A subunits mediate LTP (Liu et al., 
2004; Massey et al., 2004), these studies utilized the drug NVP-AAM077, which 
was thought to be selective for the GluN2A receptor over the GluN2B receptor.  
However, NVP-AAM077 can block approximately 20% of the NMDAR-mediated 
current in GluN2AKO mice indicating lower selectivity (Berberich et al., 2005).  
Ifenprodil also has pharmacological caveats due to its complex pharmacology.  
Ifenprodil selectively blocks GluN2B-containing receptors over GluN2A-
containing receptors at high levels of glutamate, while it actually potentiates 
NMDAR currents at low glutamate concentrations (Kew et al., 1996).  The role of 
GluN2A and GluN2B subunits in LTP will need further study with region and 
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developmental age drawing important consideration when interpreting results.  
With the advent of conditional GluN2BKO mice we should gain a better 
understanding of the role of these subunits in plasticity.  Indeed, conditional 
GluN2BKO in the whole forebrain or hippocampus leads to deficits in LTP and 
memory tasks (von Engelhardt et al., 2008). 
Hippocampal LTD has been shown by three independent labs to be 
insensitive to GluN2B blockade with ifenprodil (Morishita et al., 2007).  This 
suggests that hippocampal LTD induction does not require GluN2B receptors.  
Other studies suggest that the GluN2B antagonist blockade of LTD is state 
dependent, in that LTD is blocked by ifenprodil at a basal state, but not following 
depotentiation (Massey et al., 2004).  Recently, ifenprodil has been shown to 
block deficits in spatial working memory and the induction/expression of an in 
vivo LTD following acute exposure to endocannabinoids at CA3-CA1 synapses 
(Han et al., 2012).                   
 
Long-term Synaptic Depression in the Striatum 
Long-lasting neuroadaptations at glutamatergic synapses are not limited 
to the hippocampus, but include brain regions like the striatum as well (Figure 3, 
Table 1).  Indeed, plasticity at excitatory synapses on MSNs in the striatum has 
been clearly demonstrated.  While plasticity in the striatum shares similarities 
with plasticity seen in the hippocampus there are some notable exceptions, 
including a much more prominent neuromodulatory role for dopamine.  Long-
lasting changes in the strength of synaptic connections in the dorsal lateral 
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striatum are likely to influence striatal control over motor activity.  Induction of 
LTP or LTD is dependent on the age of the animal and subregion within the 
dorsal striatum examined (Partridge et al., 2000).  Unlike the hippocampus and 
cerebral cortex, ex vivo studies in adult rodent brain slices using high frequency 
stimulation (HFS) with or without concurrent depolarization typically leads to the 
induction of LTD rather than LTP at glutamatergic synapses in the dorsal lateral 
striatum (Calabresi et al., 1992c; Calabresi et al., 1996; Kerr and Wickens, 2001; 
Bonsi et al., 2003) and this form of LTD is independent of NMDAR activation 
(Calabresi et al., 1992c).  Instead, induction of striatal HFS-LTD is dependent on 
membrane depolarization, activation of voltage-gated calcium channels, 
increases in postsynaptic calcium, coactivation of D1R and D2R signaling and 
metabotropic glutamate receptors (mGluRs)(Calabresi et al., 1992c; Calabresi et 
al., 1996; Choi and Lovinger, 1997a; Sung et al., 2001).    Indeed, either D1R or 
D2R antagonists are able to block HFS-LTD and mGluR antagonist significantly 
attenuate LTD magnitude (Calabresi et al., 1992c).    Additionally, this form of 
LTD is absent in mice that lack the D2 receptor (Calabresi et al., 1997; Choi and 
Lovinger, 1997a) or the dopamine-regulated phosphatase regulator DARPP-32 
(Calabresi et al., 2000).  Alternatively, muscarinic acetylcholine receptor 
antagonists enhance the magnitude of LTD (Bonsi et al., 2008), while nicotinic 
acetylcholine receptor antagonists prevent LTD induction (Partridge et al., 2002). 
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Figure 3.  Striatal LTP/LTD. (left) Schematic diagram of mechanisms thought 
to be involved in striatal LTP.  LTP is thought to involve the activation of 
NMDARs, along with either A2aR or D1R activation in indirect or direct 
pathway neurons, respectively. Increases in calcium may activate CaMKII and 
drive new AMPARs to the synapse. (right) Schematic diagram of the 
mechanisms thought to be involved in striatal LTD.  Postsynaptic 
depolarization activates Cav1.3 voltage-gated calcium channels (VGCC) while 
metabotropic glutamate signaling converges to activate endocannabinoid 
(eCB) release.  eCB act on CB1Rs to decrease the probability of release (via 
VGCC or vesicle fusion). 
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Striatal LTP 
(Modulators or Mediators) 
Striatal LTD 
(Modulators or Mediators) 
NMDAR activation (No Mg2+ ACSF) 
D1R activation 
A2aR activation 
mACh (M1R signaling) 
BDNF 
PKA/PKC 
DARRP-32 
Animal age 
Subregion of dorsal striatum 
 
Depolarization 
Increases in intracellular calcium levels 
Group 1 mGluR1s activation 
L-type VGCC activation (Cav1.3) 
Endocannabinoids (eCB) 
D2R activation 
CB1R activation 
DARPP-32 
mACh (M1R signaling) 
nACh 
Animal age 
Subregion of dorsal striatum 
 
 
 
 
 
 
 
 
 
Table 1.  Known Mediators and Modulators of Dorsal Striatal LTP/LTD 
47 
 
At least some of these receptors/signaling molecules likely modulate, 
rather than mediate LTD in striatum (Table 1).  For example, Lovinger’s group 
found that L-type calcium channel activation with modest depolarization and 
synaptic activity is sufficient for LTD, bypassing both D2Rs and mGluRs 
(Adermark and Lovinger, 2007b).   Studies from this group further revealed that 
the mechanism underlying expression of striatal LTD is a reduction in the 
probability of release as indicated by increases in the paired-pulse ratio (PPR, a 
measure of short-term plasticity where a second EPSC is triggered shortly after 
the first leading to increases or decreases in the second response compared to 
the first) and coefficient of variation (CV, the SD of the EPSC amplitude 
normalized to the mean amplitude where the inverse square of CV is directly 
proportional to quantal content)
 
of evoked excitatory responses following LTD 
induction (Choi and Lovinger, 1997a, b).  Also supporting a presynaptic site of 
expression, LTD is associated with a decrease in mEPSC frequency, but not 
amplitude.  This form of LTD is thought to be induced postsynaptically yet 
expressed presynaptically, evoking the need for a retrograde messenger.   
Common retrograde messengers include endocannabinoids (eCB) such 
as anandamide and 2-arachidonyl glycerol.  Retrograde signaling via eCBs has 
become a prominent theme in synaptic plasticity throughout the brain.  In the 
striatum, unlike other brain regions, depolarization alone is not sufficient to 
release eCBs to modulate glutamatergic transmission.  Rather, there is an 
additional requirement for mGluR activation to induce eCB release (Kreitzer and 
Malenka, 2005).   Additionally, striatal D2 receptor activation is known to mobilize 
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endocannabinoid release as well (Giuffrida et al., 1999).  The release of eCB 
postsynaptically can activate presynaptic CB1 receptors, which are Gi/o-coupled 
G-protein coupled receptors that suppress release at excitatory and inhibitory 
synapses (Szabo et al., 1998; Gerdeman and Lovinger, 2001; Huang et al., 
2001).  Studies using cannabinoid receptor (CB1R) agonists and antagonists and 
CB1R knockout mice support a role for postsynaptic endocannabinoids acting on 
presynaptic CB1Rs in a retrograde manner to induce LTD (Gerdeman et al., 
2002; Kreitzer and Malenka, 2005).  However, activation of CB1R alone is not 
enough to generate LTD, additional presynaptic stimulation is needed (Adermark 
and Lovinger, 2007a; Singla et al., 2007).  This suggests that downstream 
signaling from CB1Rs synergize with depolarization-induced mechanisms, like 
calcium entry, to produce LTD.  Indeed the striatum is enriched with CB1Rs.  
Within the striatum CB1R mRNA is expressed with a gradient in the striatum with 
expression levels higher in the lateral striatum with a gradual decrease moving to 
the medial striatum with little expression in the ventral striatum (Matyas et al., 
2006; Martin et al., 2008).  CB1R mRNA is expressed in cortical pyramidal 
neurons that project to the striatum (Tsou et al., 1998).  While there is convincing 
functional data supporting the ability of CB1 receptors to suppress glutamatergic 
release (Gerdeman and Lovinger, 2001; Huang et al., 2001; Kofalvi et al., 2005), 
controversy exists over the ability of antibodies to recognize the expression of 
CB1 receptors on presynaptic glutamatergic receptor terminals (Matyas et al., 
2006).  Additional work and better antibodies are needed for a clearer 
understanding of eCB signaling in the striatum.       
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It is also unclear whether endocannabinoid-mediated LTD (eCB-LTD) 
exists on both direct and indirect populations of neurons or if eCB-LTD can only 
exist on indirect, D2R containing MSNs.  Lovinger’s and Surmeier’s groups 
provided data consistent with a model in which both direct and indirect pathway 
MSNs support eCB-LTD via a cholinergic interneuron D2 receptor-dependent 
reduction in M1 receptor tone (Wang et al., 2006).  The resulting reduction in M1 
receptor tone promotes the opening of Cav1.3 calcium channels, which then 
enhances endocannabinoid production and CB1 receptor activation.  More 
recently the idea that a reduction in both ACh release and M1R signaling is 
critical for the induction of eCB-LTD in both direct and indirect pathway MSNs 
has been shown (Tozzi et al., 2011).  However data from the Malenka lab 
suggests that only indirect pathway MSNs can elicit eCB-LTD (Kreitzer and 
Malenka, 2007).  These discrepancies could possibly be explained by the use of 
D1R-EGFP versus M4R-EGFP mice to label direct pathway MSNs.  Another 
possibility for the role of D2 signaling in eCB-LTD might be the need to inhibit 
A2a adenosine receptor signaling impeding efficient EC synthesis and therefore 
eCB-LTD (Fuxe et al., 2007).  More recently, evidence agreeing with this idea 
that antagonism of A2a receptors promotes eCB-LTD in indirect pathway MSNs 
(Lerner et al., 2010).  Additional conflicting data is reported by Calabresi’s group 
showing that stimulation of M1 receptors can facilitate the induction of striatal 
LTP in ACSF lacking magnesium (Calabresi et al., 1999).  A recent publication 
showed that following repeated administration of ∆9-Tetrahydrocannabinol 
(THC), eCB-LTD was abolished for 3-4 days following treatment.  This loss of 
50 
 
LTD was associated with the development of THC tolerance with repeated 
administration, because a single injection of THC did not alter eCB-LTD.  
Functional tolerance in this model is reflected by a loss of available CB1R or an 
uncoupling of downstream G-protein signaling.  Indeed, reduced field EPSCs 
following CB1R agonist application and reduced CB1R radioligand binding were 
observed in the THC tolerant group.  Using a negative spike-timing dependent 
plasticity (STDP) protocol they were able to induce LTD of EPSPs with layer 5 
cortical stimulation in D2R-expressing MSNs, but not in D1R-expressing MSNs.  
The STDP-LTD was lost in chronically treated THC mice.  Additionally, these 
effects were specific to the dorsal lateral striatum, because LTD in the dorsal 
medial striatum, which was mediated by a different signaling mechanism, was 
not affected by repeated THC.  It was found that the induction of eCB-LTD 
depended on the activation of L-type VGCC, but not NMDARs.  Furthermore SK 
channel inhibition rescued eCB-LTD in tolerant mice (Nazzaro et al., 2012).  
Additional studies will be needed to better understand the reasons for the 
discrepancies in the literature for eCB-LTD in D1R-expressing and D2R-
expressing MSNs.                     
An additional form of LTD induced via low frequency stimulation (LFS, 5-
10min, 10-13Hz) can also be detected in the dorsolateral striatum (Kreitzer and 
Malenka, 2005; Ronesi and Lovinger, 2005).  Like HFS-LTD, LFS-LTD is blocked 
by D2R and CB1R antagonists or blunted by blockers of L-type calcium 
channels.  However, LFS-LTD differs from HFS-LTD in that it unaffected by 
postsynaptic depolarization, postsynaptic calcium chelation, mGluR antagonists, 
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and an intracellular anandamide membrane transport inhibitor.  The induction of 
LFS-LTD does not occlude the induction of HFS-LTD suggesting both forms of 
LTD can occur at the same synapses.  This presents a scenario where HFS-LTD 
is favored under strong bouts of cortical stimulation along with correlated 
postsynaptic depolarization, while LFS-LTD would be favored under moderate 
frequency cortical stimulation uncorrelated with postsynaptic depolarization.     
LTD is also the major form of plasticity observed in the ventral striatum.  
Typical stimulation protocols consist of 10-13Hz stimulation applied for several 
minutes in the presence of GABAA receptor antagonists, leading to induction of a 
robust LTD of evoked excitatory transmission (Robbe et al., 2002b; Hoffman et 
al., 2003; Mato et al., 2004).  This form of LTD, which is blocked by CB1R 
antagonists and in CB1RKO mice, is mediated by the postsynaptic release of 
eCB, which activate presynaptic CB1Rs on glutamatergic terminal afferents to 
the NAc (Robbe et al., 2001).  The activation of Gi/o-coupled CB1Rs leads to the 
decrease in probability of glutamate release (Robbe et al., 2001).  Consistent 
with this finding, eCB-mediated LTD is associated with a decrease in the sEPSC 
frequency, but not amplitude.  Additionally, intracellular calcium-chelation and 
antagonism of mGluR5 receptors blocks the induction of eCB-LTD, but NMDAR 
antagonists do not affect this form of LTD.  The group1 mGluR agonist, DHPG, 
elicits LTD in the nucleus accumbens and 13Hz eCB-LTD is occluded following 
DHPG-LTD suggesting a similar shared mechanism.  Interestingly, this form of 
LTD is blocked by prior chronic cocaine administration (Fourgeaud et al., 2004).   
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A second form of LTD is observed in the nucleus accumbens, mediated by 
presynaptic mGluR2/3 receptors and inhibition of P/Q-type calcium channels by 
the cAMP/PKA pathway (Robbe et al., 2002c).  Both mGluR2/3 agonists and 
tetanic stimulation (three times for 1 sec at 100Hz, 20sec intervals) leads to 
mGluR2/3LTD in a majority of experiments.  mGluR2/3 LTD, like eCB-LTD, leads 
to an increase in the paired pulse ratio indicative of a decrease in the probability 
of release of glutamate.  mGluR2/3 LTD induced by tetanic stimulation is also 
independent of NMDARs, postsynaptic intercellular calcium concentrations and 
was occluded by prior mGluR2/3 agonist-induced chemical LTD.  
Finally, a third form of LTD is observed in the nucleus accumbens.  This 
form of LTD can be induced by three bursts of 5Hz stimulation for 3min paired 
with depolarization to -50mV or 1Hz for three minutes (Thomas et al., 2000; 
Thomas et al., 2001).  This low frequency stimulation paired with depolarization 
induces LTD, which unlike other forms is dependent on NMDARs (Thomas et al., 
2001).  This form of LTD is dependent on internal calcium, but independent of 
mGluRs and D1 and D2 receptor activation (Thomas et al., 2000).       
  
Long-term Potentiation in the Striatum 
In addition to LTD, LTP can also occur at glutamate synapses on MSNs, 
but it is in general less well characterized.  Interestingly, induction of striatal 
plasticity depends on the postnatal age of the animal and subregion of the dorsal 
striatum.  In the dorsal lateral striatum HFS stimulation in young animals (P12-
14) leads to the induction of LTP, while in older animals (P15-34) it leads to LTD.  
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Conversely, in dorsal medial striatum LTP is induced across both age ranges 
(Partridge et al., 2000).  While the story is currently far from complete, striatal 
LTP may share some features with CA1 hippocampal LTP described above 
(Bliss and Collingridge, 1993), in particular that it is dependent on NMDARs for 
induction (Calabresi et al., 1997; Yamamoto et al., 1999; Partridge et al., 2000; 
Kerr and Wickens, 2001; Dang et al., 2006; Popescu et al., 2007), and has been 
observed both in vitro and in vivo (Charpier and Deniau, 1997; Charpier et al., 
1999; Dos Santos Villar and Walsh, 1999).  Interestingly, high frequency 
stimulation and depolarization concurrently with pulsatile application (Wickens et 
al., 1996), but not bath application (Arbuthnott et al., 2000), of dopamine in 
normal aCSF (perhaps mimicking the natural pulsatile release of dopamine) 
leads to the induction of LTP instead of LTD in the dorsal striatum.   
As mentioned above, less is known about striatal LTP relative to LTD, 
largely because of difficulty in identifying consistent means by which to induce 
and record the LTP at a single cell level.  For example in many striatal LTP 
studies, aCSF lacking magnesium is used to both unblock the NMDA receptor 
and likely increase release probability (Calabresi et al., 1992a; Centonze et al., 
1999; Calabresi et al., 2000; Nazzaro et al., 2012).  Potassium channel blockers 
have also been used as a means of facilitating striatal LTP (Wickens et al., 1998; 
Norman et al., 2005).  Like LTD, striatal LTP appears to be heavily modulated by 
dopamine, apparently in a receptor-specific manner.  D2 receptor knockout mice 
are reported to exhibit LTP with high frequency stimulation in normal aCSF 
(Calabresi et al., 1997).  Moreover, application of a D2 receptor antagonist can 
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enhance LTP induced in magnesium-free aCSF in wildtype mice, suggesting D2 
receptors exert negative control on LTP induction (Calabresi et al., 1997).  
Pharmacological inhibition of D1 receptors, genetic knockout of D1 receptors or 
postsynaptic inhibition of PKA/PKC activity blocks the induction of LTP (Akopian 
et al., 2000; Calabresi et al., 2000; Centonze et al., 2001; Kerr and Wickens, 
2001; Centonze et al., 2003; Ding and Perkel, 2004; Fino et al., 2005). DARRP-
32 knockout mice, presumably via loss of PP1 inhibition, also prevent the 
induction of LTP in magnesium-free aCSF (Calabresi et al., 2000).  Striatal LTP 
may also depend on the activation of M1 acetylcholine (Calabresi et al., 1999; 
Lovinger et al., 2003) and mGluRs (Gubellini et al., 2003).  In agreement with a 
role for M1 acetylcholine receptors in striatal LTP, blockade of M2 acetylcholine 
receptors enhances LTP (Calabresi et al., 1998).  Another player in striatal LTP 
has been identified recently, the activation of TrkB receptors by its ligand BDNF 
(Jia et al., 2010).  BDNF is released by corticostriatal terminals and TrkB 
receptors are found on both direct and indirect pathway MSNs (Lobo et al., 
2010).  Recently, repeated administration of THC was shown not to have an 
effect on LTP induction, but blocks subsequent depotentiation (Nazzaro et al., 
2012), a process dependent on NMDAR and protein phosphatase-mediated 
signaling (Picconi et al., 2003).   
With D1 receptor stimulation necessary for LTP induction and D2 
stimulation necessary for LTD induction, how can distinct populations of MSNs 
expressing only D1 or D2 receptors elicit both LTP and LTD?  This question was 
addressed by Shen et al. using spike-timing dependent plasticity (STDP) in D1- 
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and D2-EGFP BAC transgenic mice (Shen et al., 2008).  STDP involves the 
precise timing of converging synaptic activity and back-propagating action 
potentials and has been studied in many systems after its initial discovery 
(Magee and Johnston, 1997; Markram et al., 1997).  If an evoked excitatory 
postsynaptic potential (EPSP, a depolarization of a neuron induced by 
presynaptic stimulation increasing the likelihood of generating an action potential) 
precedes postsynaptic spiking by a few milliseconds then this continued pairing 
leads to LTP, whereas reversing the order induces LTD.  Shen et al. report that 
disruption of adenosine A2a receptors - not D1R - blocked the induction of LTP 
on D2R MSNs.  LTD in D2R MSNs induced with STDP, like conventional HFS-
LTD, can be blocked by the single addition of either D2R antagonists, CB1R 
antagonists or mGluR5 antagonists.  In D1R MSNs LTD was only induced in the 
presence of D1R antagonists, while D2R antagonists had no effect on LTD.  So it 
seems that in D1 MSNs D1 receptors and mGluR5 receptors have antagonistic 
actions while in D2 MSNs it seems that adenosine A2a receptors substitute for 
D1 receptors to antagonize mGluR5.  Thus, although this study showed that 
dopamine plays a key role in determining the directionality of plasticity, dopamine 
is not essential for the induction of striatal LTP/LTD under these conditions.  
Another study using STDP concluded that both LTP and LTD induction in the 
striatum is D1R-dependent and NMDAR-dependent with directionality 
determined by timing and order of EPSPs and backpropagating action potentials 
(Pawlak and Kerr, 2008; Pawlak et al., 2010).  Like the hippocampus, this study 
also suggested LTP involved a postsynaptic insertion of AMPA receptors via the 
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unsilencing of synapses, but additional work is needed to confirm if a similar 
mechanism functions in the striatum. 
As in the dorsal striatum, LTP is observed in the ventral striatum, but with 
some notable differences.  High frequency stimulation (100Hz), in physiologically 
normal magnesium concentrations, elicits LTP in field recordings in the NAc 
(Pennartz et al., 1993; Kombian and Malenka, 1994; Mazzucchelli et al., 2002; 
Schramm et al., 2002; Li and Kauer, 2004; Yao et al., 2004).  This form of LTP is 
blocked by acute amphetamine, dopamine, or by dopamine receptor agonists (Li 
and Kauer, 2004).  However after chronic administration of amphetamine the 
attenuation of LTP is lost.   Another induction protocol uses pairings of 
depolarization via an intracellular patch pipette with low frequency stimulation to 
induce LTP (Kombian and Malenka, 1994).  Induction of LTP using this pairing 
approach, while sensitive to intracellular calcium concentration, is not blocked by 
acute amphetamine treatment (Li and Kauer, 2004).  These results suggest that 
dopamine receptor activation normally decreases responses to high frequency 
stimulation without disrupting excitatory synaptic transmission at low frequency.  
Indeed D1R stimulation decreases glutamatergic transmission in the NAc 
response to both single and multiple stimuli (Pennartz et al., 1993; Harvey and 
Lacey, 1996; Nicola et al., 1996; Beurrier and Malenka, 2002).  Additionally, 
NMDARs are required for this form of LTP induction in the NAc (Kombian and 
Malenka, 1994).  Interestingly, the activation of glutamatergic basolateral 
amygdala afferents that innervate ventral striatum enhances LTP at cortical 
glutamatergic synapses on MSNs (Popescu et al., 2007).  
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In summary, it seems that repetitive stimulation of corticostriatal afferents 
can lead to the development of LTP or LTD depending on conditions.  Therefore 
it will be crucial to better understand and identify the factors that control the 
directionality, induction and maintenance of plasticity in the striatum.  Separating 
the direct and indirect projection neurons role in plasticity as well as determining 
effects of local interneurons and local networks as well determining how differing 
methodologies affect plasticity in the striatum will all be important in better 
understanding the mechanisms underlying motor function and disease.   
 
Glutamatergic Plasticity and Motor Skill Learning 
Long lasting changes in synaptic efficacy at synapses leads to long lasting 
changes on the cellular and network levels, which correlate with modifications in 
animal behavior and performance.  Deletion of the obligatory GluN1 subunit of 
the NMDAR in the striatum leads to a disruption of motor learning on the 
accelerating rotarod and a disruption in dorsal striatum LTP and ventral striatum 
LTD (Dang et al., 2006).  Yin et al. were able to correlate the acquisition and 
consolidation of a long-lasting motor skill to alterations in plasticity in the dorsal 
striatum.  Differing regions of the dorsal striatum subserve different forms of 
motor and procedural learning.  The dorsal medial region of the striatum, or 
associative striatum, is preferentially involved in the rapid acquisition of action-
outcome contingencies while the dorsal lateral, or sensorimotor striatum, is 
involved in the gradual acquisition of habit based learning (Hilario and Costa, 
2008).  Experiments recording activity of MSNs in both in the dorsal medial and 
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dorsal lateral striatum in vivo in freely moving mice during a motor learning task 
found regional differences in neural activity at differing time points during learning 
(Yin et al., 2009).  During early time points on the rotarod the dorsal medial 
striatum showed the largest increase in activity, while at later time points when 
learning had reached a plateau dorsal lateral striatum activity peaked.  In 
agreement with these data, excitotoxic lesions in the dorsal medial striatum only 
affected early motor skill learning, while dorsal lateral striatum excitotoxic lesions 
only affected late learning.  To determine if these changes corresponded to 
changes in synaptic strength, saturation experiments were performed by inducing 
LTD.  Yin et al. found that it was more difficult to saturate LTD in the dorsal 
medial striatum at early time points and found it more difficult to saturate LTD in 
the dorsal lateral striatum at late time points in motor skill acquisition.  These 
data suggest that early in motor skill acquisition the dorsal medial striatum 
undergoes synaptic potentiation while at later time points in acquisition the dorsal 
lateral striatum undergoes potentiation.  Additionally, using whole cell voltage 
clamp they saw an increase in the sEPSC amplitude in the dorsal lateral striatum 
following extended training suggesting a postsynaptic increase in 
function/number of AMPARs which is reflective of synaptic potentiation.  
Furthermore, recordings from D1 and D2-EGFP BAC mice during motor skill 
acquisition suggested that late in training the potentiation of excitatory 
transmission in the dorsal lateral striatum occurs predominantly in D2 receptor 
expressing MSNs while becoming less dependent on the activation of D1 
receptors (Yin et al., 2009).  In all these data show that LTP of glutamatergic 
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transmission in the dorsal striatum is necessary for the acquisition of motor skill 
learning.   
Exciting new research has dissected the learning of new action sequences 
and its disruption in nigrostriatal disorders.  In operant tasks where mice learn to 
press a lever to obtain a food reward, researchers have found striatal neural 
activity corresponding to the initiation or termination of an action sequence.  
About one third of MSNs showed lever-press related activity as well as an 
increase or decrease on initiation or completion of the action sequence, which 
actually increased over repeated training.  Using a striatal-specific NMDAR1 
knockout mouse they were able to show that start/stop activity and sequence 
learning were both disrupted (Jin and Costa, 2010).                             
 
Role of the Striatum in Habit Learning 
The neural circuits underlying the acquisition of goal-directed actions 
(action-outcome learning) or actions sensitive to value of the outcome have been 
shown to be different than the circuitry underlying the formation of habits 
(stimulus-response learning).  The dorsal striatum has been shown to play a 
critical role in both (Yin and Knowlton, 2006).  Extended training, different 
reinforcement schedules and drugs of abuse can shift goal-directed behaviors to 
habitual responding.  While habits can be beneficial, losses in voluntary control 
and compulsive drug seeking highlight a maladaptive form of habit learning – 
addiction. 
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To study whether instrumental behavior is being performed because of its 
outcome or not, researchers developed experimental tools to parse out goal-
directed actions from habits.  Initially animals are trained on a fixed ratio (FR) 
schedule, where a certain number of lever presses equate to reward delivery, to 
acquire operant responding for food.  Following initial training the animals can be 
switched to differing training schedules.  Random ratio (RR) schedules have 
been shown to lead to goal-directed schedules, while random interval schedules 
promote habitual behavior (Balleine and Dickinson, 1998). Additionally, 
overtraining helps to transition goal-directed to habit-based learning.  To 
determine whether an action is habitual, a devaluation procedure can be used 
(Hilario et al., 2007).  If an action is habitual, then it should not be dependent on 
the outcome of the reward.  First an animal is trained to press a lever for a 
specific food reward that is different than the food given under restriction 
conditions.  Following acquisition the animals are given free access to the reward 
prior to a session leading to sensory-specific satiety.  If the behavior is goal-
directed then the animals responding under extinction conditions will fall off 
compared to control, but if responding is not sensitive to pre-feeding then it is 
thought that the behavior is habitual (Figure 4).  While behaviors that are 
impervious to devaluation may be suggestive of habit learning additional tests 
are used to confirm this initial assessment.  Contingency degradation or 
disrupting the contingency between the performance of the action and the 
outcome is another way of determining if behavior is habit based (Hammond, 
1980; Dickinson et al., 1996; Corbit et al., 2002).  Under contingency conditions 
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animals are given “free rewards” or rewards that are delivered without an operant 
response.  Like before if operant responding is maintained following contingency 
degradation then the behavior is thought to be habitual.  Another task used to 
look at goal-directed versus habit learning is omission (Davis and Bitterman, 
1971; Yin et al., 2006).  Initially animals are trained that pressing a level equals 
food reward.  Following training during omission in order to obtain the reward 
animals must omit from pressing the lever that was initially paired with reward.  
Omission is one of the most rapid ways for reducing the performance of goal-
directed actions. 
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Goal-directed actions have been shown to be controlled by dorsal medial 
striatum and its pre-limbic cortex and medial dorsal thalamic inputs (Corbit and 
Balleine, 2003; Corbit et al., 2003; Yin et al., 2005a; Yin et al., 2005b; Shiflett et 
al., 2010).  In contrast, habit learning involves the dorsal lateral striatum and 
infralimbic cortex and associated inputs (Killcross and Coutureau, 2003; Yin et 
al., 2004).  Interestingly, a lesion of the nigrostriatal input to the dorsal lateral 
Figure 4.  Parsing Goal-directed and Habit-based Learning in Rodents.  
Devaluation and Contingency Degradation are two assays to determine if an 
animal’s behavior is goal-directed or habit based.  Following acquisition of operant 
training with a distinct reinforcer (Ensure) animals are given free 1 hour access to 
either Ensure or another generalized reinforcer chow in the home cage.  In 
contingency degradation the animal is offered “free” rewards which are delivered 
non-contingently.  In a five minute extinction test following devaluation or 
contingency degradation if the behavior is goal directed, then lever press 
responding should decrease, but if the behavior is habitual then responding should 
remain the same.  Adapted from (Hilario and Costa, 2008) 
63 
 
striatum seems to disrupt habit learning and instead support goal-directed 
behaviors (Faure et al., 2005).  Also repeated administration drugs of abuse like 
cocaine and amphetamine can increase activity in the dorsal lateral striatum and 
favor a shift to habitual behavior (Nelson and Killcross, 2006; Nordquist et al., 
2007; Takahashi et al., 2007).  Evidence suggests that goal-directed learning and 
habit learning compete with each other, with lesions of dorsal medial striatum 
turning instrumental responding habitual (Yin et al., 2005b).  Work in freely 
moving rodents analyzing task-related oscillations in field potential activities 
recently suggested that during early instrumental learning in vivo spiking in the 
ventromedial striatum is associated with gamma-band (70-90Hz) bursts, however 
after repeated training when behavior becomes habitual there is an increase in 
global beta-band bursts (15-28Hz) with gamma-band bursts waning (Howe et al., 
2011).                      
Studies have tried to better understand the molecular players and 
signaling cascades involved in habit learning.  Data suggests that signaling 
through CB1R is necessary for habit formation (Hilario et al., 2007).  Additionally, 
A2a adenosine receptor knock-out mice show disrupted habit learning (Yu et al., 
2009).  Recently, a study examined the effects of prolonged THC exposure on 
striatal plasticity and behavior.  Behaviorally, the chronically treated THC mice 
exhibited greater habitual responding compared to controls during devaluation 
and omission tests.  Infusions of apamin, a SK channel antagonist, rescued goal-
directed behavior in the THC tolerant mice (Nazzaro et al., 2012).  Another 
recent study using selective lesioning has suggested that the anterior portion of 
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the central amygdala is involved in the acquisition of habits (Lingawi and 
Balleine, 2012).  Without a direct projection from the central amygdala (CeA) to 
the dorsal lateral striatum it seems plausible that an indirect route via the 
thalamus or substantia nigra pars compacta underlies the CeA role in habit 
learning.  Overall, the concerted interplay of molecules and circuits underlying 
the formation of goal-directed and habits are just beginning to be understood 
making it an exciting area of research in coming years.         
 
Alterations in Striatal Glutamatergic Synapses Following Dopamine 
Depletion 
Lesions of the nigrostriatal dopamine neurons that innervate the striatum 
lead to a disruption in habit based learning.  The hallmark of PD is the loss of the 
majority of dopamine neurons.  It will be interesting to understand the potential 
mechanistic overlap in habit learning and the maladaptive alterations that occur 
in PD.   With the known interplay of dopamine and glutamate in the striatum it is 
important to understand how the loss of dopamine in the striatum alters 
glutamatergic synaptic transmission to better understand PD.  I review some of 
the literature below.   
Unilateral lesion of the nigrostriatal dopaminergic pathway with 6-OHDA is 
one of the most widely used animal models of PD leading to profound 
biochemical, morphological, electrophysiological and behavioral changes that in 
many cases mimic alterations described in patients with Parkinson’s disease.  
Behaviorally, unilateral dopamine depletion leads to deficits in rotarod 
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performance, locomotor performance and increased limb-use asymmetry 
(Picconi et al., 2004a).  Morphologically, the loss of dendritic spines from MSNs 
also is seen in both dopamine depletion models (Ingham et al., 1989; Ingham et 
al., 1993) and in patients with Parkinson’s disease (Anglade et al., 1996).  While 
spine loss is occurring following dopamine depletion the remaining spines 
undergo changes as well.  For example, an increase in the number of perforated 
synapses or synapses with bifurcated active zones - often seen after 
manipulations that enhance excitatory transmission (Edwards, 1995)- is 
observed following dopamine depletion (Ingham et al., 1998) and in PD patients 
(Anglade et al., 1996).  Additional studies also point to dopamine depletion 
leading to an increase in glutamatergic transmission.  Indeed, increased 
glutamate release from corticostriatal synapses (Lindefors and Ungerstedt, 1990) 
and increases in spontaneous glutamatergic transmission are seen following 
dopamine depletion (Galarraga et al., 1987; Calabresi et al., 1993; Tang et al., 
2001; Gubellini et al., 2002; Picconi et al., 2004a).  This increased sEPSC 
frequency following dopamine depletion can be renormalized by the addition of a 
D2 receptor agonist (Picconi et al., 2004a).  This would suggest that dopamine 
tone normally exerts negative modulation on glutamatergic transmission.  
Conversely, work out of Surmeier’s lab demonstrated that decreases, rather than 
increases, in spontaneous glutamatergic transmission - coinciding with spine loss 
- were only seen following dopamine depletion in indirect pathway MSNs (Day et 
al., 2006).  These differences could be due to differing experimental methodology 
like the inclusion of cesium in the patch pipette which blocks potassium channels 
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and improves space clamp and voltage control at distal synapses.  Another point 
for comparison was that this study only looked at sEPSC frequency following 
reserpine treatment, a drug known to reversibly deplete all monoamines without 
dopamine cell and terminal loss. Yet, another more recent study examining the 
effects of 6-OHDA dopamine depletion in the mouse found the opposite results 
where D1R-expressing MSNs showed reductions in sEPSC frequency about a 
month following lesion (Warre et al., 2011).  Time after lesion, methodical 
considerations and compensatory mechanisms following dopamine loss may 
underlie these discrepancies.      
Calabresi’s group amongst others has suggested that dopamine depletion 
leads to a global inability to induce striatal LTP in magnesium-free aCSF 
(Centonze et al., 1999; Kerr and Wickens, 2001; Picconi et al., 2003; Picconi et 
al., 2004b) and prevents the induction of LTD ex vivo (Calabresi et al., 1992c).  
Alternatively, Malenka and colleges have shown that LTD is absent only in 
indirect pathway MSNs in reserpine and 6-OHDA treated animals.  This eCB-
LTD, in addition to locomotor activity and catalepsy, could be rescued by a D2 
receptor agonist or inhibitors of endocannabinoid degradation (Kreitzer and 
Malenka, 2007).  This finding is intriguing since D2R-dependent expression of 
LTD has been reported in both D1R and D2R-containing MSNs (Wang et al., 
2006).  Recently, Shen et al. showed that in animals lesioned with 6-OHDA, 
STDP leads to a flip in the polarity of plasticity so that LTP induction protocols 
induce LTD now in D1 MSNs (Shen et al., 2008).  While in D2 MSNs LTP 
remained following dopamine depletion and could be rescued with a D2R 
67 
 
agonist.  However, ex vivo slice data contrasts with in vivo LTD where alpha-
methyl-para-tyrosine-induced dopamine depletion (Reynolds and Wickens, 2000) 
or blockade with D1R antagonists (Floresco et al., 2001) does not block LTD 
induction.   
 
Alterations in Glutamatergic Synapses Following Subsequent Levodopa 
Administration 
Administration of levodopa plus a peripheral dopa-decarboxylase inhibitor 
like benserazide is currently one of the most effective therapeutic options in 
Parkinson’s disease.   The therapeutic efficacy of levodopa is presumed to be 
due to its ability to counteract neuroadaptations that occur in the absence of 
dopamine innervation (Obeso et al., 2000).  Experimentally, levodopa 
administration renormalizes many behavioral, biochemical, and 
electrophysiological deficits seen following dopamine depletion.  However after 
chronic administration with dopamine replacement therapies the formation of 
abnormal involuntary movements or dyskinesias appears.  Independent of the 
degree of dopamine denervation, dyskinesias are surprisingly observed only in a 
subpopulation of rats and monkeys that undergo unilateral dopamine depletion 
followed by levodopa administration.  Data suggests that early administration of 
levodopa (4 weeks post lesion) decreases the percentage of animals that 
eventually develop dyskinesias (Marin et al., 2009).  Normal animals and patients 
that are given levodopa do not develop dyskinesias, suggesting that changes 
that take place following dopamine depletion are important in revealing 
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dyskinesias.   Behaviorally in nondyskinetic rats chronic levodopa administration 
rescues rotarod performance and limb-use asymmetry (Picconi et al., 2003; 
Picconi et al., 2004b).  The loss of striatal LTD seen following dopamine 
depletion can be rescued by application of dopamine or a combination of D1 and 
D2 receptor agonists (Calabresi et al., 1992b; Calabresi et al., 1992c).  Also the 
ex vivo induction of striatal LTP is rescued following levodopa administration at 
dopamine depleted synapses whether or not the rats exhibit dyskinesias (Picconi 
et al., 2003).  However, in animals that showed dyskinetic behaviors, 
depotentiation – a reversal of LTP induced by low frequency stimulation and 
mediated by phosphatases - could not be produced (Picconi et al., 2003).  This 
same study showed that levodopa increased the phosphorylation of DARPP-32 
at Thr34, to presumably inhibit PP1, in dyskinetic rats versus non-dyskinetic rats.   
Additionally, in 6-OHDA lesioned rats levodopa reverses hypersensitivity of D2 
receptors and renormalizes glutamatergic spontaneous EPSC frequency (Picconi 
et al., 2004a).  Biochemical data implicate abnormalities in the subcellular 
localization, levels and phosphorylation state of the NMDAR GluN2B subunit in 
animals eliciting levodopa-induced dyskinesias (Oh et al., 1999; Dunah et al., 
2000; Hallett et al., 2005; Gardoni et al., 2006).  Moreover, GluN2B antagonists 
have shown efficacy in the reduction of dyskinesias (Hallett and Standaert, 
2004). With these data it is conceivable that pharmacological modulation of 
striatal glutamatergic synaptic plasticity might prove useful in the treatment of 
motor symptoms observed in PD. 
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CaMKII Inhibition as a Therapeutic Target in Parkinson’s Disease 
As mentioned above, CaMKII is a key signaling molecule in synaptic 
plasticity.  Both the Colbran and Calabresi labs found increases in the 
phosphorylation state of threonine 286 in CaMKIIα following dopamine depletion 
(Picconi et al., 2004b; Brown et al., 2005).  In both studies, levodopa 
administration was able to restore levels of phosphorylated CaMKIIα to normal.  
The increased Thr286 phosphorylation of CaMKIIα persisted for up to 20 months 
post lesion, but increased phosphorylation of GluR1Ser831, a CaMKII substrate, 
was only detected 9-20 months after dopamine depletion.  Additionally Picconi et 
al. showed that intra-striatal injection of CaMKII inhibitors (KN93 or a membrane-
permeant CaMKII inhibitor peptide) rescued LTP deficits following dopamine 
depletion, as well as limb-use asymmetry and rotarod performance.  Together 
these data suggest an important role for downstream signaling molecules like 
CaMKII in the aberrant plasticity and disrupted motor output following dopamine 
depletion.   
 
Effects of Drugs of Abuse on Plasticity in the Striatum 
 
Psychostimulants like cocaine and amphetamine, as well as other drugs of 
abuse, increase dopamine levels by blocking dopamine re-uptake in the nucleus 
accumbens and in the dorsal striatum (Everitt et al., 2008).  Animals chronically 
treated with drugs of abuse show long-lasting modifications in excitatory 
transmission in the striatum.  In the nucleus accumbens shell chronic 
administration of cocaine leads to the depression of glutamatergic synaptic 
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strength reflected by decreases in the AMPAR/NMDAR current ratio (an index of 
the relative AMPA-and NMDA-mediated currents contribution to EPSCs), the 
amplitude of miniature EPSCs, and the magnitude of LTD (Thomas et al., 2001).  
This suggests the cocaine administration leads to the induction of LTD in vivo.  
Indeed, this form of NAc LTD was blocked by a peptide that disrupts clathrin-
mediated endocytosis or by a GluA2-derived peptide that blocks regulated AMPA 
receptor endocytosis a major mechanism underlying LTD.  This GluA2-derived 
peptide also disrupted the development of behavioral sensitization, an 
enhancement in the locomotor activating effects of cocaine with repeated 
administration, which has been shown to correlate with LTD (Brebner et al., 
2005).  eCB-LTD is abolished following single injection of cocaine and this effect 
is blocked in D1 receptor KO mice and when D1 receptor antagonist are 
administered with cocaine (Fourgeaud et al., 2004).  Additionally this form of LTD 
is blocked in morphine withdrawn animals (Robbe et al., 2002a), during cocaine 
self-administration (Martin et al., 2006), and after the chronic treatment with 
cannabis derivatives (Hoffman et al., 2003).  These data suggest that LTD is 
induced in vivo following chronic drug administration, therefore occluding 
subsequent LTD ex vivo.  In addition to electrophysiological changes following 
psychostimulant exposure long lasting increases in spine density are observed 
following cocaine or amphetamine administration in the nucleus accumbens 
(Robinson and Kolb, 2004).   
Recently, it has been demonstrated that extended withdrawal following 
chronic cocaine administration leads to synaptic potentiation in the NAc shell 
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region and that subsequent re-exposure to cocaine reverses a synaptic 
potentiation to a synaptic depression (Kourrich et al., 2007).  These data suggest 
that drug history determines the directionality of the plasticity in the NAc shell.  
Additionally, exposure to cocaine leads to the development of silent synapses in 
adulthood, accompanied by the insertion of new GluN2B subunits of the NMDA 
receptor (Huang et al., 2009).  Along with changes in synaptic transmission, 
drugs of abuse like cocaine and amphetamine can impart long lasting changes in 
the intrinsic excitability of NAc MSNs.  Chronic cocaine or amphetamine 
exposure leads to decreases in excitability in the nucleus accumbens shell region 
that starts within 1-3 days and persists for at least 2 weeks.  The same drug 
regimen leads to an increase in intrinsic excitability in the NAc core region during 
early withdrawal (1-3 days), but returns to baseline after protracted withdrawal (2 
weeks).  These bidirectional changes in intrinsic excitability seem to be mediated 
by changes in the A-type potassium current (Kourrich and Thomas, 2009).   
Interestingly, chronic cocaine administration leads to a downregulation of 
the postsynaptic density scaffolding protein PSD-95.  Downregulation of PSD-95 
correlates with synaptic potentiation and a PSD-95 targeted deletion enhances 
LTP and augments the locomotor activating effects of cocaine (Yao et al., 2004).  
Cyclin-dependent kinase 5 (CDK5) is a downstream target gene of the 
transcription factor deltaFosB, which accumulates in striatal neurons following 
cocaine administration.  Enhanced cyclin-dependent kinase 5 (CDK5) expression 
in the NAc occurs following short access to self-administered cocaine (Seiwell et 
al., 2007), while inhibition of CDK5 augments both the development and 
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expression of cocaine sensitization and enhances the incentive-motivational 
effects of cocaine (Taylor et al., 2007).   
In all, drugs of abuse have been shown to modulate both the induction 
and directionality of plasticity in the nucleus accumbens.  Like in the dorsal 
striatum the interactions between glutamatergic and dopaminergic systems are 
important for plasticity in this region.  While many drugs have a common end 
point of elevating dopamine acutely in nucleus accumbens, chronic drug 
administration often leads to long lasting modification of synapses, emphasizing 
the importance of drug history, including withdrawal, when interpreting whether 
LTP or LTD is expressed.    
 
Striatal MSN Intrinsic Excitability 
MSNs are known for a hyperpolarized resting membrane potential (-80mV 
or lesser), low input resistance, and a prolonged delay for first action potential 
firing (Kita et al., 1984; Kawaguchi et al., 1989).  Several types of potassium 
conductances shape the firing patterns of MSNs and underlie their 
hyperpolarized basal resting membrane potential (Nisenbaum and Wilson, 1995).  
One prominent player, the inwardly rectifying potassium channel (Kir), is a 
voltage sensitive potassium channel that is permeable to potassium at 
hyperpolarized potentials, but blocked by intracellular polyamines at depolarized 
potentials.  Inwardly rectifying potassium conductances, predominately Kir2, are 
open at rest contributing to a hyperpolarized resting membrane potential, rapid 
membrane time constants, and low input resistance (Uchimura et al., 1989; Jiang 
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and North, 1991; Nisenbaum et al., 1996; Mermelstein et al., 1998).  Upon 
depolarization or upstate transition, inwardly rectifying potassium channels 
inactivate and both A-type potassium currents, KV4.2 (fast inactivating) and 
KV1.2 (slow inactivating), as well as a persistent Kv7 conductance activates and 
generates a  slow depolarization and long delay to first AP (Surmeier et al., 1989; 
Surmeier et al., 1991; Nisenbaum et al., 1996; Tkatch et al., 2000; Shen et al., 
2004; Shen et al., 2005).  The voltage ramp to first AP is shaped by Kv1 and Kv7 
(KCNQ) potassium channels, as well as Nav1 sodium channels and Kv4 
potassium channels (Tkatch et al., 2000; Shen et al., 2004; Shen et al., 2005; 
Carrillo-Reid et al., 2009).  Additionally, depolarization activates both small (SK) 
and large (BK) calcium-activated potassium channels along with Kv1 and Kv7 
channels which together act to counter depolarization and slow action potential 
firing (Bargas et al., 1999; Galarraga et al., 2007).  More recently it has been 
found that spatially convergent synaptic inputs can recruit Cav3 calcium channels 
and NMDARs to produce a regenerative event (Plotkin et al., 2011).   
Alterations in CaMKII activity is linked to alterations in intrinsic excitability. 
Autonomously active CaMKII suppresses neuronal excitability by increasing cell-
surface expression of an A-type K+ channel, Kv4.2, via phosphorylation (Roeper 
et al., 1997; Park et al., 2002; Varga et al., 2004).  In addition, CaMKII inhibition 
in medial vestibular nucleus neurons increases intrinsic excitability via a 
reduction in BK-type calcium activated potassium currents (Nelson et al., 2005).  
In dissociated cortical neurons, CaMKII inhibition induces hyperexcitability and 
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neurotoxicity via dysregulated glutamate/calcium signaling (Ashpole et al., 
2012b).    
While the D1R-containing and D2R-containing MSN subclasses have 
many similar properties, notable differences have arisen.  Initial hints of these 
differences were observed using post hoc reverse-transcriptase polymerase 
chain reaction (RT-PCR) to identify direct and indirect pathway MSNs 
(Mermelstein et al., 1998).  More recently, a novel translational profiling approach 
using BAC transgenic mice allows for the affinity purification of polysomal 
mRNAs from direct or indirect pathway MSNs assisting in the identification of 
molecular changes (Heiman et al., 2008).  Indirect pathway neurons had Kir 
channels that inactivated at more hyperpolarized potentials and had smaller 
amplitudes than direct pathway MSN.  Further studies confirmed that D2R-
containing MSNs fire at nearly twice the rate of D1R-containing MSNs in 
response to depolarizing current injection (Kreitzer and Malenka, 2007).  Other 
differences include indirect pathway MSNs exhibit greater inhibition by 
muscarinic M1 receptors activation than directly pathway MSNs (Shen et al., 
2007).  Additionally, indirect pathway MSNs showed increased input resistance 
and a more depolarized resting membrane potential and these differences persist 
throughout development (Gertler et al., 2008).  MSNs also differ in their activity 
level during cortically driven up state transitions (Wickens and Wilson, 1998).  
While indirect pathway MSN Kir channel expression contributes to enhanced 
excitability, differences still persist following inactivation with substantial 
depolarization suggesting other players are involved.  More recent observations 
75 
 
using bacterial artificial chromosome (BAC) mice suggest that the underlying 
reason for enhanced excitability in indirect pathway MSNs is smaller dendritic 
trees than direct pathway MSNs (Gertler et al., 2008).    
Neuromodulators like dopamine and acetylcholine shape the firing 
properties of MSNs through alterations in sodium, potassium and calcium 
channels.  Activation of D1R on direct pathway MSNs reduces sodium currents 
(Schiffmann et al., 1995) and enhances Kir (Pacheco-Cano et al., 1996) together 
reducing MSN excitability.  Yet in the upstate D1R activation can enhance L-type 
calcium currents and block slowly inactivating potassium current which should 
enhance spiking (Surmeier et al., 1995; Nisenbaum et al., 1998; Carter and 
Sabatini, 2004).  These seemingly contradictory findings allow D1R signaling in 
the downstate to act as a filter opposing up state transitions, however once in the 
up state D1R can enhance MSN firing.  D2R activation on indirect pathway 
MSNs leads to opposing effects.  D2R stimulation reduces up state transitions 
and reduces spiking in the upstate by inhibiting L-type calcium channels 
(Hernandez-Lopez et al., 2000).  M1R activation in MSNs inhibits Kir channels 
via phospholipase C activation, blocks persistent potassium currents mediated by 
Kv7 channels, and inhibits N- and P/Q- type calcium channels which couple to 
SK and BK channels (Shen et al., 2005; Shen et al., 2007).  In all M1R activation 
increases MSN excitability and increases the likelihood of up state transitions.               
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Conclusions 
The striatum represents a major site of plasticity in the basal ganglia.  
Interactions between fast excitatory glutamatergic synaptic transmission and 
slower dopaminergic and cholinergic modulation are critical for plasticity in this 
region.  This is a region of complex anatomy that exhibits a wealth of long-lasting 
synaptic modifications.  Dopamine’s importance is reflected by altered plasticity 
seen following dopamine depletion, subsequent dopamine replacement therapies 
and chronic administration of drugs of abuse.  We are just beginning to 
understand how plasticity in the striatum influences normal behaviors and its role 
in disease.  The advent of BAC D1-EGFP and D2-EGFP transgenic mice to 
separate direct and indirect pathway MSNs along with targeted whole cell 
recordings of specific interneuron populations will continue to aid our 
understanding. New techniques utilizing channelrhodopsin or halorhodopsin, 
which can control firing rate of transfected cells with light in vitro or in vivo, will 
accelerate our knowledge of basal ganglia function and open the possibility of 
specific neural circuit control (Gradinaru et al., 2009).  Gaining a more complete 
understanding of mechanisms underlying synaptic plasticity in the basal ganglia 
will hopefully allow for basic understanding of basal ganglia associated behaviors 
as well as open new avenues for therapeutic intervention in disease.   
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Hypothesis 
Inhibition of striatal CaMKII alters glutamatergic synaptic transmission and 
intrinsic excitability 
 
Specific Aims 
1. Test the hypothesis that genetic inhibition of CaMKII regulates synapse 
number in medium spiny neurons 
2. Test the hypothesis that genetic inhibition of striatal CaMKII alters MSN 
intrinsic excitability 
3. Test the hypothesis that inhibition of CaMKII alters striatal-related 
behaviors     
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Chapter II 
 
MATERIALS AND METHODS 
 
Generation of EAC3I-4 Transgenic Mice 
For generation of double transgenic EAC3I-4 X tTA animals, heterozygous 
transgenic mice carrying the tTA gene driven by an alpha CaMKII promoter 
fragment were bred to heterozygous mice carrying the EAC3I transgene fused to 
EGFP driven by the tetO promoter.  The CaMKIIα-tTA mice were obtained from 
Dr. Eric Kandel’s lab and are maintained at Vanderbilt University.  The 
autocamtide-3 derived inhibitory peptide (EAC3I) sequence (KKALHRQEAVDAL) 
mimics the autoinhibitory region of the CaMKII regulatory domain (residues 278-
290) and acts by competitively binding to the catalytic site.  In in vitro biochemical 
assays AC3-I blocks the phosphorylation of an autocamtide-2 substrate by 
purified rat CaM kinase with an IC50 of 3µM (Braun and Schulman, 1995; Wu et 
al., 2002), with a ≥100-fold reduced potency toward protein kinase C, CaM 
kinase I or CaM kinase IV (Braun and Schulman, 1995; Patel et al., 1999; Vest et 
al., 2007).  EAC3-I is made up of the AC3-I peptide fused N-terminal to enhanced 
green fluorescent protein (EGFP) to stabilize and mark cellular and tissue 
distribution.  In a previous study, EAC3I was transgenically expressed in the 
heart and total CaMKII activity in extracts was reduced by ≈40% (Zhang et al., 
2005).  This level of inhibition is likely to be a substantial underestimate of in vivo 
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inhibition, because proteins were diluted upon homogenization due to mosaic 
transgene expression.   
I quantified the level of mosaicism in our EAC3-I mouse by staining with a 
NeuN antibody (1:1000, Millipore) to label all neurons (See supplemental for 
detailed immunohistochemical labeling).  Manual counts of the number of EGFP 
positive neurons versus total number of NeuN stained neurons in z-stacks in the 
dorsal lateral striatum were made in Metamorph (Molecular Devices; Sunny Vale, 
CA), providing an estimate of the percent of cells expressing the transgene.  
TetO-linked transgene expression is controlled using mouse chow containing 
200mg/kg Doxycycline (DOX) (Bio-Serv; Frenchtown, NJ).  For DOX rescue 
experiments pregnant dams were fed DOX and weaned pups continued with the 
same food.  At 6 weeks DOX was removed and the transgene was allowed to be 
expressed for 4-5 weeks.  All DOX recordings were made between 10-11 weeks.   
All mice had been inbred onto a C57BL/6 background for more than seven 
generations.  GluA1 knockout mice and wildtype littermates 8-16 weeks of age 
were utilized.  
 
Brain Slice Preparation 
All procedures were performed according to Vanderbilt University 
Institutional Animal Care and Use Committee approved procedures.  Male and 
female EAC3I-4 transgenic mice or littermate controls (9-13 weeks or 3-4 weeks 
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animals when indicated) were decapitated under anesthesia (Isoflurane). The 
brains were quickly removed and placed in ice-cold sucrose-artificial 
cerebrospinal fluid (ACSF): (in mM) 194 sucrose, 20 NaCl, 4.4 KCl, 2 CaCl2, 1 
MgCl2, 1.2 NaH2PO4, 10.0 glucose, and 26.0 NaHCO3 saturated with 95% 
O2/5% CO2.  Hemisected coronal slices 300 µm in thickness were prepared using 
a Tissue Slicer (Leica).  Slices containing dorsal lateral striatum were collected 
rostral to the crossing of the anterior commissure (Bregma 1.10–0.2 mm) 
(Franklin and Paxinos 1997).  Slices were then stored in a heated (approximately 
28°C), oxygenated (95% O2-5% CO2) holding chamber containing ‘normal’ ACSF 
[ACSF: (in mM) 124 NaCl, 4.4 KCl, 2 CaCl2, 1.2 MgSO4, 1 NaH2PO4, 10.0 
glucose, and 26.0 NaHCO3] for 1 hour and then transferred to a submersion-type 
recording chamber (Warner Instruments) where they were superfused with 
heated (28°C) oxygenated ACSF at a rate of about 2-3 ml/min.  Preparation of 
GluA1KO animals and controls brain slices used very similar methodology except 
the high sucrose ACSF contained (in mM): 194 sucrose, 30 NaCl, 4.5 KCl, 1 
MgCl2, 26 NaHCO3, 1.2 NaH2PO4, and 10 glucose and 250 µm thick brain slices 
were placed in 30°C oxygenated ACSF containing (in mM): 124 NaCl, 4.5 KCl, 2 
CaCl2, 1 MgCl2, 26 NaHCO3, 1.2 NaH2PO4, and 10 glucose for 30 minutes 
followed by 30 minutes at room temperature before moving hemisections to the 
recording chamber.  
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Whole-Cell Voltage Clamp Recordings 
MSNs of the dorsal lateral striatum were directly visualized with infrared 
video microscopy (Olympus BX51WI with QImaging Rolera-XP Camera).  Only 
highly expressing EGFP-containing MSNs were selected for study and compared 
to neighboring MSNs visually devoid of EGFP expression.  Recording electrodes 
(3-6 MΩ) were pulled on Flaming-Brown Micropipette Puller (Sutter Instruments) 
using thin-walled borosilicate glass capillaries (WPI).  EPSCs were evoked by 
local fiber stimulation with bipolar nichrome electrodes.  Stimulating electrodes 
were placed on the border of the corpus callosum and dorsal lateral striatum 100-
300 µm dorsal to the recorded neuron, and electrical stimulation (5-20 V with a 
100-150 µs duration, Grass Instruments) were applied at 0.05Hz unless 
otherwise noted.  This location most likely stimulates both cortical and thalamic 
glutamatergic axons onto MSNs.  Recording electrodes (3-6 MΩ) were filled with 
(in mM) Cs+ gluconate (117), HEPES (20), EGTA (0.4), TEA (5), MgCl2 (2), ATP 
(4), GTP (0.3) pH 7.35, 285-290 mOsm.  Series resistance averaging 16 MΩ 
(ranging 8-30 MΩ) was monitored and experiments with changes greater than 
20% were omitted.   AMPAR EPSCs and sEPSCs were isolated by adding 25µM 
picrotoxin and recording at a holding potential of -70mV in normal ACSF.  To 
isolate mEPSCs 1uM TTX was added in addition to sEPSCs recording 
conditions.  In all experiments a time period of at least 5 minutes post break in 
was allowed for internal solution exchange and stabilization of membrane 
properties.  GluA1KO sEPSC recordings were conducted similarly except 
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recording ACSF contained 50 µM picrotoxin and internal solution contained (in 
mM) 120 CsMeSO3, 5 NaCl, 10 TEA-Cl, 10 HEPES, 5 QX-314, 1.1 EGTA, 0.3 
Na-GTP, and 4 Mg-ATP, 295-300 mOsm.  GluA1 WT and KO littermate mice 
were 8-16 weeks of age at time of recording.  In PPR experiments evoked 100-
200 pA responses were elicited with the interstimulus interval set at 40 ms, 50 ms 
and 60 ms. For MK-801 experiments NMDAR currents were pharmacologically 
isolated (25 µM picrotoxin, 10 µM NBQX) and held at +40 mV while a stable ten 
minute baseline (0.05 Hz) was acquired.  After a stable baseline was acquired 
the stimulator was switched off and 10 µM MK-801 was washed on for seven 
minutes.  Following the wash-in period the stimulator was turned on (0.1 Hz) and 
the time constant for decay of the integral of the NMDAR current was calculated 
using nonlinear regression one-phase decay.  For baclofen modulation of PPR, 
20 sweeps of approximately 200pA EPSCs (0.05 Hz) were collected to establish 
a baseline.  Following a wash-in of 10uM baclofen for 8 minutes, an additional 20 
sweeps were collected.  Additional 20 sweeps were taken at 10 minutes and 20 
minutes post washout.  CV was calculated by dividing the SD of the amplitude of 
the evoked EPSCs by the mean.  For rectification experiments evoked AMPAR-
mediated EPSCs were isolated in 25 µm picrotoxin and 100 µm DL-APV 
containing aCSF while the voltage was stepped from -70mV to +40mV in 10mV 
steps.  0.1mM spermine was included in the standard cesium internal solution to 
avoid dialysis of endogenous polyamines.  The rectification index (RI) was 
calculated as the ratio of the amplitude of AMPAR-mediated currents evoked at -
70mV over +40mV.  All signals were acquired via a Multiclamp 700B amplifier 
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(Axon Instruments), digitized at 10 kHz, filtered at 2 kHz and analyzed via 
pClamp 10.2 software (Axon Instruments).  Holding current and series resistance 
were all monitored continuously throughout the duration of experiments.  
Experiments in which changes in series resistance were greater than 20% were 
not included in the data analysis.  
Statistical analyses were performed using Graphpad Prism 5.04.  Two-
tailed unpaired Student’s t-test (t) were used unless variance differed significantly 
(Bartlett’s test for equal variances) then non-parametric Mann-Whitney (U) tests 
were used.  One or Two-way analysis of variance (ANOVA) (F) were used when 
indicated with Neuman-Keuls Multiple Comparison post hoc test.  Non-
parametric Kruskal-Wallis tests (H) were used with Dunn’s Multiple Comparison 
post hoc test when variances differed significantly (Bartlett’s test for equal 
variances).  All values given are presented as average ± SEM.  Cumulative 
probability plots were analyzed with Kolmogorov-Smirnov (KS) test. 
 
Whole-Cell Current Clamp Recordings 
Slices were prepared as before, but perfused with ACSF containing (in 
mM):  NaCl (124), NaH2PO4 (1.25), KCl (2.5), CaCl2 (2.5), MgSO4 (2), NaHCO3 
(26), Glucose (11) pH=7.35, 300-305mOsm.  Recording electrodes were filled 
with in (mM): K+ gluconate (120), NaCl (4), HEPES (10), Mg-ATP (4), Na-GTP 
(0.3), KCl (20), Na+ Phosphocreatine (10) pH= 7.3, 285-290 mOsm.   MSNs 
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were identified by their intrinsic membrane properties (i.e. resting membrane 
typically more negative than -80 mV, inward and outward rectification in response 
to somatic positive and negative current injections, and a long depolarizing ramp 
to delayed first spike discharge (Kawaguchi et al., 1989).  Recordings were 
rejected if the initial Vm was more positive than -75 mV.  Resting membrane 
potential or zero current potential was determined right upon break-in.  
Spontaneous excitatory postsynaptic potentials after 5 minutes post break in 
were recorded for 4 minutes with the cell dynamically current clamped at -85mV.   
Resting membrane potential was monitored and current was injected to maintain 
the resting potential at -85 mV.  For current-voltage (IV) relationships positive or 
negative current injections were given in 20 pA steps until the cell reached 
threshold and fired a single AP.  Five additional current injections steps (20 pA 
each) were given above threshold.  Input resistance was monitored throughout 
the experiment and the cell was rejected if the input resistance changed by more 
than 20%.  Healthy cells showed APs that crossed +30 mV and stable resting 
membrane potentials.     
 
Lucifer Yellow Intracellular Fills, Confocal Imaging and Measurement of 
Dendritic Structure 
Transgenic EAC3I mice (3-4 months) were perfused with 10 ml room 
temperature phosphate buffered saline (PBS) followed by 100 ml of 4% 
paraformaldehyde solution delivered over 10-20 minutes.  Brains were post-fixed 
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in ice cold paraformaldehyde solution for an additional hour before 200 µm thick 
coronal sections of the precommissural striatum were prepared on a vibrating 
microtome (Leica; Buffalo Grove, IL).  MSN cell bodies in dorsolateral striatum 
were visualized at 40X.  Randomly selected EAC3I-expressing (EGFP-positive) 
MSNs and non-fluorescent (EGFP-negative) MSNs in the dorsal lateral striatum 
were iontophoretically filled with an 8% solution of Lucifer yellow (LY; Sigma-
Aldrich, in 50 mM Tris-HCl, pH 7.4) using hyperpolarizing current (3-5 nA for 8-10 
minutes).   Slices were fixed in 4% paraformaldehyde/PBS overnight at 4°C and 
then coverslipped using Prolong Gold mounting solution (Invitrogen; Grand 
Island, NY).  
Digital images of MSN dendritic segments located 80-100 µm distal to the 
cell soma were captured using a Zeiss LSM 710 confocal microscope with x63 oil 
immersion objective and x2.5 digital zoom.  Spine density of three to four 
dendritic segments emanating from different primary dendrites was averaged to 
yield a mean spine density value per MSN.  A total of 17 EAC3I-negative MSNs 
and 16 EAC3I-positive MSNs were analyzed; these were obtained from four 
different mice of each genotype.  After the confocal images were coded by 
someone not involved in the study, another person unaware of the animal or 
genotype of the MSN being examined used Imaris (Version 5.5; Bitplane) to 
quantify dendritic spine density.  A three-dimensional perspective in “surpass” 
mode of the software package was generated and images were processed with 
background subtraction thresholding and smoothed with a Gaussian filter.  
86 
 
Dendritic segments were modeled with the largest and smallest diameters set at 
2 µm and 1 µm, respectively.  Florescence in each dendritic segment was 
thresholded manually to capture all dendritic spines.  The minimum terminal point 
spine diameter was set at 0.143 µm and the fluorescence contrast threshold was 
set at 1.  Identified spines were counted and marked in 3D on a rotating version 
of the image.  Finally, each structure identified as a spine by the Imaris software 
was visually verified.  In order to determine total dendritic length and generate a 
Sholl analysis (number of dendritic branches intersecting circular rings drawn 
around the soma every 20 µm distal to the soma), we used Neurolucida Explorer 
(MicroBrightField; Willington, VT). 
     
Immunohistochemistry 
Mice were perfused with 10mL of ice cold 0.1M PBS followed by 20 mL of 
ice cold 4% paraformaldehyde /0.1M PBS.  Brains were postfixed in the same 
fixative overnight at 4°C and then cyroprotected with 30% sucrose/0.1M PBS 
until the brain equilibrated.  Parasagittal sections (100µm thick) or coronal slices 
(40µm) were taken on a Leica cryostat.  The slices were counterstained with nissl 
stain (Neurotrace 530/615, Life Technologies).  Free-floating, coronal slices were 
washed in 4X PBS and then permeabilized in 0.5% TritonX/PBS for 30 minutes.  
The slices were then blocked in 10% normal donkey serum/0.1% TritonX/PBS for 
1 hour at room temperature.  Some slices were stained with a primary antibody 
to NeuN (mouse clone A60; 1:2000, Chemicon/Millipore), a neuronal marker in 
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10%/NDS/0.1% TritonX/PBS and placed on a rocker at 4°C for 48 hours.  Slices 
were then washed 4X10mins in PBS.  A secondary antibody conjugated to CY5 
(Jackson ImmunoResearch) and raised against the primary antibody host was 
added to the slices and incubated for two hours at room temperature.  Slices 
were then washed 4X10 minutes and mounted on Fisher Superfrost Plus slides 
(Fisher Scientific).  Slices were allowed to dry for 5-20 minutes and coverslipped 
with Aqua Poly/mount (Polysciences, Inc).  EGFP and fluorescent probes were 
imaged with Zeiss 510 or 710 confocal microscopes.  
          
Sample Collection and Quantification of Biogenic Amine Levels 
Mice were anesthetized with isofurane and quickly decapitated.  Brains 
were quickly dissected (less than a minute) and slices 1mm thick were made of 
the striatum and quickly frozen on dry ice.  1mm tissue punches were collected 
and placed at -80C.  Detection and quantification of monoamine levels and 
metabolites was performed by the Vanderbilt Neurochemistry Core.  
Determinations are achieved using two dedicated waters high performance liquid 
chromatography systems equipped with autosamplers and either a Decade II 
electrochemical (monoamines) or 474 scanning fluorescence (amino acids) 
detector(Hnasko et al., 2006). 
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Pharmacology 
Picrotoxin, (+)Mk-801 maleate ((5S,10R)-(+)-5-Methyl-10,11-dihydro-5H-
dibenzo[a,dicyclohepten-5,10-imine maleate), NBQX (2,3-Dioxo-6-nitro-1,2,3,4-
tetrahydrobenzo[f]quinoxaline -7-sulfonamide), (R)-Baclofen ((R)-4-Amino-3-(4-
chlorophenyl)butanoic acid), and DL-APV (DL-2-Amino-5-phosphonopentanoic 
acid) were purchased from Tocris (Ellisville, Missouri).  DMSO (0.05%) (Sigma) 
was used as a vehicle for picrotoxin. 
  
Rotarod 
All animals were handled for three days prior to starting behavioral testing.  
Animals were placed on an accelerating rotarod (4-40rpm) for up to 5 minutes.  
Latency to fall was measured.  Three trials with a 30 minute ITI were given on 
day 1 followed by five trials on day 7. 
  
Locomotor Sensitization 
Mice were habituated to handling and injection for three days prior to the 
beginning of the experiment.  Sessions were performed using automated 
experimental chambers (27.9×27.9 cm; MED-OFA-510; MED Associates, 
Georgia, VT) under constant illumination within a sound-attenuated room. 
Analysis of locomotor activity was performed using Activity Monitor v5.10 (MED 
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Associates).  For each of 5 days, mice were first injected with saline (10 ml/kg), 
and then placed in open field chambers for 30 min and activity was recorded.  
Immediately after the 30 min session, each mouse was injected with cocaine (10 
mg/kg; 10 ml/kg) and placed back into the same chamber and activity was 
recorded for 30 min. Two weeks following the 5th day, mice underwent a 
challenge session that was identical to the other sessions.   
 
Operant Testing 
Operant training chambers were as described (Olsen and Winder 
Neuropsychopharmacology (2009)), with levers mounted 2.2 cm above the grid 
floor and cue lamps (yellow LEDs) mounted 2 cm above them.  Mice were food 
restricted where chow was available 2 hours per day.  Subjects first underwent a 
single day of magazine training (50 non-contingent reinforcers of 25% Ensure 
given on a VI-30 interval) where neither lever was available.  In subsequent daily 
sessions, mice underwent operant conditioning in a food self-administration task.  
Operant sessions were conducted between 0900-1400 h. During operant 
training, mice were trained to lever press for access to a liquid reinforcer (25% 
Ensure) delivered by a liquid dipper (ENV-302W). The dipper was available for 
10 s after head entry into the dispenser, and the cue lights remained illuminated 
until the end of the 10-s access.   
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At the beginning of each session, the house light was illuminated, the 
exhaust fan was turned on, and an initial noncontingent reinforcer was available 
concurrent with illumination of the cue lights.  After retrieving the initial reinforcer, 
both levers were extended.  Each mouse was assigned either the left or right 
lever to be the active lever, and the side of the active lever was counterbalanced 
between mice within each genotype.   
Completion of the required ratio on the active lever resulted in illumination 
of the cue lights and elevation of a dipper cup containing ~40 ul of liquid food 
reinforcer (25% Vanilla Ensure®).  The dipper was available for 10 seconds after 
head entry into the dispenser, and the cue lights remained illuminated until the 
end of the 10-second access.  The experiment began with 6 30-min sessions 
where each active lever press was reinforced (Fixed Ratio-1, FR-1).  Next, mice 
were advanced to a random-ratio 5 (RR-5) schedule of reinforcement, where 
each lever press had a 20% chance of being reinforced (30-min sessions, 50 
reinforcers maximum).  Mice underwent 4 days of RR-5 testing, then 4 days each 
of RR-10 (10% chance of reinforcement per lever press; 50 reinforcers 
maximum) and RR-20 (5% chance of reinforcement per lever press; 25 
reinforcers maximum) testing.  Following RR-20 testing, mice were tested using a 
devaluation procedure, where mice were prefed either the reinforcer (25% 
Ensure) or standard lab chow on one day, with pre-feeding of the alternate food 
type on the subsequent day (order counterbalanced within genotype).  
Prefeeding lasted one hour and occurred immediately prior to testing in the 
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operant chamber under extinction conditions.  Next, mice had 4 days of RR-20 
under standard food restriction schedule (2 hour/day access), and then mice 
were tested under conditions of contingency degradation for 3 sessions.  Under 
these conditions, 25 reinforcers were given in a non-contingent manner at a rate 
that the group (genotype) had previously earned under RR-20 conditions and 
lever pressing was recorded (although there was no consequence of lever 
pressing).   
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CHAPTER III 
 
GENETIC INHIBITION OF CAMKII IN DORSAL STRIATAL MEDIUM SPINY 
NEURONS REDUCES FUNCTIONAL EXCITATORY SYNAPSES AND 
ENHANCES INTRINSIC EXCITABILITY 
 
Introduction 
The striatum is the major input nucleus of the basal ganglia (Yin and 
Knowlton, 2006).  Dysfunction in this region is associated with drug addiction, 
Parkinson’s disease and other disorders (Jenner, 2008; Kreitzer and Malenka, 
2008; Milnerwood and Raymond, 2010; Redgrave et al., 2010; Luscher and 
Malenka, 2011; Wan et al., 2011; Yang and Lu, 2011).  The striatum is primarily 
composed of projection GABAergic medium spiny neurons (MSNs) that integrate 
glutamatergic excitatory transmission with modulatory dopaminergic 
transmission.  Since MSN firing is thought to be driven primarily by excitatory 
drive, understanding the basic mechanisms of glutamatergic transmission onto 
MSNs is necessary to understand how the striatum functions in health and 
disease. 
Calcium-calmodulin-dependent kinase II (CaMKII) is a Ser/Thr kinase that 
is highly expressed in the striatum, constituting ~0.7% of total striatal protein 
(Erondu and Kennedy, 1985).  CaMKII assembles into dodecameric complexes 
that in the striatum predominantly contain CaMKIIα and CaMKIIβ isoforms 
(Lisman et al., 2002).  As a major constituent of the postsynaptic density (PSD) in 
the dorsal striatum (Fukunaga et al., 1988) as well as other forebrain regions 
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(Cheng et al., 2006; Baucum et al., 2012), CaMKII is activated by N-methyl-D-
aspartate-receptor (NMDAR)-mediated calcium influx (Silva et al., 1992; Giese et 
al., 1998; Hinds et al., 1998).  CaMKII is a key modulator of hippocampal and 
cortical pyramidal cell glutamate synapse function (Wayman et al., 2008; Lee et 
al., 2009; Lucchesi et al., 2011).  CaMKII can phosphorylate many downstream 
substrates including the ionotropic glutamate receptors NMDARs and α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) (Barria et al., 
1997a; Mammen et al., 1997; Benke et al., 1998; Derkach et al., 1999; Lee et al., 
2000; Strack et al., 2000).  Indeed, in hippocampal pyramidal cells, CaMKII 
activation enhances synaptic trafficking of AMPARs and channel function (Lledo 
et al., 1998; Shi et al., 1999; Hayashi et al., 2000; Shi et al., 2001).  In addition, a 
constitutively active form of CaMKII can decrease intrinsic excitability of 
hippocampal neurons as well as MSNs in the nucleus accumbens shell (Varga et 
al., 2004; Kourrich et al., 2012).  While much is known about the role of CaMKII 
at glutamate synapses on glutamatergic projection neurons such as hippocampal 
and cortical pyramidal neurons, relatively little is known for GABAergic cells.  
Indeed, little CaMKII is expressed in GABAergic interneurons (Jones et al., 1994; 
Liu and Jones, 1996; Sik et al., 1998), making GABAergic projection cells such 
as MSNs, which are highly enriched in CaMKII, unique targets for studying the 
role of CaMKII in synaptic transmission and intrinsic excitability.   
Previous studies have implicated striatal CaMKII in Parkinson’s disease 
(PD) and addiction.  CaMKII is hyperactivated after striatal dopamine depletion, 
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and CaMKII inhibition rescued striatal synaptic plasticity and motor deficits found 
in animal models of Parkinson’s disease (Picconi et al., 2004b).  Striatal CaMKII 
is also essential for the motivational effects of reward cues on goal-directed 
behaviors (Wiltgen et al., 2007) as well as curbing D1R-mediated cocaine 
hyperlocomotion (Stein and Hell, 2010) and modulating excitability following 
chronic cocaine administration(Kourrich et al., 2012).  Thus, a better 
understanding of CaMKII’s role in striatal glutamatergic synaptic transmission 
may suggest new approaches to treat PD and addiction.  
In addition to its postsynaptic roles, CaMKII modulates a variety of 
presynaptic functions, including trafficking of synaptic vesicles (Llinas et al., 
1985; Lin et al., 1990; Waxham et al., 1993; Stefani et al., 1997; Chi et al., 2001), 
P/Q type calcium channels (Elgersma et al., 2002; Hojjati et al., 2007; Jiang et 
al., 2008), voltage-gated sodium channels (Carlier et al., 2000; Wagner et al., 
2006), catecholamine synthesis (Yamauchi et al., 1981; Atkinson et al., 1987) 
and dopamine transporter function (Fog et al., 2006; Binda et al., 2008).  Thus, 
an investigation of the role of CaMKII within striatal MSNs requires a cell-specific 
approach.  To accomplish this, we generated a transgenic mouse line that 
expresses a CaMKII inhibitory peptide selectively within dorsal striatal MSNs.  
Using this line, we found that CaMKII inhibition in dorsal striatal MSNs leads to a 
loss of functional glutamatergic synapses and an increase in intrinsic excitability.  
These findings shed light on the neural mechanisms underlying the development 
of striatal neural circuits, learning and memory, and motor behavior.         
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Results 
Characterization and in vivo localization/expression of CaMKII inhibitory (EAC3I) 
peptide   
 To determine the role CaMKII plays in modulating glutamatergic 
transmission onto MSNs in the dorsal lateral striatum, we generated a transgenic 
mouse model with striatally enriched expression of a CaMKII inhibitory peptide 
fused to enhanced green fluorescent protein (EGFP) referred to hereafter as 
EAC3I (Braun and Schulman, 1995).  The EAC3I peptide inhibits all isoforms of 
CaMKII, as well as both calcium-dependent and independent forms of the kinase, 
and the fusion with EGFP allows for visualization of the regional and cellular 
distribution of the transgenically expressed protein.  EAC3I was previously 
utilized in another transgenic line to examine the role of CaMKII in the heart 
(Zhang et al., 2005).  To spatially and temporally regulate EAC3I expression, the 
tetracycline transactivator (tTA) is driven by a CaMKIIα promoter fragment with 
the tTA gene product driving expression of EAC3I (Figure 5A).  Constitutive 
expression of the EAC3I transgene has no overt effect on viability or on gross 
brain morphology, and is silenced by including doxycycline (DOX, 200 mg/kg) in 
the animals’ chow for two weeks (Figure 5B).  The alpha CaMKII promoter 
normally restricts transgene expression to the forebrain, but this founder line 
exhibits enrichment of EAC3I expression in the MSNs of the dorsal striatum 
(Figure 5C, 5D), presumably due to integration-site dependent effects.  Little to 
no expression of the inhibitor was seen in cortex and thalamus (Figure 5C, 5D). 
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The EAC3I peptide is expressed in a mosaic pattern throughout the dorsal 
striatum, with 34±4% of neurons containing the inhibitory peptide (Figure 5D). 
The mosaicism observed is common in transgenic animals and different founder 
lines utilizing the alpha CaMKII promoter fragment to drive transgene expression 
show differing expression patterns throughout the forebrain (Mayford et al., 1996; 
Kaufman et al., 2008).  However, we observed no overlap of signal between 
EGFP positive neurons and striatal cholinergic and GABAergic interneuron 
markers such as ChaT, parvalbumin, NPY, and calretinin (Figure 6).  At higher 
magnification the EAC3I inhibitory peptide was observed in the MSN cell soma, 
dendrites and dendritic spines (Figure 5E).  Dense expression of EAC3I was 
detected in both the globus pallidus and in the substantia nigra pars reticulata 
(Figure 5C, 5F, 5H), but higher magnification images revealed the staining was 
localized to axons (Figure 5F), demonstrating that both indirect and direct 
pathway MSNs contain the inhibitory peptide (Figure 5C, 5F, 5H). 
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Figure 5. Characterization and in vivo localization/expression of CaMKII 
inhibitory (EAC3I) peptide in EAC3I mice. (A) Schematic of breeding strategy for 
production of EAC3I mice.  CaMKIIalpha promoter drives expression of tTA which 
binds to the tetO promoter and drives expression of EAC3I peptide fused to EGFP.  
(B) (Top) Brain slice of EAC3I under brightfield (left) and EGFP epifluorescence 
(right).  (Bottom) Brain slice of EAC3I as above following 3 weeks of doxycycline 
feeding (200 mg/kg).  Note lack of EAC3I-EGFP expression.  (C) Sagittal section of 
EAC3I mouse brain showing restricted endogenous EAC3I-EGFP expression (green) 
and nissl stain (red, neuronal marker).  Scale bar 500µm.  (D) Coronal image of 
mosaic expression of endogenous EAC3I-EGFP expression (green) in dorsal lateral 
striatum with a NeuN stain (blue, neuronal marker). Note little to no expression of 
EAC3I peptide in cortex. CC=corpus callosum, Scale bar 100 µm.  (E) 63X image of 
unstained EAC3I-EGFP expressing MSN (green=endogenous EGFP signal).  Note 
expression in soma, dendrites and dendritic spines (arrows).  Scale bar 10 µm.  (F) 
Images of globus pallidus (GP) (left) and substantia nigra pars reticulata (SNR) (right) 
showing MSN axon terminals (green) and nissl stain (red).  GP and SNR cell somas 
(red, nissl stain) are devoid of EGFP signal.  CP=cerebral peduncle.  Scale bars 20 
µm.  (G) (left) DIC image of patch pipette on a MSN in whole cell mode, (right) 
epifluorescence image of left panel confirming EAC3I-EGFP expression.  Scale bar 
20 µm.  (H) Overlaid coronal images showing EAC3I-EGFP MSN axon terminal field 
expression in globus pallidus (left) and substania nigra pars reticulata (right) 
confirming indirect and direct pathway expression, respectively. Scale bar 0.5 mm. 
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Figure 6. Striatal Interneuron Markers Do Not Colocalize with EAC3I 
Peptide. (A) 20X confocal image of dorsal lateral striatum from an EAC3I 
mouse of endogenous EGFP expression (green) and striatal ChAT 
immunopositive interneurons (red, 0/70 ChAT positive neurons contained 
EGFP).  Scale bar 100µm, inset 50µm. (B) Like A, but striatal parvalbumin 
immunopositive interneurons labeled (red, 0/37 parvalbumin positive neurons 
contained EGFP). Scale bar 100µm, inset 50µm. (C) Like A, but striatal NPY 
immunopositive interneurons labeled (red, 0/22 NPY positive neurons 
contained EGFP).  Scale bar 100µm, inset 50µm.  (D) Like A, but striatal 
calretinin immunopositive interneurons labeled (red, 0/15 calretinin positive 
neurons contained EGFP). Scale bar 100µm, inset 50µm.   
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Effects of CaMKII inhibition on MSN glutamatergic inputs in dorsal lateral 
striatum 
We initially recorded spontaneous excitatory postsynaptic currents 
(sEPSCs) from MSNs using whole-cell voltage clamp in the presence of 
picrotoxin to isolate excitatory transmission.  In this and subsequent 
electrophysiological analyses, we compared three control groups of MSNs with 
one experimental group: Control 1) MSNs from tTA- /tetO-EAC3I- mice (Wt), 
Control 2) MSNs from tTA+ /tetO-EAC3I- mice (tTA), Control 3) EGFP negative 
MSNs from tTA+/tetO-EAC3I+ mice (NON EGFP) and  Experimental 4) EGFP 
positive MSNs from tTA+/tetO-EAC3I+ mice (referred to as EAC3I MSNs 
(EGFP)).   
In adult mice no differences in sEPSC amplitudes were observed between 
MSNs from the four groups described above (in pA, Wt 13.39±0.81; tTA 
11.98±1.27; NON EGFP 14.97±1.38; EGFP 14.78±0.67) [F (3, 33) =1.46; p=NS; 
Figure 8A, 8G].  However, sEPSC frequency was markedly reduced in EAC3I 
MSNs relative to all control MSN groups (in Hz, Wt 3.20±0.24; tTA 2.85±0.17; 
NON EGFP 2.99±0.63; EGFP 1.07±0.15) [H (3, 33) =19.85; p=0.0002]; Figure 
8A, 8D].  Similar results were observed in sEPSC frequency in 3-4 week old mice 
(in Hz, NON EGFP 3.94±1.05; EGFP 1.08±0.23) [U (9) =3.000; p=0.0341; data 
not shown].  Additionally, we did not observe any differences in AMPAR-
mediated current voltage relationship between EAC3-I containing and lacking 
MSNs (Rectification Index (RI) = -70mV/+40mV, NON EGFP 1.97±0.18; EGFP 
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1.75±0.24) [t (8) =0.575; p=0.58; Figure 7A, 7B].  To determine if the decrease in 
sEPSC frequency was due to a change in the intrinsic electrical activity in the 
slice, we also examined activity-independent miniature EPSCs (mEPSCs) in the 
presence of TTX.  Similar to the results with sEPSCs, mEPSC frequency was 
also reduced in EAC3I MSNs (in Hz, Wt 3.62±0.32; tTA 4.88±0.67; NON EGFP 
3.89±0.41; EGFP 0.97±0.40) [F (3, 22) =9.688; p=0.0008]; Figure 8B, 8E], 
suggesting that this effect is independent of presynaptic excitability.   
 
 
 
 
 
Figure 7. AMPA Current Voltage (IV) Relationships are Not Altered 
Between EAC3I-Containing and EAC3I-Lacking MSNs. (A) Averaged 
normalized whole-cell IV relationships (-70mV to +40mV, 10mV steps) 
from EAC3I-containing (EGFP) and neighboring EAC3I-lacking 
(NONEGFP) MSNs (NON EGFP: n=5; EGFP: n=6; p=0.1751).  (B) 
Pooled data showing no change in rectification index (RI) (+40mV/-
70mV) (NON EGFP: n=5; EGFP: n=6; p=0.4775).  Error bars denote 
SEM, N.S. = not significant.    
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Figure 8.  In vivo expression of EAC3I decreases s/mEPSC frequency in dorsal 
lateral striatum MSNs.  (A) Representative sEPSC traces for NON EGFP (black) and 
EGFP (CaMKII-inhibited, green).  Scale bars 50 ms and 10 pA.  (B) Representative 
mEPSC traces for NON EGFP (black) and EGFP (CaMKII-inhibited, green).  Scale bars 
50 ms and 10 pA.  (C) Representative sEPSC traces for NON EGFP (black) and EGFP 
(CaMKII-inhibited, green) MSNs from animals that were fed DOX from birth to six weeks 
and then removed to allow EAC3I transgene expression.  Recordings were made 4-5 
weeks following DOX removal at a similar age to previous.  The scale bars are 50 ms and 
10 pA.   (D) (Left) Average sEPSC frequencies from EAC3I-containing MSNs compared 
to controls, (right) Cumulative probability distributions of sEPSC inter-event intervals (Wt: 
n=7, p=0.0001; tTA: n=5, p=0.0001; Non EGFP: n=9, p=0.0009; versus EGFP: n=13).  
(E) (left) Average mEPSC frequency from EAC3I MSNs compared to controls, (right) 
cumulative probability distributions of mEPSC frequency (Wt: n=5, p=0.0022; tTA: n=6, 
p<0.0001; Non EGFP: n=6, p=0.0019; versus EGFP: n=6).  (F) (Left) Average sEPSC 
frequencies from EAC3I-containing MSNs versus controls, (right) cumulative probability 
distributions of sEPSC inter-event intervals (Wt: n=8, p=0.99; tTA: n=7, p=0.99; Non 
EGFP: n=8, p=0.99; versus EGFP: n=10).  (G) (left) Average sEPSC amplitudes, (right) 
cumulative probability distributions of sEPSC amplitude (Wt: n=7, p=0.91; tTA: n=5, 
p=0.26; Non EGFP: n=9, p=0.99; versus EGFP: n=13).  (H) (left) Average mEPSC 
amplitude, (right) cumulative probability distributions of mEPSC amplitude (Wt: n=5, 
p=0.90; tTA: n=6, p=0.71; Non EGFP: n=6, p=0.96; versus EGFP: n=6).  (I) (left) Average 
sEPSC amplitudes, (right) cumulative probability distributions of sEPSC amplitude from 
animals that were fed DOX from birth to six weeks and then removed to allow EAC3I 
transgene expression  (Wt: n=8, p=0.99; tTA: n=7, p=0.34; Non EGFP: n=8, p=0.99; 
versus EGFP: n=10).   * P <0.05; ** P <0.01; *** P < 0.001; error bars represent SEM, 
N.S. = not significant.  Note: All neurons in panels A-I are held at -70mV during 
recordings.     
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The use of the tTA expression system provides DOX-dependent control of 
EAC3I expression (Figure 5B).  We suppressed expression of the transgene by 
supplementation of food with DOX (200 mg/kg) for both the dam and her litter 
until 6 weeks of age, and then recorded from EAC3I-expressing MSNs 4 weeks 
after removal of DOX.  Under these conditions, the global expression of EAC3I 
was markedly lower than in non-DOX exposed mice, as has been previously 
noted with the tTA expression system (Bejar et al., 2002).  Notably, sEPSC 
frequency in the EAC3I MSNs was not significantly different from controls (in Hz, 
Wt 2.91±0.46; tTA 2.65±0.48; NON EGFP 2.55±0.39; EGFP 2.42±0.39) [F (3, 32) 
=0.2434; p=NS]; Figure 8C, 8F].  These data indicate that the sEPSC frequency 
phenotype observed in no-DOX EAC3I MSNs is not likely due to an insertion site 
artifact.   
 
MSN CaMKII inhibition reduces excitatory transmission independently of 
changes in release probability 
The canonical interpretation of a reduction in s/mEPSC frequency is via a 
reduction in the probability of glutamate release or the number of release sites/ 
number of synapses.  In order to better understand the mechanism(s) underlying 
the reduction in s/mEPSC frequency in EAC3I MSNs we first examined paired-
pulse ratios (PPR) of evoked EPSCs, a measurement that inversely correlates 
with neurotransmitter release probability (Zucker and Regehr, 2002).  The PPR 
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of evoked EPSCs on control MSNs did not differ from that observed on EAC3I 
MSNs [PPR 40ms ISI: (Wt 1.10±0.03; tTA 1.16±0.15; NON EGFP 1.20±0.10; 
EGFP 1.01±0.07) H (3, 33) =2.436; p=NS; PPR 60ms ISI: (Wt 1.12±0.07; tTA 
1.17±0.16; NON EGFP 1.01±0.07; EGFP 0.94±0.06) F (3, 33) =1.377; p=NS; 
Figure 9A, 9B, 9C].  To show that we could predictably manipulate PPR we used 
the GABABR agonist baclofen (10 µM).  Baclofen acts presynaptically to reduce 
the probability of release and therefore increase PPR at a number of CNS 
synapses (Zucker and Regehr, 2002; Lei and McBain, 2003).  Baclofen 
increased the PPR in EAC3I MSNs to a similar extent as in control MSNs 
suggesting that release probability was modifiable in the CaMKII-inhibited cells 
and not at a floor (NON EGFP baseline 1.13±0.11, 10 µM baclofen 2.29±0.28, 20 
min washout 1.38±0.14; EGFP baseline 1.04±0.11, 10 µM baclofen 1.94±0.43, 
20 min washout 1.30±0.14) [F (1, 9) =0.5403; p=NS; Figure 9E].  Similar results 
were observed with coefficient of variation (CV) measures of evoked EPSCs, 
where baclofen application enhanced CV to the same degree in EAC3I MSNs 
and controls (NON EGFP baseline 0.21±0.05, 10µM baclofen 0.56±0.07, 20 min 
washout 0.24±0.07; EGFP baseline 0.23±0.05, 10µM baclofen 0.52±0.11, 20 min 
washout 0.31±0.06) [F (1, 9) =0.0047; p=NS; Figure 9D].  Additionally, we found 
that baclofen significantly decreased the sEPSC frequency to a similar extent in 
both EAC3I MSNs and controls (NON EGFP baseline 100±22.4%, 10 µM 
baclofen 37.8±11.1%; EGFP baseline 100±33.2%, 10µM baclofen 40.4±10.2%) 
[F (1, 9) =0.0025; p=NS; Figure 9F].  
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Figure 9.  Dorsal lateral striatum MSN CaMKII inhibition reduces excitatory 
transmission independently of changes in release probability.  (A) (Upper 
trace, black) NON EGFP (EAC3I-lacking) MSN PPR (50 ms ISI) example trace 
baseline (average of 20 sweeps, 0.05 Hz).  (Middle trace, black) EAC3I-lacking 
MSN PPR (50 ms ISI) example trace post 10 µM Baclofen wash in (average of 20 
sweeps, 0.05 Hz).  (Bottom trace, black) EAC3I-lacking MSN PPR (50 ms ISI) 
example trace 20 minutes post wash out of drug (average of 50 sweeps, 0.05 
Hz).  (B) Same as in (A), but for an EGFP (EAC3I-containing) MSN.  (C) Average 
PPR recorded by paired-pulse stimulation eliciting EPSCs with two different 
interstimulus intervals (40 and 60 ms) for EAC3I-containing MSNs versus all 
controls. (Wt: n=9; tTA: n=6; NON EGFP: n=9; EGFP: n=10; 40 ISI p=0.38, 60 ISI 
p=0.27).  (D) Baclofen increases the CV of EPSCs. Coefficient of variation 
(CV=SD/Mean) change of EPSCs from before, during and after application of 
baclofen for EAC3I-containing and EAC3I-lacking MSNs (NON EGFP: n=6; 
EGFP: n=5; p=0.95).  (E) Baclofen increases the PPR. PPR (50ms ISI) for 
EAC3I-containing and EAC3I-lacking MSNs before, during and after application of 
baclofen (NON EGFP: n=6; EGFP: n=5; p=0.48).  (F) Baclofen decreases sEPSC 
frequency.  Plot of normalized sEPSC frequency post 10 µM Baclofen compared 
to baseline for EAC3I-containing and EAC3I-lacking MSNs (NON EGFP: n=6; 
EGFP: n=5; p=0.96).  Note:  All MSNs held at   -70mV during recordings.    
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Changes in s/mEPSC frequency could also theoretically be produced by 
changes in synaptic glutamate concentration.  To address this possibility, we 
utilized MK-801, an uncompetitive, activity-dependent and irreversible antagonist 
of NMDARs (Huettner and Bean, 1988).  After obtaining a stable baseline of 
evoked NMDAR-mediated EPSCs at +40mV in the presence of picrotoxin and 
NBQX, the stimulator was switched off and 10µM MK-801 was applied to the 
slice.  After eight to ten minutes to allow the drug to equilibrate in the bath the 
stimulator was turned back on and the subsequent rate of inhibition of the 
NMDAR-mediated EPSC was calculated.  The rate of inhibition was not 
significantly different between non-EGFP and EAC3I MSNs (tau in seconds, 
NON EGFP 80.82±9.65; EGFP 87.07±8.59) [t (9) =0.6469; p=NS; Figure 10A, 
10B], suggesting that the levels of glutamate at both synapses is not significantly 
different.  Together, the lack of effect of CaMKII inhibition on PPR, baclofen 
modulation or MK-801 rate of blockade point to a postsynaptic mechanism for the 
decreased sEPSC frequency in the CaMKII-inhibited cells, which we interpret as 
a decrease in the number of functional synapses.  
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Figure 10. Dorsal lateral striatum MSN CaMKII inhibition does not 
alter the level of glutamate at the cleft.  (A) Normalized average 
NMDAR-mediated EPSC Charge (AUC) measured with 0.1 Hz 
stimulation in the presence of 10 µM Mk-801 over time for EAC3I-
containing and EAC3I-lacking MSNs.  (B) The rate of NMDA-mediated 
EPSC decay is best fit with a single exponential decay function.  The time 
constant (tau) in seconds was not significantly different between groups 
(NON EGFP: n=6; EGFP: n=5; p=0.65).  All neurons held at +40mV to 
relieve NMDAR-dependent voltage blockade by magnesium. 
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CaMKII inhibition does not alter dendritic spine density, but reduces dendritic 
length and complexity 
We next examined dendritic spine density, dendritic length and branching 
complexity in CaMKII-inhibited versus neighboring non-inhibited cells.  Previous 
work has suggested a correlation between changes in mEPSC frequency and 
dendritic spine density (Day et al., 2006; Fu et al., 2007; Lu et al., 2011b; Verpelli 
et al., 2011), although this is not always the case (Ding et al., 2012).  
Additionally, CaMKII has been shown to modulate dendritic length in the 
hippocampus (Fink et al., 2003).  There was no difference in spine density 
related to expression of the transgene (NON EGFP 18.03 ± 0.52 spines per 10 
µm vs.; EGFP 17.95 ± 0.85) [t (31) =0.087; p=NS; Figure 11A, 11B].  However, 
we observed a significant reduction in total dendritic length (NON EGFP 1538 ± 
99 µm vs.; EGFP 1134 ± 78) [t (31) =3.158; p=0.0035; Figure 11C, 11D].  Sholl 
analysis revealed a significant overall decrease in dendritic branching (F (1,31) 
=28.55; p<0.0001), with Bonferroni post-hoc analyses revealing specific 
significant decreases at  40 and 60 µm distal to the cell soma (Figure 11E).  
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Figure 11.  CaMKII Inhibition Does Not Alter Dendritic Spine 
Density, but Decreases Dendritic Length and Complexity.  
Rendering and quantification of a confocal image of a Lucifer yellow 
filled dendritic segment (80-100 µm from the cell soma) from a MSN 
from the dorsal lateral striatum.  (A) (top) Confocal image of EAC3I-
lacking MSN (NON EGFP) and the Imaris dendrite and spine model 
overlaid from segment above.  (below) Same as above, but for an 
EAC3I-containg MSN segment.  Scale bars 1.5 µm.  Fluorescent 
signal (green) pertains to Lucifer yellow fill.   (B) Average dendritic 
spine density (number of spines/10 µm) scatter plot for each neuron. 
NON EGFP n=17, EGFP n=16; p=0.93. (C) Neuronal reconstructions 
of representative EAC3I-lacking (NONEGFP) and EAC3I-containing 
(EGFP) dorsal striatal MSNs.  Scale bar 50µm.  (D)  Average total 
dendritic length in EAC3I-lacking (black) and EAC3I-containing 
(green) MSNs.  (E)  Sholl analysis of dendritic complexity in EAC3I-
lacking (black) and EAC3I-containing MSNs (green).  **p <0.01, *p 
<0.05; error bars represent SEM. Thank you to Hui-dong Wang for 
data collection.    
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GluA1 KO mimics EAC3I decrease in sEPSC frequency 
The AMPAR GluA1 subunit is critical for activity-dependent postsynaptic 
strengthening of excitatory synapses, and is inserted into the synaptic membrane 
in a CaMKII-dependent process in hippocampal neurons (Hayashi et al., 2000).  
Mice lacking the GluA1 subunit of the AMPAR have deficits in CA1 LTP 
(Zamanillo et al., 1999) (but see (Mack et al., 2001) ) and deficits in learning and 
memory (Reisel et al., 2002; Bannerman et al., 2004; Schmitt et al., 2005; 
Wiedholz et al., 2008).  Additionally, reductions in CaMKIIα mRNA and protein 
levels are seen in the hippocampus of GluA1 KO animals (Zhou et al., 2009).  If 
the CaMKII inhibition-dependent reduction in functional glutamatergic synapses 
on striatal MSNs is due to defects in synaptic GluA1 insertion, then we predicted 
that GluA1 knockout mice should mimic EAC3I mice in terms of sEPSC 
frequency and amplitude.  Thus, we measured sEPSC frequency and amplitude 
in adult GluA1 KO versus control mice in the dorsal lateral striatum.  We found 
that the loss of the GluA1 receptor also led to a significant reduction in sEPSC 
frequency (in Hz, control 3.2±0.8; GluA1KO 1.4±0.3) [U (31) =66; p=0.0133; 
Figure 12A, 12B], but not sEPSC amplitude (in pA, control 18.3±0.5; GluA1KO 
18.1±0.4) [t (31) =0.3576; p=N.S.; Figure 12A, 12C].  The similarity in synaptic 
outcomes of the GluA1 KO and EAC3I expression reinforces the idea that a 
common pathway has been affected.  
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Figure 12.  GluA1KO Mice Mimic the EAC3I Mice Decrease in sEPSC 
Frequency.  (A) Example traces of sEPSCs collected from dorsal lateral 
striatum MSNs in Wt (top) and GluA1KO (bottom).  Scale bars 0.5 sec, 30 pA 
(Control: n=15; GluA1KO: n=18; p=0.013).  (B) (left) Average sEPSC 
frequency in GluA1KO versus controls. (right) Cumulative probability graph of 
inter-event interval.  (C) (left) Average sEPSC amplitude in GluA1KO versus 
controls.  (right) Cumulative probability graph of amplitude (Control: n=15; 
GluA1KO: n=18; p=0.72).  * P <0.05 ; error bars represent SEM.  All MSNs 
were held at -70mV. Thank you to Brian Mather for data collection.     
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MSN CaMKII inhibition leads to enhanced intrinsic excitability 
To further examine the impact of CaMKII inhibition on physiological 
responses of dorsal striatal MSNs, we next examined excitatory drive and 
excitability of these cells under current clamp conditions.  As expected from our 
voltage clamp experiments with sEPSCs, we also observed a robust decrease in 
the frequency of sEPSPs in the CaMKII inhibited cells versus control neurons in 
current clamp (in Hz, Wt 3.18±0.29; tTA 3.09±0.06; NON EGFP 3.04±0.33; 
EGFP 1.78±0.18) [F (3, 19) =4.704; p=0.0154; Figure 13A, 13C].  Surprisingly, 
however, we also observed a significant increase in sEPSP amplitude in the 
CaMKII-inhibited cells versus controls (in mV, Wt 0.48±0.05; tTA 0.47±0.10; NON 
EGFP 0.55±0.05; EGFP 0.77±0.09) [F (3, 19) =3.605; p=0.0367; Figure 13A, 
12D].  As similar effects were not observed with sEPSC amplitudes, this 
suggested a change in excitability of EAC3I neurons.  In order to further test this 
idea we measured basal intrinsic excitability.  EGFP cells possessed a 
significantly more depolarized resting membrane potential (in mV, Wt -
86.30±0.50; tTA -85.61±0.50; NON EGFP -85.52±0.38; EGFP -83.61±0.68) [H 
(3, 78) =8.588; p=0.0353; Figure 13E] and had significantly increased input 
resistance compared to control cells (in MΩ, Wt 75.85±9.90; tTA 91.98±6.22; 
NON EGFP 70.48±5.54; EGFP 122.65±13.81) [H (3, 79) =19.89; p=0.0002; 
Figure 13F].  This suggests that CaMKII inhibition moves the resting membrane 
potential closer to firing threshold and increases membrane resistance to 
enhance the propagation of depolarizing current from distal MSN dendrites.  Next 
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we examined the voltage responses to differing current injections.  While 
injecting minimal current to maintain resting membrane potential at -85 mV, a 
series of hyperpolarizing and depolarizing current injections were given in 20 pA 
steps.  The threshold for 1st AP or rheobase current injection was significantly 
lower in the CaMKII inhibited MSNs versus control (in pA, Wt 357±32; tTA 
285±28; NON EGFP 357±30; EGFP 194±17) [F (3, 78) =9.393; p<0.0001; Figure 
13G].  The firing threshold was not significantly different amongst groups (in mV, 
Wt -36.4±1.3; tTA -35.3±1.5; NON EGFP -33.4±0.8; EGFP -37.0±0.9) [F (3, 78) 
=2.516; p=0.0649], suggesting that input resistance changes are a major 
contributor to changes in rheobase.  Also CaMKII inhibited cells exhibited 
increased spiking over a range of suprathreshold current injections [F (3,60) 
=5.425; p=0.0023; Figure 13H] versus control, reflecting a decrease in the 
interspike interval.  Taken together, these data show that CaMKII inhibition 
enhances the intrinsic excitability of MSNs. 
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Figure 13.  CaMKII inhibition enhances MSN intrinsic excitability.  (A) 
Traces of EAC3I-lacking (NON EGFP, black) and EAC3I-containing MSNs 
(EGFP, green) sEPSPs recorded at -85 mV.  Scale bars 0.6 mV, 200 ms.  (B) 
Traces of EAC3I-lacking (black) and EAC3I-containing MSNs (green) with 20pA 
hyperpolarizing and depolarizing current injections (-120 pA to +100 pA above 
AP threshold, 20 pA steps).  Scale bars 200 ms, 20 mV.  (C) Average sEPSP 
frequency in EAC3I-containing MSNs versus controls (Wt: n=4; tTA: n=4; NON 
EGFP: n=9; versus EGFP: n=6; p=0.015).  (D) Average sEPSP amplitude 
(current clamped at -85 mV) in EAC3I-containing MSNs versus controls (Wt: 
n=4; tTA: n=4; NON EGFP: n=9; versus EGFP: n=6; p=0.037). (E) Resting 
membrane potential (RMP) (mV) of EAC3I-containing and control MSNs (Wt: 
n=18; tTA: n=15; NON EGFP: n=22; versus EGFP: n=24; p=0.0043).  (F) Input 
resistance of EAC3I-containing and control MSNs (Wt: n=18; tTA: n=15; NON 
EGFP: n=22; versus EGFP: n=24; p=0.0002).  (G) Rheobase current injection or 
current injection to reach 1st AP in EAC3I-containing and control MSNs (Wt: 
n=18; tTA: n=15; NON EGFP: n=22; versus EGFP: n=24; p<0.0001).  (H) Firing 
frequency (Hz) after 4 sweeps (20 pA steps) following threshold firing in EAC3I-
containing and control MSNs (Wt: n=18; tTA: n=15; NON EGFP: n=22; versus 
EGFP: n=24; p=0.0023).   * P <0.05; ** P <0.01; *** P < 0.001; error bars 
represent SEM. 
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Discussion 
We present converging lines of evidence that dorsal striatal MSN CaMKII 
inhibition decreases functional synapse number and increases intrinsic 
excitability.  Inhibition of CaMKII in MSNs leads to a decrease in sEPSC 
frequency, without a change in release probability, glutamate levels at the 
synaptic cleft or dendritic spine density.  These observations are consistent with 
a decrease in the number of functional synapses.  In addition to changes in 
excitatory transmission, inhibition of CaMKII leads to an enhancement of MSN 
intrinsic excitability.  These data suggest that CaMKII coordinates opposing 
regulation of excitatory transmission and intrinsic excitability in MSNs, serving as 
a cellular rheostat.  
CaMKII inhibitors such as KN62 and KN93 have been useful tools in 
probing CaMKII functions, but these drugs also inhibit voltage-gated K+ and Ca2+ 
channels (Li et al., 1992; Ledoux et al., 1999), and do not inhibit the autonomous 
activity of Thr286-autophosphorylated  CaMKII (Tokumitsu et al., 1990; Sumi et 
al., 1991).  In addition, in dendritic spines where the concentration of calmodulin 
and CaMKII are extremely high (~100µM) (Faas et al., 2011; Feng et al., 2011), 
KN-62 (10 µm) only partially decreases CaMKII activity (Lee et al., 2009).  The 
EAC3I peptide we used inhibits all isoforms of CaMKII, including CaM-stimulated 
and autonomous activity, with low micromolar potency (Braun and Schulman, 
1995; Chen et al., 2001; Zhang et al., 2005).  EAC3-I is ≥100-fold selective for 
CaMKII over protein kinase C, CaM Kinase I or CaM kinase IV (Braun and 
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Schulman, 1995; Patel et al., 1999).  The AC3-I peptide sequence differs from 
another highly selective CaMKII-inhibitor, AIP, by only one amino acid residue 
(Vest et al., 2007).  It is also important to consider the localization of CaMKII 
inhibition when interpreting these results.  CaMKII is highly expressed in 
dopamine terminals, which densely innervate the striatum, where it stimulates 
dopamine efflux via the dopamine transporter in the presence of amphetamine 
(Fog et al., 2006).  In addition, CaMKII is present in glutamatergic projections, 
which form the presynaptic terminal onto MSN spines and dendrites (Liu and 
Jones, 1996; Fog et al., 2006), where it may modulate release events (Chi et al., 
2001; Elgersma et al., 2002; Hojjati et al., 2007; Jiang et al., 2008).  Our 
transgenic strategy resulted in the selective expression of the CaMKII inhibitor in 
the postsynaptic MSN, where it cannot directly affect the function of the 
glutamatergic and dopaminergic terminals, consistent with the lack of change in 
glutamate release parameters in EAC3I MSNs (Figures 9, 10).    
We demonstrated that CaMKII inhibition decreases s/mEPSC frequency 
with no changes in presynaptic function.  The lack of a bimodal distribution in the 
s/mEPSC frequency data suggests that CaMKII inhibition similarly affect both 
direct and indirect pathway MSNs.  Changes in s/mEPSC frequency are 
traditionally interpreted as alterations in presynaptic quantal content; the product 
of changes in release probability or synapse number.  However, multiple lines of 
evidence suggest that presynaptic function is unaltered.  Together these data 
suggest that CaMKII inhibition decreases functional synapse number.  One 
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possibility is that CaMKII inhibition produces a loss of functional synaptic 
connections.  Alternatively, there could be an increase in the number of silent 
synapses which contain NMDARs but no AMPARs and are typically abundant 
early in development (Liao et al., 1992; Isaac et al., 1995; Liao et al., 1995; 
Durand et al., 1996; Wu et al., 1996; Kerchner and Nicoll, 2008).  A further 
possibility is that CaMKII inhibition could increase the numbers of silent modules 
of synapses or increase the number of AMPAR-lacking subregions of the 
synapse due to local nature of basal synaptic transmission (Raghavachari and 
Lisman, 2004; Lisman and Raghavachari, 2006).  In the hippocampus, silent 
synapses can be unsilenced following NMDAR activation by the introduction of 
new AMPAR to the synapse, underlying a common mechanism of LTP of 
synaptic glutamatergic transmission (Shi et al., 1999; Hayashi et al., 2000; Park 
et al., 2004; Adesnik et al., 2005).  Previous research has suggested a direct role 
for CaMKII in the unsilencing of synapses in the hippocampus (Pettit et al., 1994; 
Lledo et al., 1995; Shirke and Malinow, 1997; Pi et al., 2010a).  Additionally, 
CaMKII is required for the formation of new synapses and/or morphological 
growth following hippocampal LTP induction (Toni et al., 1999; Jourdain et al., 
2003; Lee et al., 2009; Ciani et al., 2011a).    
Striatal CaMKII inhibition did not alter dendritic spine density, suggesting 
that the decrease in s/mEPSC frequency could best be explained by some 
spines lacking active presynaptic terminals or increased numbers of silent 
synapses.  However, the significant increase in the input resistance of EAC3I-
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positive MSNs should enhance sampling of mEPSCs from more distal dendritic 
sites, potentially increasing s/mEPSC frequency.  These data together suggest 
that decreases in s/mEPSC frequency in EAC3-I MSNs are potentially 
underestimated.  Alternatively, some of these effects may be due to decreased 
dendritic length and complexity seen in EAC3I-positive MSNs.  However, it is not 
clear whether distal MSN synapses are sampled in our s/mEPSC analyses due 
to cable filtering effects previously reported (Williams and Mitchell, 2008) .  
Hippocampal βCaMKII has been shown to modulate dendritic length and 
branching as well as synapse number (Fink et al., 2003).  These results suggest 
that CaMKII plays important roles in modeling MSN dendritic morphology.  The 
alpha CaMKII promoter fragment that drives EAC3I expression reportedly turns 
on around P5 (Kelly et al., 1987; Sugiura and Yamauchi, 1992, 1994a, b).  This 
would lead to inhibition of CaMKII in early postnatal development and continuing 
into adulthood.  The effects of this longer term genetic CaMKII inhibition 
contrasts with the typically minimal effects of acute, short term application of a 
related CaMKII inhibitor peptide, AIP, on basal glutamatergic transmission in the 
CA1 and CA3 region of the hippocampus (Sharma et al., 2008; Buard et al., 
2010; Shen et al., 2010; Ciani et al., 2011b).  Conversely, expression of CaMKII 
inhibitor peptides CaMKIIN or AIP over 2-6 days reduced hippocampal CA1 
AMPAR-mediated, but not NMDAR-mediated EPSCs (Goold and Nicoll, 2010).  
Another report suggests a CaMKII inhibitor peptide, CN19, persistently 
decreased hippocampal CA1 field EPSPs or EPSCs amplitudes at higher 
concentrations disrupting the CaMKII/NMDAR complex (Sanhueza et al., 2011).  
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These data suggest that disruption of the CaMKII/NMDAR complex, a complex 
that increases following strong synaptic stimulation (Leonard et al., 1999) and is 
necessary for LTP (Barria and Malinow, 2005; Zhou et al., 2007), may offer an 
alternative mechanism underlying our observed effects.    
Endogenous CaMKIIα levels peak around 3 weeks postnatally, which is a 
crucial time for synaptogenesis and synapse maturation (Hanley et al., 1987; 
Kelly et al., 1987; Sugiura and Yamauchi, 1992).  The apparent decrease in 
functional synaptic connections in CaMKII inhibited MSNs in adulthood may have 
four possible explanations:  1) CaMKII activity is necessary for the normal 
unsilencing of synapses in the adult; 2) Ongoing CaMKII activity is required to 
maintain functional synapses; or 3) CaMKII is needed early in synaptogenesis to 
turn initially silent synapses into functional ones; or 4) the CaMKII-mediated 
decrease in dendritic length may underlie the reduction in total synapse number.  
The decrease in sEPSC frequency in EAC3I MSNs was detected as early as 
three weeks postnatally, suggesting a large proportion of synapses were never 
unsilenced or perhaps never formed.  In the hippocampus both 
electrophysiological and anatomical studies at light and electron microscopic 
levels suggest that in the first few weeks of life many synapses start as NMDAR-
only synapses or silent synapses (Rao and Craig, 1997; Gomperts et al., 1998; 
Nusser et al., 1998; Petralia et al., 1999; Takumi et al., 1999).  Synapse 
unsilencing involving the trafficking of new AMPARs (GluA4-containing) to the 
synapse in early postnatal development is dependent on activity, but is 
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independent of CaMKII (Zhu et al., 2000; Esteban et al., 2003).  Instead, PKA 
plays an important role early in postnatal development (<P9) in plasticity in the 
hippocampus being necessary and sufficient for GluA4 incorporation, but 
requiring additional CaMKII activity for GluA1 receptor incorporation (Esteban et 
al., 2003; Yasuda et al., 2003; Man et al., 2007).  These data suggest that the 
similar synaptic phenotypes of GluA1KO and EAC3I mice arise from disruption of 
a common mechanism.  However, it is interesting that the phenotype of the 
EAC3I cells is also virtually identical to that recently reported for MSNs in 
SAPAP3 knockout mice (Chen et al., 2011b; Wan et al., 2011).  Intriguingly, 
SAPAP3 may be phosphorylated by CaMKII, possibly assisting in synaptic 
targeting of GluA1R  (Dosemeci and Jaffe, 2010).  Thus, it will be important for 
future studies to directly identify downstream MSN proteins regulated by CaMKII. 
 
It is also possible that differences in the relative innervation of MSNs by 
cortical and thalamic inputs impacts the synaptic phenotypes.  Indeed, 
differences in release probability have been observed between the two inputs 
(Smeal et al., 2007; Ding et al., 2008; Ding et al., 2010).  Our measures of 
sEPSC and mEPSC frequency are likely comprised of both cortical and thalamic-
mediated glutamate release, yet our data do not rule out the possibility that 
inhibition of MSN CaMKII may have a greater influence on one of these 
excitatory synapses over the other.   
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CaMKII inhibition also leads to alterations in intrinsic excitability that may 
serve to broadly counteract the reduced s/mEPSC frequency.  Although we 
expected a decrease in sEPSP frequency in current clamp based on the sEPSC 
results, we observed significantly larger sEPSP amplitudes.  This is likely due to 
enhanced intrinsic excitability.  In CaMKII-inhibited neurons we observed more 
depolarized resting membrane potentials, increased membrane resistance, 
decreased rheobase current injection, and increased firing frequency.  
Autonomously active CaMKII has been shown to suppress neuronal excitability 
by increasing cell-surface expression of an A-type K+ channel, Kv4.2, via 
phosphorylation (Roeper et al., 1997; Park et al., 2002; Varga et al., 2004).  In 
addition, CaMKII inhibition in medial vestibular nucleus neurons increased 
intrinsic excitability via a reduction in BK-type calcium activated potassium 
currents (Nelson et al., 2005).  Changes in Kv4.2 or BK activity following CaMKII 
inhibition could account for the differences in firing that we observed in EAC3I 
cells.  However, modulation of Kir 2 channels may be responsible for the 
changes in input resistance and resting membrane potential (Cazorla et al., 
2012).  A recent study showed that acute CaMKII inhibition in cortical cultures 
leads to increased excitability, but also increased cell death (Ashpole et al., 
2012a).   We did not note increased cell death, nor did membrane properties hint 
at unhealthy EAC3I-expressing cells.  The differences in these studies may be 
attributed to the fact that MSNs are GABAergic cells bypassing potential 
excitotoxicity vulnerabilities seen with recurrent excitatory connections in the 
cortex.  Alternatively, cortical cultures – which are often more excitable - may 
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have a more difficult time regulating extracellular glutamate levels, something 
that is not as problematic in ex vivo slice preparations.       
The opposing regulation of excitatory transmission and excitability 
observed in these studies suggests that CaMKII may serve as a molecular 
fulcrum to counterbalance changes in enhanced excitatory input with decreases 
in excitatory output.  It is important to note in the present dataset we cannot rule 
out that possibility that one of these adaptations is compensatory to the other, 
rather than both being directly initiated by CaMKII inhibition.  Regardless, this 
likely has important implications for the modulation of basal ganglia circuitry 
underlying habit learning, addiction and neurodegenerative disease.  CaMKII 
plays a role in setting the number of functional synapses and therefore may 
provide a substrate for experience dependent plasticity in the striatum.  Dorsal 
striatal CaMKII may be crucial early in postnatal development as well as in 
adulthood entraining new motor repertoires and refining synaptic connections as 
those motor skills are refined into habits later in life.  With the inhibition of CaMKII 
leading to a decrease in the number of functional contacts, CaMKII may function 
in the dendritic and synaptic maturation processes, from nascent filopodia to 
mature dendritic spine (Jourdain et al., 2003; Lee et al., 2009), or alternatively be 
important in maintaining existing synaptic connections.  Further investigation will 
be needed to determine the precise role of CaMKII in striatal synaptic maturation.     
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CHAPTER IV 
 
MOSAIC GENETIC INHIBITION OF CAMKII IN DORSAL STRIATAL MEDIUM 
SPINY NEURONS AFFECTS STRIATAL-BASED BEHAVIORS 
 
Introduction 
CaMKII is highly expressed in the striatum, the main input nucleus of the 
basal ganglia, and it is known to interact and phosphorylate numerous 
downstream substrates playing an important role in synaptic plasticity and 
learning (Erondu and Kennedy, 1985; Lisman et al., 2002).  CaMKII abundance 
and localization places it in a position to control corticobasal ganglia circuits that 
play a role in voluntary movements and motivated behaviors.  While an important 
role of CaMKII  in hippocampal-mediated learning is well known (Lisman et al., 
2012), little is known of its role in striatal learning.  The dorsal striatum has been 
implicated in the formation of goal-directed and habit based learning as well as 
the formation of action sequences (Yin and Knowlton, 2006; Robbins et al., 
2008).  Additionally, this region is implicated in neurodegenerative diseases, like 
Huntington’s and Parkinson’s disease, as well as obsessive compulsive disorder, 
Tourette’s, dystonia and addiction.     
Striatal-dependent behaviors in mice can be studied using instrumental 
and non-instrumental learning paradigms.  Instrumental learning paradigms 
require an animal to perform an operant behavior, like pressing a lever for a food 
reward.  Differing operant schedules can promote differing types of behavioral 
learning.  A random ratio schedule, where an animal is rewarded on a 
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percentage of total lever presses, is known to promote goal-directed learning 
(Hilario and Costa, 2008).  Under certain conditions, like overtraining or using 
random interval schedules, habitual behavior develops.  Goal-directed learning is 
sensitive to changes in the value of the reinforcer, while habitual learning is 
insensitive to devaluation of the reinforcer (Yin et al., 2004, 2006).  This switch 
from flexible, goal-directed actions which involve the associative corticobasal 
ganglia network to a more rigid habitual action governed by the sensorimotor 
network is thought to involve synaptic plasticity at glutamatergic synapses in the 
dorsal striatum (Yin and Knowlton, 2006; Yin et al., 2009).   
Hippocampal CaMKII is known to be both necessary and sufficient for the 
induction of long-term potentiation (LTP) of glutamatergic transmission, a neural 
correlate of learning and memory.  Disruption or removal of CaMKII in the 
hippocampus disrupts spatial learning and working memory (Lisman et al., 2012).  
Differing forms of plasticity are thought to be involved in striatal-based learning; 
we hypothesized that CaMKII activity in medium spiny neurons of the striatum is 
necessary for motor learning, goal-directed and habitual behavior.  To test this 
hypothesis, we ran transgenic mice expressing a CaMKII-inhibitory peptide 
(EAC3I) only in medium spiny neurons in the striatum through numerous 
behavioral tasks.  We examined open field locomotor activity, motor learning on 
the rotarod, fixed ratio and random ratio responding for food reward in EAC3I 
transgenic mice and their transgene lacking littermates.  Additionally, we used 
devaluation and contingency degradation to determine if CaMKII plays a role in 
goal-directed or habit based learning.  If an action is habitual, then devaluation of 
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the reinforcer or breaking up the contingency between the action and the reward 
outcome by offering “free” rewards should have no effect on performance.  
Conversely, if the behavior is goal-directed then performance should be reduced 
following devaluation or contingency degradation.  We observed that inhibition of 
CaMKII did not disrupt rotarod motor learning or behavioral sensitization to 
cocaine, yet disrupted goal-directed behaviors and prevented the goal-directed to 
habit learning transition.                         
 
Results 
Effects of dorsal striatal CaMKII inhibition on locomotion in the novel open field 
Rodents placed into a novel environment will initially exhibit elevated 
locomotor activity as they explore their new surroundings which then decreases 
over time as they habituate to the environment (Wiedholz et al., 2008).  We 
examined both EAC3I mice and controls in a novel open field where locomotor 
activity was tracked over a sixty minute session.  While both groups habituated 
over the sixty minute period, EAC3I double transgenic mice showed reduced 
total locomotor activity compared to wildtype and EAC3I single transgene 
containing mice.  Similar results were observed when locomotor activity was 
separated into five minute bins [F(3,23)=7.282, p=0.0017; Figure 14A,14B].  
However, single tTA mouse locomotor activity was equivalent to double 
transgenic EAC3I mice, suggesting that inclusion of the tTA transgene leads to a 
hypolocomotor phenotype as reported previously (McKinney et al., 2008).  
Additionally, there were no statistical differences in time spent in the center of the 
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open field, a crude measure of overall anxiety, between EAC3I mice and controls 
[F(3,23)=2.121, p=0.13; Figure 14C] (Pogorelov et al., 2005).  
 
  
  
 
 
 
 
Mosaic inhibition of dorsal striatal CaMKII does not affect simple motor learning 
To examine simple motor learning often a rotarod test is used consisting 
of an accelerating rotating bar that mice must maintain their balance.  Mice 
performing in a rotarod task undergo rapid improvement in performance in early 
trials with more gradual improvements as performance stabilizes and the motor 
task is well learned.  During the early learning phase of this task the dorsal 
medial striatum is thought to be engaged, but later once the skill is automatized 
the dorsal lateral striatum predominates (Yin et al., 2009).   Previously, motor 
Figure 14.  EAC3I Mouse Locomotor Activity and Center Time in the Novel 
Open Field.  (A) Total distance traveled (cm) in the novel open field over 60 
minutes.  (B) Total distance traveled plotted in 5 minute bins over 60 minutes. (C) 
Amount of time spent in a 4X4 inch square in the center of the open field area.  
More time in the center is associated with reduced anxiety. ** = p<0.01, Error bars 
represent SEM.   
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learning on the accelerating rotarod was shown to be disrupted by striatal-
specific disruption of the GluN1 subunit of the NMDAR (Dang et al., 2006; 
Beutler et al., 2011).  CaMKII activation lies downstream of NMDAR activation, 
so we tested the hypothesis that inactivation of dorsal striatal CaMKII would 
disrupt motor learning on the accelerated rotarod.  EAC3I and controls were run 
on the accelerating rotarod for multiple trials to test for motor learning.  
Surprisingly, both groups exhibited similar learning curves over the multiple trials, 
suggesting normal motor learning in the EAC3I mice [F(1,68) =0.7369; p=N.S.; 
Figure 15A].  This lack of an effect in behavior could be due to the mosaicism of 
expression of the CaMKII inhibitory peptide throughout the dorsal striatum with 
other non-expressing MSNs compensating for the loss of CaMKII.  Alternatively, 
striatal NMDARs may also have roles in rotarod motor learning outside of CaMKII 
signaling.  
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Behavioral sensitization by cocaine is normal in EAC3I mice  
Behavioral sensitization produced by cocaine is dependent on 
dopaminergic projections from the ventral tegmental area (VTA) to the nucleus 
accumbens (NAc) (Thomas et al., 2008; Schmidt and Pierce, 2010; Wolf and 
Ferrario, 2010).  Injection of a CaMKII inhibitor into the VTA enhances acute 
cocaine locomotor activity while reducing the expression of behavioral 
sensitization, indicating that inhibition of CaMKII affects both the acute and 
chronic locomotor effects of cocaine(Licata et al., 2004).  Expression of the 
CaMKII inhibitory peptide is considerably reduced in the nucleus accumbens of 
Figure 15.  Mosaic Dorsal Striatal CaMKII Inhibition Does Not Alter Rotarod 
Motor Learning or Behavioral Sensitization to Cocaine. (A) Latency to fall on 
the accelerating rotarod measured over eight trials on two days separated by a 
week in EAC3I mice versus combined controls.  (B) Cumulative distance traveled 
over 30 minutes following a 10mg/kg cocaine injection (i.p.) over five consecutive 
days followed by a challenge injection given two weeks after the fifth injection in 
EAC3I versus combined controls.  Note mice are habituated to the locomotor 
chambers for thirty minutes prior to injection of cocaine.  * P <0.05; ** P <0.01; *** 
P < 0.001; error bars represent s.e.m. 
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EAC3I mice.  As expected there was no difference in the degree of behavioral 
sensitization to repeated cocaine injections (10mg/kg, i.p.) in EAC3I versus 
control mice over five days, nor was there a difference in locomotor activity 
following a challenge dose of cocaine 14 days later [F(1,28) =1.161; p=N.S.; 
Figure 15B].   
 
EAC3I mice have deficits in random ratio-supported operant behavior 
We next tested the hypothesis that striatal CaMKII plays a role in goal-
directed learning.  We used escalating random ratio (RR) operant schedules that 
have been shown to be associated with goal-directed  learning (Packard and 
Knowlton, 2002; Yin and Knowlton, 2006; Wiltgen et al., 2007; Hilario and Costa, 
2008; Dias-Ferreira et al., 2009).  We trained EAC3I and control animals to lever 
press under fixed ratio responding (FR-1) for highly palatable food (25% Ensure).  
We initially trained them on FR-1 for six days where mice had access to both an 
active lever and an inactive lever.  There was no significant difference between 
EAC3I and control mice in active or inactive lever pressing during FR-1 training 
[active F(1,35) =2.506; p=N.S.; inactive F(1,35) =0.3947; p=N.S.; Figure 16A] 
suggesting that operant learning and activity levels are similar.    
Following six days of FR-1 training the mice were switched to escalating RR 
schedules where a lever press equated to a probability of reinforcement of the 
Ensure reward.  RR schedules have been shown previously to promote the 
acquisition of goal-directed behavior (Hilario et al., 2007).  Animals were trained 
for four days on a RR5 schedule of reinforcement (probability of reinforcement, 
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P=0.2), followed by four days on a RR10 schedule (probability of reinforcement, 
P=0.1), and then four more days on a RR20 schedule (probability of 
reinforcement, P=0.05).   With the  increasing work load over the increasing 
random ratio schedules the EAC3I mice showed increasing deficits in random 
ratio responding [RR-5, F(1,35) =19.27 p<0.0001; RR-10, F(1,35) =9.787 
p=0.0026; RR-20, F(1,35) =10.85 p=0.0016; Figure 16B].  These data together 
suggest that inhibition of dorsal striatal CaMKII leads to deficits in a model of 
goal-directed learning.  As an additional control for differences in reward 
sensitivity, we tested food conditioned place preference (CPP).  Following four 
days of conditioning 25% ensure on a designated paired side of the chamber 
twice a day, both EAC3I and control mice showed similar levels of CPP on a 
probe test [t(14) =1.108; p=N.S.; Figure 17].  This suggests that the rewarding 
properties of ensure was similar across genotypes. 
 
EAC3I mice show greater devaluation and contingency degradation 
 In order to investigate if lever pressing following a RR-20 schedule was 
goal-directed or habitual we performed a devaluation and contingency 
degradation tests.  The data were normalized to the last day of RR-20 
responding.  During the devaluation test, EAC3I mice responded significantly 
less during the devalued condition, when the outcome they pressed for during 
training was devalued by sensory-specific satiety (Ensure), than during the non-
devalued condition (chow) [F(1,33)=2.180; p<0.05; Figure 18A], suggesting 
greater goal-directed behavior.  Although it seems unlikely that the previous 
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results are were driven by differences in hedonics or value processing, we used 
a different task to determine if the EAC3I mice had impairments in performing 
actions based off the consequences of their behavior.  We performed 
contingency degradation where the delivery of reward was given non-contingent 
to lever pressing.  Under extinction conditions the EAC3I mice showed greater 
reduction in responding in the first session under contingency degradation 
suggesting greater goal-directed behavior [F(1,33)=3.636; p<0.05; Figure 18B].  
In all these data suggest that EAC3I mice are operating in a goal-directed 
manner after extended training, with CaMKII inhibition possibly disrupting the 
natural transition from goal-directed to habit based learning.       
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Figure 16.  EAC3I Mice have Deficits in Responding on a Random Ratio 
Schedule for Food.  (A) Number of active lever presses (left) and inactive 
lever presses (right) for EAC3I versus combined controls on a fixed ratio-1 
schedule for 25% Ensure over six, 30 minute sessions.  (B) Rate of lever 
presses per minute on a random ratio schedule (RR-5, RR-10, and RR-20; 
20%, 10%, 5% chance of reinforcement, respectively) over four daily, 30 
minute sessions. Note the enhanced deficit in EAC3I mice versus controls 
over increasing random ratio schedules.  * P <0.05; ** P <0.01; *** P < 0.001; 
error bars represent s.e.m.  Thank you to Chris Olsen and Erin Watt for data 
collection. 
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Figure 17.  EAC3I mice show normal conditioned reinforcing responses 
to food in a CPP paradigm.  (A) (left) Difference score between paired 
ensure side to non-paired side in EAC3I mice and combined controls. (middle) 
Time on food side pre and post CPP training in control mice. (right) Time on 
food side pre and post CPP training in EAC3I mice.  Thank you to Chris Olsen 
for data collection.       
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Figure 18.  EAC3I mice show greater devaluation and contingency 
degradation.  (A) Normalized lever presses to last RR-20 day in grouped 
controls (Wt and single transgenics) and EAC3I mice given 1 hour pre-
feeding with Ensure (devalued) or chow (valued, control).  Note greater 
devaluation in EAC3I group in the reinforcer specific Ensure group.  (B)  
Normalized lever presses to last RR-20 day in grouped controls (Wt and 
single transgenics) and EAC3I mice following extinction conditions with non-
contingent reward delivery.  Note greater contingency degradation in EAC3I 
mice on the first session.  *p<0.05, Error represents SEM.   
A B 
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Discussion 
The expression of behavioral sensitization is thought to be dependent on 
the nucleus accumbens (Thomas et al., 2008).  Since there was little to no 
expression of EAC3I in the nucleus accumbens, normal behavioral sensitization 
to repeated cocaine administration in the EAC3I mice is not unexpected.  While 
previous reports suggest that rotarod motor learning is dependent on the striatal 
expression of GluN1 subunits of the NMDAR (Dang et al., 2006), we did not 
encounter any deficits in motor learning on the rotarod in the EAC3I mice versus 
controls.  We hypothesize CaMKII inhibition in only a subpopulation of MSNs 
along with the simplicity of the motor task allows other non-inhibited MSNs to 
compensate and maintain normal motor learning.  Alternatively, this motor 
learning task may require signaling downstream of the NMDAR that does not rely 
on CaMKII. 
The everyday process of turning goal directed responses, requiring 
concentration and monitoring of the response, into an automatic habit is one way 
we balance the need for behavioral flexibility for efficiency of repeated motor 
scenarios.  It is known that the cortico-basal ganglia circuits underlie normal goal-
directed and habit based learning.  The associative cortical inputs to the dorsal 
medial striatum are implicated in the formation and execution of goal directed 
actions, while the dorsal lateral aspect of the striatum is necessary for the 
formation of habits (Balleine and Dickinson, 1998; Yin et al., 2005b; Yin and 
Knowlton, 2006).  Mosaic inhibition of CaMKII did not inhibit the acquisition of 
FR-1 responding for food and did not disrupt food CPP, suggesting that the 
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EAC3I mice had similar reward sensitivity to controls in these tasks.  However, 
following random ratio training, under a schedule that was previously shown to 
bias for goal-directed behavior (Hilario et al., 2007; Dias-Ferreira et al., 2009), 
EAC3I mice showed increasing deficits with increasing random ratio schedules.  
Additionally, the EAC3I mice showed greater devaluation and contingency 
degradation to the satiety-specific reinforcer suggesting the animals are 
responding in a goal-directed manner.  In controls we did not observed these 
differences suggesting that habit learning has been engaged.  Inhibition of MSN 
CaMKII may disrupt the natural goal-directed to habitual learning that takes place 
with extended skill training.  Disrupted synaptic transmission combined with 
enhanced excitability of MSNs could underlie some of the deficits seen in random 
ratio responding, possibly disrupting normal goal-directed behavior and 
preventing or facilitating the normal transition to habit based learning.  It begs the 
question why motor learning on the rotarod was intact, yet deficits in goal-
directed behaviors were witnessed.  Possibly goal-directed learning requires a 
larger local network of MSNs and inhibiting CaMKII in a minority of neurons 
prevents normal goal-directed actions from being established, while rotarod 
learning may be more diffusely stored requiring fewer neurons.  Additional study 
will be needed to better understand the role of CaMKII in habit learning.                  
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CHAPTER V 
 
THE ROLE OF THE GLUN2B SUBUNIT OF THE NMDAR IN STRIATAL 
GLUTAMATERGIC SYNAPTIC TRANSMISSION AND ITS ROLE IN 
STRIATAL-BASED BEHAVIOR 
 
Introduction 
The dorsal striatum is an area of the brain that underlies the formation of 
goal-directed actions as well as the formation of habits (Yin and Knowlton, 2006).  
Its importance underlying normal, voluntary movements is underscored by 
neurodegenerative diseases such as Parkinson’s and Huntington’s disease, both 
of which disrupt synaptic transmission on MSNs and ultimately manifest 
behavioral deficits (Kreitzer and Malenka, 2008).  More recently, additional 
attention has been given to the dorsal striatum’s role in drug addiction, a 
maladaptive form of habit-based learning (Koob and Volkow, 2010).  The GluN2B 
subunit of the NMDAR has received a lot of attention, being implicated in learning 
and memory, pain perception, stroke, feeding behaviors and numerous human 
neurological disorders including alcoholism, anxiety disorders, schizophrenia, 
Parkinson’s disease, and Huntington’s disease (Yashiro and Philpot, 2008; Wu 
and Zhuo, 2009; Gardoni et al., 2010; Chen et al., 2011a; Lai et al., 2011; Qiu et 
al., 2011; Raymond et al., 2011; Wang et al., 2011).  The GluN2B subunit is 
highly expressed in the striatum (Chen and Reiner, 1996), yet its role in synaptic 
transmission, plasticity and behavior in this region is not well understood.      
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The NMDA receptor is a heteromeric ligand-gated ion channel that passes 
sodium, potassium and calcium as well as interacts with multiple intracellular 
proteins.  It is comprised of a combination of four subunits from seven known 
subunits including obligatory GluN1 subunits (formerly NR1, ζ1), and some 
combination of GluN2A-2D (formerly NR2A-2D or ε1-4), and/or GluN3A-3B 
(formerly NR3A-3B) (Yashiro and Philpot, 2008).  The predominant GluN2 
subunits in the striatum are the GluN2A and GluN2B subunits, which in turn 
dictate NMDAR-mediated EPSC kinetics as well as localization, binding partners, 
and intracellular signaling (Traynelis et al., 2010).  GluN2A and GluN2B subunits 
are incorporated into a di-heteromeric (GluN1/GluN2A or GluN1/GluN2B) or in a 
tri-heteromeric (GluN1/GluN2A/GluN2B), with around one-third of the subunits in 
the tri-heteromer form in the adult hippocampus - yielding unique functional 
properties (Al-Hallaq et al., 2007).  Levels of GluN2B are high in most forebrain 
regions in late embryonic development, but in the first weeks of postnatal 
development GluN2B subunits are progressively replaced with GluN2A subunits 
as the synapse matures (Sheng et al., 1994; Flint et al., 1997; Roberts and 
Ramoa, 1999).  This developmental switch from GluN2B to GluN2A is seen in 
the striatum (Monyer et al., 1994; Wenzel et al., 1997).  This GluN2B to GluN2A 
switch has been shown to alter the threshold for synaptic plasticity induction and 
has been shown to be bidirectionally regulated by activity and experience 
(Quinlan et al., 1999; Bellone and Nicoll, 2007).   
Studies using transgenic mice have lent some insight into the role GluN2B 
plays in synaptic plasticity.  Overexpression of GluN2B in the forebrain of 
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transgenic mice leads to enhanced activation of NMDAR receptors enhanced 
LTP to stimulation at both 10Hz and 100Hz.  Additionally, GluN2B 
overexpressing mice showed enhanced long term memory for novel objects , 
enhanced fear memory (contextual and cued), and enhanced spatial memory in 
the Morris water maze (Tang et al., 1999).  Alternatively, overexpression of 
GluN2B c-terminal tails actually show reductions in LTP magnitude and exhibit 
learning deficits, presumptively through disruption of the CaMKII-GluN2B 
complex (Zhou et al., 2007). 
While the role of GluN2B in synaptic plasticity in the hippocampus and 
cortex has been studied, the contribution of GluN2B to NMDAR-mediated 
synaptic plasticity and learning and memory remains a controversial field.  
Conflicting reports propose different roles for hippocampal GluN2B in LTP and 
LTD (Liu et al., 2004; Massey et al., 2004; Morishita et al., 2007).  Understanding 
the role of the GluN2B subunit has been clouded by nonselective inhibitors, 
complex pharmacology (Neyton and Paoletti, 2006; Paoletti and Neyton, 2007) 
and the fact that traditional GluN2B knock out animals die soon after birth 
(Kutsuwada et al., 1996),  To circumvent this issue and study the role of the 
GluN2B subunit in the adult striatum, an area that has received much less 
attention, we utilized a conditional GluN2BKO mouse line.  The current work 
explores excitatory glutamatergic transmission in the dorsal striatum in the 
conditional GluN2BKO animal, dendritic spine density, as well as the effects of 
GluN2B deletion on striatal-based behaviors.  Additionally, we explore the effects 
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of deletion of GluN2B at early postnatal versus adult time points to better 
understand the effects of GluN2B on synaptogenesis and adult striatal circuits.   
 
Results 
 
Mouse Model and Validation of GluN2B deletion 
We utilized a double transgenic mouse model where a fragment of the 
alpha CaMKII promoter drove expression of the tetracycline transactivator (tTA) 
and its expression product bound to the tetO promoter of CRE recombinase 
which would excise the floxed GluN2B gene (Wills et al., 2012) (Figure 19A).  
Overtly the mice did not exhibit gross morphological differences, yet the 
conditional GluN2B KO mice showed a strong trend for a decrease in weight [in 
grams, Controls 25.14 ± 0.76, GluN2BKO 22.65 ± 0.63; U(38)=111.5, p= 0.067; 
data not shown].  The alphaCaMKII promoter restricted the deletion of GluN2B to 
only the forebrain.  Western blot analysis of 1mm tissue punches isolated from 
the dorsal lateral striatum revealed the virtual absence of GluN2B protein 
[percent of control, 1 ± 0.02; t(9)=6.298, p< 0.0001; Figure 19B], similar to other 
results utilizing a similar mouse model (von Engelhardt et al., 2008).  
Furthermore, consistent with previous studies utilizing GluN2BKO mice to 
examine hippocampal excitatory transmission (von Engelhardt et al., 2008; 
Brigman et al., 2010; Wills et al., 2012), we observed a significant decrease in 
the decay time of evoked NMDAR-mediated EPSCs [in ms, Control 242.1±31, 
GluN2BKO 56.34±7; t(14)=8.093, p< 0.0001; Figure 19C]. 
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Figure 19.  Breeding Strategy and Verification of GluN2BKO.  (A) 
Schematic of breeding strategy for production of GluN2BKO mice. Mice are 
homozygous for the GluN2B (fl,fl) allele and heterozygous for either the 
CaMKIIα-tTA or tetO-CRE transgene.  (B) Western blot analysis of GluN2B, 
GluN1, and GluN2A protein levels from 1mm punches of the dorsal lateral 
striatum (shown above) in control (single transgene and wildtype littermates) 
and GluR2BKO mice.  Representative western blot of GluN2B protein levels 
shown in control (CT) and GluN2BKO (KO).  (right) Representative traces 
and quantification of decay time for NMDAR EPSCs from control and 
GluN2B KO mice. Scale bars 30ms, 0.1 (scaled to 1)  ***P<0.0001.  Error 
bars represent SEM. Thank you to Julie Healy for western data.     
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Basal Glutamatergic Synaptic Transmission in GluN2B KO Mice 
To better understand the impact of GluN2B deletion on glutamatergic 
synaptic transmission we probed the levels of other NMDAR subunits and 
associated proteins in the dorsal lateral striatum.  Similar to other GluN2BKO 
animals (Brigman et al., 2010; Badanich et al., 2011; Wills et al., 2012), GluN1 
levels were significantly reduced [percent of control, 23 ± 0.05; t(9)=9.307, p< 
0.0001; Figure 19B], while GluN2A showed only a trend for a decrease in protein 
levels [percent of control, 53 ± 0.11; t(9)=1.883, p=0.093; Figure 19B]. 
 Additionally, we took 1mm punches of M1 motor cortex, a region that 
sends excitatory glutamatergic afferents to the dorsal lateral striatum, in the 
same brain slice.  Similarly, in the motor cortex we saw a highly significant 
reduction in GluN2B [percent of control, 20 ± 0.09; t(10)=3.810, p< 0.0034; data 
not shown] as well as GluN1 [percent of control, 51 ± 0.134; t(10)=2.789, p< 
0.0191; data not shown].  GluN2A protein levels were not significantly reduced 
[percent of control, 84 ± 0.07; t(10)=1.058, p< 0.3148, data not shown].  
 Next we assessed basal glutamatergic synaptic transmission onto dorsal 
striatal medium spiny neurons in adult animals using whole-cell patch-clamp 
recordings.  AMPAR-mediated spontaneous excitatory postsynaptic current 
(sEPSCs) frequency was unchanged by GluN2B deletion [in Hz, Control 3.57 ± 
0.45, GluN2BKO 4.04 ± 0.43; t(28)=0.6824, p= 0.3401; Figure 20A], yet there 
was a significant increase in sEPSC amplitude [in pA, Control 12.86 ± 0.72, 
GluN2BKO 15.69 ± 075; t(28)=2.396, p=0.0235; Figure 20B].  Additionally, we 
looked at the paired-pulse ratio (PPR), a measure of presynaptic release 
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probability.  Over a range of interstimulus intervals there was no significant 
difference in the PPR [F (1,20)=0.132; p=0.7205; Figure 20E].  This suggests 
that GluN2B deletion leads to an increase in the postsynaptic function and/or 
number of AMPARs without altering the probability of release. 
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Figure 20.  Basal Glutamatergic Transmission in Adult GluN2BKO Following 
Early Postnatal Deletion of GluN2B. (A) Representative traces of sEPSC currents 
at -70mV from controls (black) and GluN2BKO (red). Scale bars 300ms, 10pA  (B) 
Quantification of sEPSC frequency and (C) sEPSC amplitude from controls and 
GluN2BKO. (D) (left) AMPAR/NMDAR ratio traces, AMPAR EPSC -70mV (black), 
dual AMPAR and NMDAR EPSC +40mV (red), AMPAR EPSC +40mV following 
100µM DL-APV, NMDAR EPSC digital subtraction (green). Scale bars 20ms, 30pA. 
(right) Quantification of AMPAR/NMDAR ratio in controls and GluN2BKO mice. (E) 
Paired pulse ratio (S2/S1) over 20ms-140ms interstimulus intervals (20ms ISI steps).  
(Above) Evoked AMPAR EPSCs elicited at differing ISI for control (black) or 
GluN2BKO (red) mice. Scale bars 5ms, 50pA. (F) (left) 50 evoked EPSCs at -70mV 
(downward, AMPAR-mediated) and at +40mV (upward, NMDAR at +50ms) for 
control (black) and GluN2BKO (red) to compute coefficient of variation (CV) 
NMDAR/AMPAR ratio. Scale bars 20ms, 40pA.  (right) Quantification of CV-
NMDAR/CV-APMAR ratio in controls (black) and GluN2BKO (red)   
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To determine if deletion of GluN2B subunit of the NMDAR altered the 
composition of AMPARs, we examined AMPAR-mediated current voltage 
relationships in dorsal lateral striatum.  In the presence of 0.1mM spermine in the 
patch pipette, to avoid dialysis of intracellular polyamines, the AMPAR-mediated 
current voltage relationships were not significantly altered [F (1,14)=0.1894; 
p=0.6706; Figure 21A, 21B].  Both plots were linear, suggesting that the 
AMPARs were GluR2 containing and the AMPAR subunit composition was not 
significantly different between GluN2B KO MSNs compared to controls. 
 
  
 
 
 
 
Figure 21.  Deletion of the GluN2B Subunit of the NMDAR Does Not 
Alter Striatal AMPAR Current Voltage Relationships. (A) Evoked AMPA-
mediated EPSCs for control (black) and GluN2BKO mice (red) isolated with 
100µM DL-APV and 25µM picrotoxin at holding potentials ranging from -
70mV to +40mV in 20mV steps. Scale bars 10ms, 100pA.  (B) Average 
normalized AMPAR-mediated current at holding potentials ranging from -
70mV to +40mV in 20mV steps in control (black) and GluN2BKO mice 
(red). Error bars represent SEM.    
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 We also examined the ratio of NMDAR-mediated to AMPAR-mediated 
evoked EPSC amplitude to compute an AMPAR/NMDAR ratio as an index of 
excitatory synaptic transmission.  We found that the AMPAR/NMDAR ratio was 
significantly enhanced using two differing methodologies [For +50ms method, 
Control 1.724 ± 0.17, GluN2BKO 5.169 ± 0.68; U(20)=8, p=0.0007; Figure 20D] 
[For digital subtraction method, Control 0.669 ± 0.11, GluN2BKO 1.747 ± 0.41; 
t(7)=3.463, p=0.0105].  These data are consistent with a previous study using a 
GluN2BKO mouse to study glutamatergic transmission in the hippocampus (von 
Engelhardt et al., 2008; Wills et al., 2012).  This increase in AMPAR/NMDAR 
ratio could be due to an increase in AMPAR number and/or function, or be due to 
a decrease in NMDAR number and/or function, or potentially a combination of 
the two.    
We also looked at the coefficient of variation (CV) of NMDAR- and 
AMPAR-mediated responses.  CV is inversely proportional to quantal content, 
the probability of release and number of synapses.  We observed a significant 
increase in the CVNMDAR/CVAMPAR ratio in the GluN2BKO group compared to 
controls [Control 0.8184 ± 0.11, GluN2BKO 1.3202 ± 0.18; t(14)=2.392, 
p=0.0313, Figure 20F].  This increase in CVNMDAR/CVAMPAR ratio was driven 
primarily by an increase in the NMDAR CV, suggesting a decrease in quantal 
content.  Quantal content, which is inversely proportional to the CV, is made up 
of the product of the probability of release and number of release sites.  We can 
assume that the decrease in quantal content is probably driven by a decrease in 
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the number of synapses given that PPR, a measure of release probability, was 
similar. 
 
Genetic deletion of the GluN2B subunit of the NMDAR leads to a decrease in 
dendritic spine density 
Given the increase in CVNMDA/CVAMPA ratio, we next assessed the role 
of GluN2B in the dorsal striatum on MSN dendritic spine density as a 
morphological correlate of synapse number.  Following golgi staining, observers 
blinded to genotype counted MSN dendritic spine density within a 10µm 
segment, 80-100µm from the cell soma beyond the primary dendrite branch 
point.  Dendritic spine density was significantly reduced in GluN2B KO animals 
compared to wildtype littermates [Segment means, Controls 10.96 ± 0.20, 
GluN2BKO 9.320 ± 0.23; t(54)=5.441, p<0.0001; Figure 22A] [Animal means, 
Controls 10.96 ± 0.39, GluN2BKO 9.489 ± 0.19; t(6)=3.368, p=0.0151].  
Combined with the increased NMDA CV data, these data suggest that deletion of 
GluN2B in the dorsal striatum may lead to a reduction in NMDAR-only synapse 
number.  
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Deletion of GluN2B in adulthood reduces sEPSC frequency 
To better understand the role of GluN2B in development, we delayed the 
deletion of the GluN2B by feeding pregnant dams and then GluN2BKO mice and 
their littermates doxycycline (200mg/kg) in their chow until P45.  We first 
confirmed that indeed GluN2B was deleted in these mice at P80, similar to 
previous recordings, by measuring the speeding of NMDAR-mediated delay 
kinetics [in seconds, Control 256.8 ± 14.53, GluN2BKO 58.31 ± 2.75; 
t(13)=10.93, p<0.0001; Figure 23D] and confirmed the loss of GluN2B by 
Figure 22.  Deletion of the GluN2B Subunit of the NMDAR Leads to a 
Reduction in Dendritic Spine Density.  (A) Average MSN Dendritic Spine 
Density (# of spines per 10µm), 80-100µ from the cell soma. ***P<0.0001. Error 
bars represent SEM.  Thanks to Bonnie Garcia for collection of the data.   
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western blot (Figure 23D, inset).  Following the removal of doxycycline we again 
assayed basal glutamatergic synaptic transmission in the mice at the same time 
point in adulthood as previous experiments.  We found that delayed deletion of 
GluN2B again led to an increase in both sEPSC amplitude [Control 12.52 ± 0.37, 
GluN2BKO 15.53 ± 0.81; t(12)=2.652, p=0.0211; Figure 23A,C] and the 
AMPAR/NMDAR ratio [Control 1.472 ± 0.22, GluN2BKO 7.967 ± 0.93; 
t(13)=8.175, p=0.0004; Figure 23E], as seen previously with GluN2B deletion 
earlier in development.  However, surprisingly we observed that the delayed 
deletion of GluN2B lead to a decrease in sEPSC frequency [Control 4.594 ± 
0.36, GluN2BKO 3.285 ± 0.18; t(12)=3.634, p=0.0034; Figure 23A,B].  This 
suggests that GluN2B plays an important role in adulthood maintaining sEPSC 
frequency, possibly via altering the number of synapses or the probability of 
release.  
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Figure 23.  Delayed Deletion of the GluN2B Subunit Effects on Glutamatergic 
Synaptic Transmission in Dorsal Striatal MSNs.  GluN2B deletion occurs at P45 
with the removal of doxycycline (200mg/kg) chow. (A) Traces of AMPA-mediated 
sEPSCs at -70mV in control (black) and GluN2BKO mice (red).  Scale bars 250ms, 
10pA.  (B) Average sEPSC frequency and (C) amplitude in controls (grey, hashed) 
and in GluN2BKO mice (red, hashed). (D) (left) Example averaged NMDAR EPSC 
traces for controls (black) and GluN2BKO (red).  Scale bars 30ms, 0.1 (scaled to 1) 
(right) Average NMDAR EPSC decay time (ms) in controls (grey, hashed) and 
GluN2BKO (red, hashed). (inset) Western blot for GluN2B in controls and 
GluN2BKO mice (KO) showing the complete loss of GluN2B in the striatum with 
doxycycline delayed GluN2B deletion.  PSD-95 and CaMKIIα are added as loading 
controls. (E) (left) AMPAR/NMDAR ratio averaged traces. Evoked AMPAR EPSC -
70mV (black), Dual AMPAR and NMDAR EPSC +40mV (red), AMPA EPSC post 
100µM DL-APV (blue), NMDAR EPSC digital subtraction (green). Scale bars 20ms, 
40pA. (right) Average AMPAR/NMDAR ratio (+50ms) in controls (grey) and in 
GluN2BKO mice (red).           
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Deletion of GluN2B subunit leads to a hyperlocomotive phenotype in the novel 
open field that can be rescued by inhibiting GluN2B later in development 
 We started to assess the effects of GluN2B deletion on behavior by 
observing locomotor activity in the novel open field in adult mice (16 weeks).  
Conditional GluN2B KO animals or wildtype littermates were placed in a novel 
open field for sixty minutes to track overall locomotor activity.  GluN2B KO mice 
exhibited similar locomotor activity in the first five minutes in the novel open field.  
However, at later time points the GluN2BKO mice showed significantly escalating 
locomotor behavior [F (1,48)=36.53; p<0.0001; Fig 24A], whereas controls 
locomotor behavior habituated to the environment as expected.  Yet there was 
no significant difference in center time, a crude measure of overall anxiety levels 
in GluN2BKO mice versus control [in seconds, Controls 325.3 ± 49, GluN2BKO 
270.6 ± 45; t(25)=0.7793, p=0.4431].  Surprisingly, this affect was rescued by 
feeding doxycycline to inhibit the deletion of GluN2B before P45 [F (1,12)=4.617; 
p=0.0572; Fig 24B].  The doxycycline food was removed at P45 allowing for the 
deletion of GluN2B to occur (Fig 24B, inset) and the animals were then examined 
at the same age as Fig 24A.  The rescue of locomotor activity by delaying the 
deletion of GluN2B suggests that GluN2B is crucial early in development for 
normal motor activity. 
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Genetic deletion of GluN2B partially disrupts motor performance on the rotarod 
 Previous work has shown that deletion of the obligatory GluN1 subunit of 
the NMDAR just from the striatum disrupted normal motor learning on the rotarod 
(Dang et al., 2006; Beutler et al., 2011).  Additionally,  transgenic mice where 
MSNs are ablated do not show any improvement over trials in an accelerating 
rotarod, showing the importance of the striatum in this task (Kishioka et al., 
2009).  To understand the effects of GluN2B subunit deletion on rotarod motor 
learning we ran mice on repeated trials (<5mins, 30 min ITI).  While both the 
Figure 24.  Effects of GluN2B deletion on Novel Open Field Locomotor 
Activity.  (A) Distance traveled (cm) in the novel open field for controls (single 
transgene, and wildtype littermates) (black) and early perinatal GluN2BKO 
animals averaged in 5 minute bins for 1 hour. (B) Distance traveled in the novel 
open field for controls (single transgene, and wildtype littermates) (black) and 
GluN2BKO animals (deleted at P45) averaged in 5 minute bins for 1 hour. (inset) 
Western blot for GluN2B in controls and GluN2BKO mice (KO) showing the 
complete loss of GluN2B in the striatum with doxycycline delayed GluN2B 
deletion.  PSD-95 and CaMKIIα are added as loading controls.  **P<0.01, 
***P<0.0001, Error bars represent SEM.    
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GluN2B KO mice and controls learned to perform better over repeated trials 
[Control 1 vs. 8, t(102)=8.862, p<0.0001; GluN2BKO 1 vs. 8, t(58)=4.051, 
p=0.0002], there was a trend for a decrease in performance in early trials and a 
significant reduction in performance in later trials in the GluN2B KO mice [F 
(1,80)=9.336; p=0.0031; Figure 25A].  These data suggest that GluN2B is not 
crucial for simple striatal motor learning, but may have some influence on overall 
motor performance.  Additionally, we looked at the effect on motor learning when 
delaying the deletion of GluN2B until after P45 by feeding doxycycline.  
Surprisingly, delaying the deletion led to greater deficits in rotarod performance 
with significant reductions seen in early trials [F (1,41)=7.225; p<0.0001; Figure 
25B].  Comparing the first trial to the last trial as a measure of motor learning 
controls showed a significant increase in the latency to fall measure indicative of 
motor learning over time [in seconds, Controls Trial 1, 113.7 ± 8.7; Controls Trial 
8, 214.0 ± 10.7; t(64)=7.294; p<0.0001].  However, the GluN2BKO failed to show 
a significant increase in the latency to fall over measure over trials suggesting 
impaired motor learning [in seconds, GluN2BKO Trial 1, 78.50 ± 15.9; 
GluN2BKO Trial 8, 124.3 ± 25.9; t(64)=1.506; p=0.1495].  This suggests that 
early deletion of GluN2B is less detrimental than GluN2B deletion in adulthood in 
striatal motor learning, possibly allowing for early adaptation and compensation 
to the loss to the GluN2B subunit.  
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Figure 25.  Effects of deletion of GluN2B subunit of the NMDAR on 
simple motor learning.  (A) Averaged latency to fall (seconds) over eight 
trials on 2 days separated by a week in control (black) and early perinatal 
GluN2BKO mice (red).  (B) Averaged latency to fall (seconds) over eight 
trials on 2 days separated by a week in control (black) and GluN2BKO mice 
(deleted at P45) (red).  *P<0.05, **P<0.01, ***P<0.0001.  Error bars 
represent SEM.      
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Discussion 
These studies indicate a key role for the GluN2B subunit in striatal 
glutamatergic synaptic transmission as well as in striatal-based behaviors.  We 
observed that deletion of GluN2B in the striatum early in postnatal development 
leads to an increases in sEPSC amplitude, AMPAR/NMDAR ratio, and 
CVNMDAR/CVAMPAR ratio coupled with decreases in dendritic spine density.  
The increase in sEPSC amplitude along with the increase in AMPAR/NMDAR 
ratio suggests an increase in number and/or function of AMPARs.  The increased 
CVNMDAR/CVAMPAR ratio data combined with no change in the presynaptic 
release probability coupled and decreased dendritic spine density suggests a 
possible decrease in the number of NMDAR-only synapses or “silent” synapses.  
Behaviorally, GluN2B deletion early postnatally led to a hyperlocomotive 
phenotype and partial performance deficits on the rotarod, but did not disrupt 
motor learning. 
Postponing the deletion of striatal GluN2B until P45 led to a similar 
synaptic phenotype with a notable difference.   The delayed deletion decreased 
sEPSC frequency, suggesting a possible decrease in the number of synapses or 
the probability of release.  Behaviorally, postponed deletion of GluN2B rescued 
the hyperlocomotive phenotype, yet worsened the behavioral deficit on the 
rotarod as well as blunting motor learning.  These data suggest that the timing of 
the GluN2B subunit deletion is crucial in determining what electrophysiological 
and behavioral phenotype observed.   
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Disrupted Glutamatergic Synaptic Transmission in the GluN2BKO mice 
 We observed an almost complete (99%) reduction in GluN2B levels in the 
striatum as well as a significant reduction in the obligatory GluN1 subunit (77%) 
necessary for heteromeric assembly suggesting that the loss of GluN2B reduced 
the number of NMDARs in total.  Previous studies using GluN2B KOs suggest 
that total GluN1 mRNA levels were unaltered, but GluN1 protein levels were 
reduced suggesting a deficit in translation or degradation of the receptor 
(Brigman et al., 2010; Badanich et al., 2011).  Indeed, the loss of GluN2B may 
impart greater NMDAR instability and greater turnover (Huh and Wenthold, 
1999).   Many other synaptic proteins such as GluA1, CaMKIIalpha and 
CaMKIIbeta were unaltered suggesting a selective alteration in glutamate 
receptors.  This pattern was similar to previously reported with the loss of 
GluN2B in the CA1 region of the hippocampus (von Engelhardt et al., 2008; 
Brigman et al., 2010) as well as similar to what is seen in the striatum (Badanich 
et al., 2011).  Additionally, confirming the loss of GluN2B the decay kinetics of 
evoked NMDAR-mediated EPSCs was significantly substantially accelerated.   
We assume that all of the NMDAR remaining in the striatum are 
heteromers of GluN1/GluN2A.  GluN2A containing NMDARs are known to have 
faster deactivation kinetics than GluN2B containing receptors fitting our data 
(Traynelis et al., 2010).  Notably we did not observe any GluN2D-like long lasting 
decay kinetics, observed previously in striatal NMDAR subunit knockout animals 
(Logan et al., 2007).  Increased sEPSCs amplitude with early postnatal GluN2B 
deletion suggests an increased number and/or function of synaptic AMPARs.  
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While we did not see an increase in crude GluNA1 levels by western blot, this 
technique is a cruder measure of total AMPARs including extrasynaptic and 
internalized receptors and not an enriched synaptic fraction.  Increased, AMPAR-
mediated synaptic transmission fits with the idea that NMDAR activation in 
synaptogenesis suppresses AMPAR function (Hall et al., 2007).  Additionally, 
AMPAR current voltage relationships were linear and unchanged between the 
GluN2BKO animals and controls, suggesting that the AMPARs are GluA2-
containing and that GluN2B subunit deletion does not significantly alter AMPAR 
subunit composition.  The increase in the AMPAR/NMDAR ratio could come from 
an increase in AMPAR-mediated transmission or a decrease in the NMDAR-
mediated component or some combination of the two.  In this case the increase 
in sEPSC amplitude along with a loss in GluN1 levels would suggest that both 
are in play.  sEPSC frequency and the paired pulse ratio (PPR) were unchanged 
between controls and GluN2BKO animals suggesting that the number of 
synapses and the probability of release are unchanged, yet we observed a 
reduction in the dendritic spine density- a morphological correlate of synapse 
number.  This reduction in dendritic spine density was similar to what was 
observed in the in CA1 or CA3 region of the hippocampus in a GluN2B KO 
animal (Akashi et al., 2009; Brigman et al., 2010) and in cultured hippocampal 
neurons after GluN2B RNA interference (Kim et al., 2005).  However, this 
contrasts the finding in the hippocampus that GluN2B deletion increases 
functional synapse number (Gray et al., 2011).  Utilizing a coefficient of variation 
AMPAR/NMDAR ratio (CV-NMDAR/CV-AMPAR ratio) a measure of quantal 
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content reflecting changes in the number of synapses and/or the probability of 
release we found a significant increase in this ratio primarily driven by an 
increase in the NMDAR CV.  This suggests a decrease in the number of 
NMDAR-only containing synapses or silent synapses.  Thus this decrease in 
“silent” synapses may be reflected by fewer dendritic spines observed and would 
not be picked up in AMPAR-mediated sEPSC frequency measures. 
 Delaying the deletion of GluN2B until P45 lead to a similar phenotype 
consisting of accelerated NMDAR-mediated decay time, loss of GluN2B from the 
striatum, increased sEPSC amplitude, and increased AMPAR/NMDAR ratio.  
However, the postponed deletion of GluN2B until adulthood resulted in a 
significantly reduced sEPSC frequency.  This may suggest that deletion of 
GluN2B in adulthood may decrease the number of functional synapses or the 
probability of release at those excitatory synapses.  This suggests that GluN2B 
subunits may play some synaptic maintenance role, protecting the synapse from 
deletion. The lack of a decrease in sEPSC frequency early in development may 
suggest a deficit in synaptogenesis of potential silent synapses.       
 
Disrupted striatal-based behaviors in GluN2B KO mice 
 Alterations in synaptic transmission and dendritic spine number were 
associated with selective striatal-based behavior disruptions.  GluN2BKO 
animals showed a hyperlocomotive phenotype with an escalating locomotor 
response in the open field compared to within session habituation observed in 
wildtype littermates.  Previous reports using NMDA antagonists as well as 
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GluN2B-preferring antagonists such as Ro 25-6981 at higher doses produced 
hyperlocomotion (Chaperon et al., 2003; Kiselycznyk et al., 2011).  Additionally, 
genetic replacement of the GluN2B subunit with the GluN2A subunit results in a 
hyperlocomotive phenotype (Wang et al., 2011).  Also GluN2BKO animals 
showed elevated locomotor activity that did not habituate, but did not show 
escalation in locomotor activity like we observed (Badanich et al., 2011).  
However, in our case when we delayed the deletion of GluN2B until P45 the 
hyperlocomotive phenotype was rescued.  This suggests that early removal of 
GluN2B in development leads to this phenotype.  It is known that levels of 
GluN2B are high in early postnatal development and then start to decline as 
GluN2A levels rise (Monyer et al., 1994; Sheng et al., 1994).  The delayed 
removal of GluN2B may allow for proper synaptogenesis and synaptic 
maturation. 
When we examined striatal-based motor learning assayed on the 
accelerating rotarod we observed that deletion of GluN2B early in postnatal 
development lead to a modest decrease in performance especially in later trials, 
but it did not disrupt overall motor learning.  Surprisingly, postponing the deletion 
of GluN2B until P45 actually led to a more severe deficit in rotarod performance 
in GluN2BKO mice.  GluN2BKO mice did not show any significant motor learning 
over repeated trials compared to littermate controls, suggesting an important role 
for GluN2B in motor learning in the striatum.  The enhanced deficit seen when 
the deletion of GluN2B is postponed until adulthood, suggests that compensation 
may be able to prevent serious motor deficits early on, but disrupting a system 
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which has utilized GluN2B signaling previously may lead to more serious deficits.  
In contrast to these data, a study using GluN2A or GluN2B antagonists injected 
into the dorsal striatum suggested that while GluN2A was crucial for motor 
learning on the accelerating rotarod, GluN2B was not (Lemay-Clermont et al., 
2011).  This discrepancy may be accounted for by issues with selectivity with the 
GluN2A antagonist, NVP-AAM077 or the greater alliance on the loss of GluN1 
subunit also seen in our studies.  Rotarod learning, especially the late 
component, seems to involve an increase in NMDAR-mediated synaptic 
transmission and is associated with an upregulation of GluN1 (Yin et al., 2009; 
D'Amours et al., 2011).  Another study showed that disrupting the interaction 
between CaMKII and the GluN2B subunit, however did not disrupt rotarod or 
locomotor activity, suggesting that the actual loss of the GluN2B or GluN1 
receptor plays the crucial role (Halt et al., 2012). 
While the differing phenotype following the delayed deletion of GluN2B 
subunit may be linked to when the subunit is removed in development an 
alternate explanation may be that there are regional differences in the 
completeness of the forebrain wide KO.  This differential regional deletion has 
been observed previously in similar GluN2BKO mice (Badanich et al., 2011). 
 In conclusion, the current study describes a genetic approach to 
understanding the role of the GluN2B subunit in striatal synaptic transmission, 
dendritic spine density and behavior.  We found that the deletion of GluN2B early 
in postnatal development shortens NMDAR-mediated currents, leads to 
potentiated AMPA-mediated synaptic transmission and a decrease in the number 
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of dendritic spines on MSNs potentially via a loss in NMDA-only or “silent” 
synapses.  A delayed deletion of GluN2B receptors in adulthood leads to a 
similar phenotype, but with a reduction in the number of functional receptors or 
probability of release.  Behaviorally, early disruption of GluN2B leads to 
disruptions in locomotor activity, while adult deletion of GluN2B results in deficits 
in striatal motor learning.  These data emphasize the importance of the GluN2B 
subunit of the NMDAR in striatal synaptic transmission and behavior.  
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CHAPTER VI 
 
GENERAL DISCUSSION 
 
 The role of glutamatergic transmission in the dorsal striatum in health and 
its dysregulation in disease states is becoming increasingly recognized.  Long-
lasting alterations in glutamatergic transmission have been connected to the 
formation of motor repertoires and the organization of habitual behavior (Yin and 
Knowlton, 2006; Yin et al., 2009).  Moreover, alterations in glutamatergic 
transmission in the striatum have been seen in models of Parkinson’s disease, 
Huntington’s disease and addiction (Picconi et al., 2004b; Kreitzer and Malenka, 
2007; Milnerwood et al., 2010; Luscher and Malenka, 2011).  Disruptive or 
maladaptive synaptic plasticity in the striatum could in part underlie the motor 
abnormalities seen in neurodegenerative disease and underlie the habitual 
nature of compulsive drug seeking in addiction.  Importantly, molecules like 
CaMKII and the NMDAR are already tied to synaptic plasticity and learning and 
memory in the hippocampus.  However, little is known about the regulation of 
glutamatergic transmission and its role in behavioral output in the striatum.  
Utilizing electrophysiological approaches along with pharmacological, genetic, 
immunohistochemical and behavioral manipulations this thesis has begun to 
elucidate some of the roles of striatal CaMKII and the GluN2B subunit of the 
NMDAR in synaptic transmission, synaptic plasticity and ultimately behavior.  
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Role of Striatal CaMKII in Glutamatergic Transmission 
 The data presented in this document suggests that MSN CaMKII in the 
dorsal striatum plays a role in setting functional synapse number and intrinsic 
excitability, acting as rheostat to modulate the output of dorsal striatal MSNs 
(Figure 26).   We find that selective genetic inhibition of CaMKII in dorsal striatal 
MSNs leads to a robust reduction in s/mEPSC frequency without altering 
s/mEPSC amplitude.  Alterations in s/mEPSC frequency are canonically 
interpreted as a presynaptic change in either release probability or the number of 
functional synapses/release sites.  Experiments designed to test for alterations in 
release probability or the concentration of glutamate at the synapse, indicate that 
inhibition of postsynaptic MSN CaMKII did not alter these measures.  Thus in 
total these data suggest that striatal CaMKII inhibition decreases the number of 
excitatory functional synapses.  Reduced dendritic length and complexity in 
EAC3I mice may account for the reduction in the number of synapses without 
any significant changes in dendritic spine density.  Alternatively, there could be 
an increase in the number of silent synapses or silent synapse modules - 
synapses which contain NMDARs, but lack AMPARs.  This fits with the idea that 
CaMKII inhibition did not reduce dendritic spine density, suggesting that at least 
some of the observed postsynaptic dendritic spines in CaMKII inhibited cells are 
indeed silent.  In the hippocampus silent synapses are abundant in early 
development and silent synapses can be unsilenced in an activity-dependent, but 
CaMKII independent manner.  However, other studies using a constitutively 
active form of CaMKII suggests a direct role for CaMKII in the unsilencing of 
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synapses.  Additionally, CaMKII has been shown to be required for the formation 
of new synapses and/or morphological augmentation following hippocampal LTP 
induction. 
   
  
 
 
Figure 26.  CaMKII Rheostat:  Effects of CaMKII Inhibition on Glutamatergic 
Synaptic Transmission and Intrinsic Excitability in the Dorsal Lateral 
Striatum.  Active CaMKII (grey, control MSN) enhances synaptic transmission 
and decreases intrinsic excitability. Inhibition of CaMKII (green, EAC3I-
containing MSN) leads to a decrease in the number of synapses and an 
increase in intrinsic excitability. 
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Differing experimental approaches could be used to examine if inhibition 
of CaMKII leads to an increase in silent synapse number.  Traditionally, silent 
synapses have been observed using minimal stimulation techniques setting the 
stimulation intensity at a threshold where no AMPAR-mediated EPSCs are 
observed, but at positive potentials where NMDAR are activated, NMDAR-
mediated currents are observed (Isaac et al., 1995).  Normally the failure rate is 
then compared before and after some manipulation, like the induction of LTP.  
These experiments, while potentially interesting, have caveats.  They are 
dependent on the stimulation intensity and location of the microstimulator to 
remain the same as well as the health of the slice.  If the number of fibers 
recruited is altered slightly by changes in the stimulator location or slice then the 
number of synaptic failures can be altered dramatically.  Additionally, because 
CaMKII is inhibited genetically we do not have a pre versus post comparison to 
measure synaptic failure rates which is crucial for interpreting results from these 
experiments.  Another approach to determine the presence of silent synapses is 
the CV-NMDAR/ CV-AMPAR ratio.  This technique has been used with success 
in the ventral striatum to detect silent synapses following repeated cocaine 
administration (Huang et al., 2009; Brown et al., 2011).  Decreases in this ratio 
are associated with a silent synapse phenotype and we did observe decreases in 
this ratio when comparing CaMKII-inhibited MSNs versus non-inhibited MSNs.  
Yet the underlying effect was driven by an increase in the ratio in the non-
inhibited MSNs versus all controls, suggesting that non-inhibited MSN may 
compensate for the loss of CaMKII in neighboring MSNs.           
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CaMKII’s Role in MSN Morphology 
We did not observe any changes in dendritic spine density with CaMKII 
inhibition.  This suggests that CaMKII is potentially not necessary for the 
formation of new synapses, but instead may control the maturation of striatal 
synaptic connections.  Indeed, previous studies have shown the importance of 
phosphorylation CaMKII at the T286 site to promote dendritic spine growth, even 
with a mutation rendering the kinase catalytically dead (Pi et al., 2010b).  Yet the 
direction of synaptic strength alteration depends on the phosphorylation state of 
the CaMKII T305/306 site (Pi et al., 2010b).  Other studies in the hippocampus 
have shown that CaMKII inhibition can block the increase in dendritic spine size 
or Wnt7a-mediated spine growth (Matsuzaki et al., 2004; Okamoto et al., 2009; 
Ciani et al., 2011b).  Prior studies have shown that βCaMKII in cultured 
hippocampal neurons modulate dendritic length as well as synapse number (Fink 
et al., 2003).  While we did not encounter a change in spine density, we observed 
a significant decrease in dendritic length and complexity.  The decrease in 
dendritic length combined with unaltered spine density may account for the 
decrease in total synapse number we propose.  However, it is not clear whether 
distal synapses are even sampled under whole-cell voltage clamp due to cable 
filtering properties previously reported (Williams and Mitchell, 2008).  The 
aforementioned study examined layer 5 pyramidal neurons; we would expect that 
dendritic filtering would be even greater in MSNs with narrow dendrites and 
numerous spines.  The CaMKII-mediated decrease in dendritic length and 
complexity may suggest developmental maturation deficits.  An interesting 
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candidate includes BDNF signaling via TrkB receptors.  Mice lacking cortical 
BDNF show altered dendritic morphology including decreases in dendritic length 
(Baquet et al., 2004).  Additionally, signaling through the TrkB receptor has been 
shown to activate CaMKII (Hasbi et al., 2009; Minichiello, 2009).                   
 
Importance of MSN-specific Inhibition of CaMKII 
 It is important to consider the localization of CaMKII when interpreting 
these results.  CaMKII is highly expressed in MSNs (Erondu and Kennedy, 
1985), but is also expressed in pyramidal neurons that form the presynaptic 
terminal on MSN dendritic spines and shafts (Liu and Jones, 1996).  Additionally, 
CaMKII is expressed in dopamine neurons which densely innervate MSNs in the 
striatum, modulating glutamatergic drive (Fog et al., 2006).  CaMKII activation 
has been shown to modulate both pre and postsynaptic activity.  Presynaptically, 
CaMKII has been shown to modulate the trafficking of synaptic vesicles via 
phosphorylation of synapsin (Llinas et al., 1985; Stefani et al., 1997; Chi et al., 
2001), P/Q type calcium channels (Elgersma et al., 2002; Jiang et al., 2008), and 
voltage-gated sodium channels (Wagner et al., 2006).  Additionally, CaMKII has 
been shown to modulate catecholamine synthesis (Atkinson et al., 1987) and 
dopamine transporter function (Fog et al., 2006; Binda et al., 2008).  Thus, we 
have utilized a cell specific approach where CaMKII is selectively inhibited only in 
dorsal striatal MSNs, eliminating cofounding interpretations on the locus of 
CaMKII inhibition and observed effects. 
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Striatal CaMKII’s Regulation of Cortical and/or Thalamic Excitatory 
Transmission 
MSNs are innervated by both cortical and thalamic glutamatergic inputs 
and differences in the release probability have been observed between these two 
inputs.  Our measures of sEPSC and mEPSC frequency are likely comprised of 
both cortical and thalamic-mediated glutamate release.  Our data do not rule out 
the possibility that inhibition of CaMKII may have a greater influence on one of 
these excitatory inputs over the other.  Previous studies have separated cortical 
versus thalamic inputs with horizontal oblique slices maintaining both cortical and 
thalamic innervation and stimulating evoked EPSCs in layer 5 of the cortex or at 
the level of the reticular nucleus preserving some of the parafascicular-
centromedian thalamic pathway (Smeal et al., 2007; Ding et al., 2008).  
Alternatively, the expression of channelrhodopsin-2 in motor cortex or in thalamic 
nuclei projecting to the dorsal striatum would be a more selective way to 
separate these two inputs (Osakada et al., 2011).  The use of modified rabies 
viruses carrying channelrhodopsin-2 which in a retrograde manner infects 
projecting brain areas will help delineate the role of these separate pathways.  In 
both cases the measured EPSC is evoked by electrical stimulation or blue light, 
respectively.  However, our main phenotype in CaMKII inhibited MSNs is a 
reduction in spontaneous or miniature EPSC frequency which involves 
spontaneous release of synaptic vesicles.  One experimental approach to select 
a pathway and record spontaneous release-like events involves swapping aCSF 
calcium for strontium.  Strontium, a divalent cation like calcium, promotes 
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asynchronous release of synaptic vesicles, by lingering strontium levels in the 
presynaptic terminal.  In strontium aCSF individual pathways could be electrically 
or optogenetically stimulated.  Following the initial large evoked EPSC miniature 
like release events occurring due to asynchronous release can be analyzed.  
However, only the amplitude measure of these events is of interest because the 
frequency of these events is altered by strontium.  Thus this makes the 
separation of cortical and thalamic spontaneous or miniature EPSC frequency 
difficult. 
 
CaMKII Inhibition in Direct and Indirect Pathway MSNs 
 There are two canonical MSN output pathways in the dorsal striatum.  The 
direct pathway MSNs are labeled by D1R expression and projections to the 
substania nigra pars reticulata.  The indirect pathway MSNs are labeled with D2R 
expression and projections to the globus pallidus.  These two pathways are 
thought to oppose one another with the direct pathway promoting movement and 
the indirect pathway inhibiting movement (Bateup et al., 2010; Kravitz et al., 
2010).  Using BAC transgenic mice to label direct and indirect pathways notable 
differences in basal synaptic transmission, plasticity and excitability have been 
observed (Kreitzer and Malenka, 2007, 2008; Grueter et al., 2010; Andre et al., 
2011).  The EAC3I CaMKII inhibitory peptide was expressed in both direct and 
indirect pathway neurons evidenced by the presence of EGFP axon terminals 
seen in the substantial nigra pars reticulata and globus pallidus, respectively.  
However, we do not know if there is a bias in the percentage of EAC3I containing 
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MSNs in direct or indirect pathway.  We did not observe a bimodal distribution in 
our sEPSC frequency data, suggesting a global loss of functional synaptic 
connections in both pathways.  It will be interesting to look at the effects of 
CaMKII inhibition in either direct or indirect pathway neurons.  Retrograde 
microspheres deposited in target regions or breeding the EAC3I to mCherry 
expressing BAC transgenics will allow for identification of these two pathways.   
Some evidence for distinct CaMKII signaling effects on direct or indirect 
pathway MSNs has already been observed.  CaMKII is known to interact with the 
M4R, a GPCR linked to Gi/o signaling which is enriched in direct pathway MSNs 
(Yasuda et al., 1993; Hersch et al., 1994).  The phosphorylation of M4R by 
CaMKII can potentiate M4R signaling and controls the behavioral sensitivity to 
dopamine (Guo et al., 2010).  I might hypothesize that inhibition of MSN CaMKII 
may alter M4R function or signaling in direct pathway MSNs.     
It is difficult to predict how the decrease in numbers of excitatory synapses 
potentially on direct and indirect pathway MSNs would alter striatal output.  
Decreased excitatory drive to MSNs should decrease the release of GABA in the 
globus pallidus and substantia nigra.  Yet we observed increased intrinsic 
excitability possibly countering these effects potentially as compensation to the 
loss in synapse number.  Also interesting is the high level of expression of the 
CaMKII inhibitor in MSN presynaptic axon terminals in the SNR and GP.  The 
presynaptic effects of CaMKII inhibition on MSN GABA release have not yet 
been studied.            
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Other Modes of CaMKII Inhibition 
 Utilizing the EAC3I mouse was a selective and cell-specific approach to 
inhibit CaMKII.  However, doxycycline mediated delay of transgene expression 
contained some caveats.  First as reported previously, silencing the transgene 
from birth and expressing the transgene later in adulthood led to significantly 
reduced levels of EAC3I expression compared to leaving the transgene on from 
birth (Bejar et al., 2002).  This fact made it difficult to interpret whether the 
expression levels or time course of CaMKII inhibition led to the observed 
phenotype.   Additionally, there was a lag time of 2-3 weeks for maximal 
expression or complete inhibition of EAC3I transgene expression when starting 
or stopping the doxycycline diet, clouding the temporal control of transgene 
expression (Bejar et al., 2002).  Other options for inhibiting CaMKII that have had 
previous success include viral expression of EAC3I in adult tissue (Zou and 
Cline, 1999; Li et al., 2010; Swaminathan et al., 2011), infusion of CaMKII 
inhibitory peptides via a patch pipette (Otmakhov et al., 1997; Shiells and Falk, 
2000; Sergeant et al., 2005), or the CaMKII T286A knock in mouse (Giese et al., 
1998; Ohno et al., 2006; Kimura et al., 2008; Sametsky et al., 2009).  Viral 
expression or patch pipette inclusion of CaMKII inhibitors may avoid issues with 
compensation seen with prolonged CaMKII inhibition in genetic models and may 
yield differing results (Bejar et al., 2002).       
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Potential Downstream Substrates of Striatal CaMKII 
There are numerous downstream substrates of CaMKII that could play a 
role in our observed decreased sEPSC frequency phenotype.  One potential 
downstream substrate of CaMKII is the GluA1 subunit of the AMPAR.  CaMKII 
regulates the trafficking of synaptic GluA1 incorporation in the hippocampus (Lee 
et al., 2000; Esteban et al., 2003).  The decreased sEPSC frequency phenotype 
in the EAC3I mice is mimicked in the GluA1KO mice suggesting a common 
mechanism.  Moreover, CaMKIIα mRNA and protein levels are reduced in GluA1 
KO animals (Zaitseva et al., 2003; Zhou et al., 2009).  Another potential 
candidate is SAPAP3; a striatally enriched scaffolding protein, which can be 
phosphorylated by CaMKII.  Intriguingly, SAPAP3 KO mice exhibit a similar 
electrophysiological phenotype as our EAC3I mice (Chen et al., 2011b; Wan et 
al., 2011).  With tens to hundreds of potential CaMKII target substrates at the 
synapse from receptors like the GluN2B subunit of the NMDA receptor 
(Omkumar et al., 1996), to scaffolding molecules like SAP90/97, PSD-95 and 
Homer 1b (Yoshimura et al., 2000; Yoshimura et al., 2002), as well as vanilloid 
receptors (Jung et al., 2004) it will be interesting to see which molecules underlie 
our observed effects.  Further study is needed to identify other downstream MSN 
proteins regulated by CaMKII. 
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Potential Effects of CaMKII on Inhibitory Synaptic Transmission in the 
Striatum 
While we have extensively isolated our studies to excitatory transmission 
in the dorsal striatum the potential effects of CaMKII inhibition on GABAergic 
transmission in the striatum remain unexplored.  MSNs receive local inhibitory 
connections from other neighboring MSNs as well as GABAergic interneuron 
innervation.  Indeed, while little is known of CaMKII’s role in inhibitory 
transmission a recent study has suggested the active CaMKII can phosphorylate 
GABAARs and enhance inhibitory synaptic transmission in the hippocampus 
(Houston et al., 2009).  Thus, it will be of interest to determine if our observed 
effects are specific to excitatory transmission or generalize to inhibitory 
transmission as well.     
 
MSN CaMKII Modulation of Intrinsic Excitability 
We have observed that inhibition of CaMKII in dorsal striatal MSNs leads 
to an increase in intrinsic excitability.  CaMKII-inhibited MSNs have more 
depolarized resting membrane potentials, increased membrane resistance, 
decreased rheobase current injection, and increased firing frequency.  This fits 
with data in the hippocampus where an autonomously active form of CaMKII has 
been shown to suppress neuronal excitability by increasing cell-surface 
expression of A-type K+ channel, Kv 4.2, via phosphorylation (Varga et al., 
2004).  CaMKII inhibition in medial vestibular nucleus neurons increased intrinsic 
excitability via a reduction in BK-type calcium activated potassium currents 
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(Nelson et al., 2005).  While both of these channels are expressed in the striatum 
and may modulate firing frequency additional mechanisms are likely responsible 
for change input resistance and resting membrane potential (Schwanstecher and 
Panten, 1994; Varga et al., 2000; Martin et al., 2004; Vacher et al., 2006).  One 
potential candidate underlying these excitability changes are the Kir2.1/2.3 
channels which are highly expressed in the striatum and when downregulated 
show a similar phenotype to the EAC3I increased excitability (Cazorla et al., 
2012).  The increase MSN intrinsic excitability we see in the EAC3I mice would 
drive greater release of GABA in both the globus pallidus and in the substantia 
nigra pars reticulata.  We did not note a bimodal distribution in the excitability 
data suggesting that the CaMKII-mediated increase in excitability occurs in both 
direct and indirect pathway MSNs.  It would be interesting to examine the effect 
of enhanced MSN excitability on downstream basal ganglia nuclei.  With the 
robust expression of CaMKII inhibitory peptide in the presynaptic terminals in 
these regions it would be interesting to look for potential circuit wide changes and 
the effects of presynaptic inhibition of MSN CaMKII.                                
 
Protracted CaMKII Inhibition: Regulation or Compensation 
Opposing regulation of excitatory transmission and excitability suggests 
that CaMKII serves as a molecular fulcrum counterbalancing decreases in 
synaptic transmission with increases in excitatory output (Figure 26).  CaMKII 
would act as a check on runaway plasticity by compensating for alterations in 
synaptic transmission or excitability.  It will be important to determine if 
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alterations in extrinsic excitability are compensations for the decreased excitatory 
drive or vice versa.  We know that the CaMKII-mediated decrease in sEPSC 
frequency is seen as early as 3 weeks, so it will be of great interest to see if the 
increase in excitability is seen early in development.  Plotting the time course of 
the development of this effect will offer a better understanding of when these 
changes occur and if one precedes the other.    
 
Effects of Early Postnatal GluN2B Deletion in Excitatory Synaptic 
Transmission in MSNs 
We observed an increase in sEPSC amplitude in GluN2B KO animals 
compared to controls with no change in sEPSC frequency.  These AMPAR-
mediate sEPSCs data suggests an increase in postsynaptic AMPAR number 
and/or function.  While at first seemingly contradictory, the loss of GluN1 in the 
CA1 region of the hippocampus late embryonically actually increases AMPAR-
EPSCs and enhances the number of functional synapses (Grooms et al., 2006; 
Ultanir et al., 2007; Adesnik et al., 2008).  This process is through to involve a 
homeostatic-like mechanism (Lu et al., 2011a).  These data suggest that 
NMDARs actually oppose AMPAR trafficking to the synapse.  Further postnatal 
deletion of GluN1, or both GluN2A and GluN2B leads to an increase in AMPAR-
EPSCs (Gray et al., 2011).  The AMPAR-mediated potentiation seen after the 
deletion of GluN1 requires the GluA2 subunit (Lu et al., 2011a).  In agreement 
with these findings we saw no alteration in AMPAR EPSC current-voltage 
relationships, a measure of GluA2 content of AMPARs.  This suggests the 
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AMPARs at the synapse in the GluN2B KO animals are GluA2-containing.  In all, 
it seems that the loss of GluN2B or the indirect loss of GluN1 seen in these 
GluN2B Kos leads to an increase in GluA2-containing AMPAR number and/or 
function.  Like previous reports with GluN2B deletion in the hippocampus (Gray 
et al., 2011), we did not see any alteration in PPR, suggesting the probability of 
release at these synapse is unaltered.  These findings are seen despite the 
major loss of GluN2B we observed in the cortex, a major excitatory input to 
MSNs.   
The deletion of GluN2B in the hippocampus leads to increased mEPSC 
frequency with no change in mEPSC amplitude, while the deletion of GluN2A 
leads to the opposite an increase in amplitude, but no change in frequency.  
Deletion of both subunits leads to an increase in frequency and amplitude. (Gray 
et al., 2011).  We find that GluN2B deletion in MSNs in our mice leads to the 
opposite phenotype.  This is in line with the deletion of GluN2B in dissociated 
cortical cultures where increases in mEPSC amplitude were observed (Hall et al., 
2007).   This may suggest that GluN2B regulation of AMPA-mediated synaptic 
transmission is different in the striatum than the hippocampus.   Yet this early 
deletion of GluN2B contrasts to the removal in the adult hippocampus where no 
alterations in sEPSC frequency or amplitude are observed (von Engelhardt et al., 
2008). It would be interesting to look at MSN mEPSC frequency and amplitude in 
GluN2A KO mice.                 
 While we did not see a decrease in sEPSC frequency or observe changes 
in PPR, we did observe a significant reduction in dendritic spine density in 
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GluN2B KO MSNs.  These observations fit with numerous other reports that the 
deletion of GluN2B reduces spine density (Akashi et al., 2009; Espinosa et al., 
2009; Gambrill and Barria, 2011).  The deletion of GluN1 does not affect dendritic 
spine density, suggesting that the loss of GluN2B is underlying this 
morphological change (Adesnik et al., 2008).  The loss of spines in the GluN2B 
KO MSNs may be due to an premature expression of GluN2A receptors 
(Gambrill and Barria, 2011).  The divergence in morphology data and sEPSC 
frequency data suggest that the loss of spines is presumably from a loss of silent 
synapses or synapses that lack AMPARs.  The increase in AMPAR/NMDAR data 
fits with the increase in sEPSC amplitude or a decrease in the NMDAR-mediated 
component.  The loss of silent synapses would remove NMDAR-only containing 
receptors.  The increase in CV-NMDAR/ CV-AMPAR ratio data we observed 
suggests that indeed the number of silent synapses is reduced in GluN2B KO 
MSNs.                 
 
Effects of Adult GluN2B Deletion on Glutamatergic Transmission in Striatal 
MSNs 
 We took advantage of the tet-OFF genetic system to delay the removal of 
GluN2B (after P45) to look at developmental and adult roles of this subunit.  We 
found that while sEPSC amplitude and AMPAR/NMDAR ratios were increased 
like in the early deletion condition, but sEPSC frequency was significantly 
reduced.  This would suggest a decrease in the probability of release or the 
number of synapses.  We would like to look at PPR and dendritic spine density at 
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this time point to further understand the mechanisms underlying the decrease in 
sEPSC frequency.  These data differ from the deletion of GluN2B in the 
hippocampus which did not alter mEPSC frequency or amplitude.  However, 
knock down of GluN2B is associated with a decrease in mEPSC frequency 
(Gambrill and Barria, 2011).  This suggests that deletion of GluN2B in striatum in 
early adolescence versus adulthood has different effects on basal glutamatergic 
transmission.   
 
Effects of GluN2B Deletion on Behavior 
  Alterations in synaptic transmission and dendritic spine number were 
associated with selective striatal-based behavior disruptions.  GluN2BKO 
animals showed a hyperlocomotive phenotype with an escalating locomotor 
response to the open field compared to within session habituation observed in 
wildtype littermates.  Previous reports using NMDA antagonists as well as 
GluN2B-preferring antagonists such as Ro 25-6981 at higher doses produced 
hyperlocomotion (Chaperon et al., 2003; Kiselycznyk et al., 2011).  Additionally, 
in mice in which the GluN2B subunit was genetically replaced by the GluN2A 
subunit exhibited a hyperlocomotive phenotype (Wang et al., 2011).  However, in 
our case when we delayed the deletion of GluN2B until P45 the hyperlocomotive 
phenotype was rescued.  This suggests that early removal of GluN2B in 
development leads to this phenotype.  The loss of GluN2B in adulthood does not 
significantly alter locomotor activity.  It is known that levels of GluN2B are high in 
early postnatal development and then start to decline as GluN2A levels rise 
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(Monyer et al., 1994; Sheng et al., 1994).  Additionally, the ability to induce 
plasticity varies with age and experience (Kirkwood et al., 1996; Quinlan et al., 
1999; Yashiro and Philpot, 2008).  In the first postnatal week, a time 
corresponding to the progressive enrichment of GluN2A subunits at the synapse, 
the efficacy of LTP induction is reduced at thalamocortical synapses (Crair and 
Malenka, 1995; Isaac et al., 1997; Lu et al., 2001).  Interestingly experience 
dependent exchange of GluN2B for GluN2A subunits in the visual cortex 
(Quinlan et al., 1999) correlates with an elevated LTP induction threshold 
(Kirkwood et al., 1996).  Together these data suggest that experience driven 
insertion of GluN2A increases the threshold for LTP induction.  Many of our early 
GluN2B deletion effects could be driven by the unchecked GluN2A expression 
earlier than normal in development.  The delayed removal of GluN2B may allow 
for proper synaptogenesis and synaptic maturation allowing for a rescue of 
locomotor behavior.    
 We observed that deletion of GluN2B early in postnatal development lead 
to a decrease in performance on the accelerating rotarod, especially in later 
trials, but it did not disrupt overall motor learning.  Surprisingly, postponing the 
deletion of GluN2B until P45 led to a more severe deficit in rotarod performance 
in GluN2BKO mice.  GluN2BKO mice did not show any significant motor learning 
over repeated trials compared to littermate controls, suggesting an important role 
for GluN2B in motor learning in the striatum.  The enhanced deficit seen when 
the deletion of GluN2B is postponed until adulthood, suggests that compensation 
prevents serious motor deficits after early deletion, but disrupting a system which 
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has utilized GluN2B signaling previously may lead to more serious deficits.  In 
contrast to these data, a study using GluN2A or GluN2B antagonists injected into 
the dorsal striatum suggested that while GluN2A was crucial for motor learning 
on the accelerating rotarod, GluN2B was not (Lemay-Clermont et al., 2011).  This 
discrepancy may be accounted for by issues with selectivity with the GluN2A 
antagonist, NVP-AAM077 or the greater reliance on the loss of GluN1 subunit 
also seen in our studies.  Rotarod learning, especially the late component, seems 
to involve an increase in NMDAR-mediated synaptic transmission and is 
associated with an upregulation of GluN1 (Yin et al., 2009; D'Amours et al., 
2011). Another study showed that disrupting the interaction between CaMKII and 
the GluN2B subunit did not disrupt rotarod or locomotor activity, suggesting that 
the actual loss of the GluN2B or GluN1 receptor plays the crucial role (Halt et al., 
2012).     
In summary, I have shown that both CaMKII and GluN2B are important for 
modulating glutamatergic synaptic transmission in the striatum and striatal-based 
behaviors.  Importantly, CaMKII can bind the GluN2B subunit of the NMDAR and 
this binding is necessary for LTP and memory formation (Barria and Malinow, 
2005; Zhou et al., 2007; Foster et al., 2010).  Conversely, GluN2A subunit does 
not interact strongly with CaMKII making the GluN2B/CaMKII an important 
complex for plasticity and learning and memory (Strack et al., 2000).  These 
molecules/complexes are good candidates in development for the regulation of 
synaptogenesis, synaptic maturation, and synaptic dynamics.  Indeed the 
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expression of GluN2A acts as a synapse stabilizer where the expression of 
GluN2B is associated with dynamic synapses (Gambrill and Barria, 2011). 
  
Implications for Striatal CaMKII and GluN2B subunit in Parkinson’s 
Disease and Addiction 
Previous studies have linked striatal CaMKII and GluN2B to Parkinson’s 
disease and addiction models.  The active form of CaMKII is elevated following 
dopamine depletion (Picconi et al., 2004b; Brown et al., 2005) and striatal 
CaMKII inhibition rescues deficits in synaptic plasticity and motor behavior found 
in models of Parkinson’s disease (Picconi et al., 2004b).  Striatal CaMKII is 
essential for the motivational effects of reward cues on goal-directed behaviors 
(Wiltgen et al., 2007), as well as curbing D1R-mediated cocaine hyperlocomotion 
(Stein and Hell, 2010), and modulating excitability following chronic cocaine 
administration (Kourrich et al., 2012).  Additionally, both acute and chronic 
amphetamine administration can modulate CaMKII levels in the striatum (Choe 
and Wang, 2002; Greenstein et al., 2007).  GluN2B levels are decreased in 
animal models of Parkinson’s disease (Oh et al., 1999; Dunah et al., 2000; 
Hallett et al., 2005) and antagonists of the GluN2B-containing receptor have 
shown antiparkinsonian actions in both rodents and monkeys (Nash et al., 2000; 
Steece-Collier et al., 2000; Nash et al., 2004).  Various lines of evidence have 
shown that drug-induced craving is accompanied by a significant upregulation of 
GluN2B subunit expression (Ma et al., 2006; Ghasemzadeh et al., 2009; 
Schumann and Yaka, 2009) and blocking GluN2B-containing NMDAR receptors 
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in the striatum can inhibit drug craving and reinstatement (Ma et al., 2006; Ma et 
al., 2007).  In all, these studies suggest that CaMKII or GluN2B inhibitors may 
represent potential useful approaches to treat Parkinson’s disease 
symptomology and potentially disrupt or reset the maladaptive alterations in 
glutamatergic transmission seen in addiction.             
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